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gdT Cells Regulate the Development of Hapten Speci®c Effector T Cells in Contact
Hypersensitivity Responses
H. Guan, C. Elmets, and H. Xu
Dermatology, University of Alabama at Birmingham, Birmingham, Alabama
gdT cells are widely located in the peripheral tissues and secondary lymphoid organs. It has been
reported that gdT cells are required for transfer of contact hypersensitivity (CHS) responses by
hapten primed T cells. However, the mechanism by which they do so remains to be elucidated.
Initial experiments employed Td gene knockout mice that are de®cient in gdT cells but are normal
in the development of abT cells. When mice were contact sensitized to DNFB, CHS responses
were signi®cantly greater in gdT cell de®cient mice than in wild type mice. Similar results were
obtained when wild type mice were depleted of gdT cells with antibody treatment before hapten
sensitization. Depletion of CD4+ T cells did not affect the increased CHS response in gdT cell
de®cient mice, suggesting that the effect of gdT cells is on CD8+ T cells and does not require
CD4+ T cells. Transfer of primed lymph node cells from hapten primed gdT cell de®cient mice
elicited a similar level of CHS in naõÈve wild type and the de®cient recipient mice, indicating that
gdT cells have little effects on the elicitation of primed T cells and CHS responses. Further
experiments demonstrated that primed CD8+ T cells from the de®cient mice exhibited
signi®cantly higher CTL activity than those from the wild type mice. The cytokine pro®le of
CD4+ T cells was not signi®cantly altered. We conclude that gdT cells down-regulate CHS
responses to hapten sensitization by limiting the development of hapten speci®c CD8 + effector T
cells during sensitization and that this effect is independent of CD4+ T cells.
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Expression of b-Defensins in Human Keratinocyte Cell Lines
S. Seo, S. Ahn, and C. Hong
Dermatology, College of Medicine, Chung-Ang University Hospital, Seoul, South Korea
Defensins, a major family of antimicrobial peptides, are small cationic, cysteine-rich peptides with a
wide range of antimicrobial activity. In human, b-defensin-1 was isolated from urine and cervical
mucous suggesting that this peptide plays an antimicrobial role in the genitourinary tract. b-
defensin-2 was identi®ed in psoriatic scale produced by keratinocytes suggesting that this peptide
contribute to defense the expansive surface of the integuments. This work was done to investigate
the expression and modulation of b-defensin mrna in human keratinocyte cell lines. Cultured
human keratinocytes were stimulated with ultraviolet B irradiation or tumor necrosis factor-a or
lipopolysaccharide to determine whether defensin mrna production occurred. Reverse transcrip-
tion polymerase chain reaction was performed to amplify defesin cDNA from stimulated
keratinocytes, and Southern blots were used to verify the speci®city of Reverse transcription
polymerase chain reaction amplication products. Expression of human b-defensins was up-
regulated with ultraviolet B irradiation, tumor necrosis factor-a and lipopolysaccharide in Hacat
cells and in comparison to the control, signi®cantly higher at 6 h post stimulation with ultraviolet B
100 mJ/§2 and peak at 12 through 18 h post stimulation with ultraviolet B 30 mJ/§2, tumor
necrosis factor-a and lipopolysaccharide. A431 cells did not show expression of human b-defensins
in unstimulated state, even after stimulation with ultraviolet B irradiation or tumor necrosis factor-
a or lipopolysaccharide. This report demonstrates the presence of defensin in the human
keratinocyte and th capacity of human keratinocytes to produce defensin mRNA in response to
ultraviolet B irradiation, tumor necrosis factor-a and lipopolysaccharide. Release of defensins by
keratinocytes in response to cytokines elaborated in in¯ammation may contribute to the host
defense response.
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Cathelicidin Antimicrobial Peptides Affect Adaptive Immunity by Regulation of
Cytokine Production
D. Lee, R. Dorschner,* and R. Gallo
Medicine/Pediatrics/Dermatology, U of California San Diego, San Diego, California; *Dermatology, VA
San Diego, San Diego, California
Cathelicidins are a-helical cationic peptides expressed by keratinocytes and granulocytes that are
thought to be important mediators of innate immunity due to their direct antimicrobial action. To
determine if their expression may in¯uence adaptive immunity, cytokine responsiveness was
measured in murine T cells, the Langerhans cell line XS52, and the human keratinocyte line HaCat
after exposure to cathelicidins. Splenocytes or CD4-puri®ed cells were stimulated with anti-CD3
and anti-CD28. At physiologic concentrations the murine cathelicidin CRAMP inhibited release
of IL4 by 78% (1096 6 249 vs. 241 6 16 pg per ml), IL13 by 88% (2884 6 874 vs. 357 6 31 pg
per ml), and IFNg by 67% (7571 6 1539 vs. 2464 6 823 pg per ml). CRAMP did not affect IL6
production (368 6 19 vs. 325 6 26 pg per ml). Similarly, CRAMP inhibited IL1 b production
from LPS stimulated XS52 cells (368 pg per ml 6 113 vs. 234 6 15), though in the absence of LPS
it stimulated IL1b release from undetectable baseline to 47.83 6 6 pg per ml. The human
cathelicidin LL-37 stimulated HaCat cells to produce IL1a (17 pg per ml 6 3 vs. 1.44 6 0.79 at 5
h) and IL6 (524 pg per ml 6 14 vs. 308 6 11 at 24 h). To determine if the decrease in cytokines was
due to direct cytotoxic effects, viability and apoptosis was determined by propidium iodide (PI)
staining and FACS analysis. CRAMP increased cell death in splenocytes (at 3 h, 19.5 6 1.7 sd. vs.
35.4 6 5.4%), and cellular debris with sub G0 DNA content (at 24 h, 12.6 6 0.5 vs. 17.4 6 1.7%).
These results show that depending on the state of cell activation cathelicidins can inhibit or induce
cytokines from T-cells, antigen presenting cells and keratinocytes. This suggests innate
antimicrobial peptides may in¯uence subsequent events in the adaptive immune response. Such
an interation is a previously unknown event in cutaneous immunity that may play a role in several
skin diseases.
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Analysis of the Regulation of Cathelicidin Antimicrobial Peptides in the Keratinocyte
Line HaCaT
V. Pestonjamasp, V. Morhenn, and R. Gallo
Dermatology, U of California San Diego, San Diego, California
Cathelicidins are a gene family of peptides that can directly kill bacteria while also inducing
eukaryotic cell effects such as leukocyte chemo-attraction and synthesis of extracellular matrix
components. Human cathelicidin (LL-37), is not detected in normal epidermis but is expressed in
skin disorders such as psoriasis, contact dermatitis and wound healing. Similarly, murine
cathelicidin (CRAMP) is induced in skin only when the normal skin is injured. Therefore,
cathelicidin expression may provide antimicrobial resistance to the skin and be bene®cial to wound
repair. To investigate the mechanisms that lead to cathelicidin expression, we have stimulated
HaCaT cells with known mediators of in¯ammation. Using quantitative RT-PCR by light-cycler,
we ®nd that the tumor promoter, phorbol myristate acetate (PMA), regulates the LL-37 expression
in a time- and concentration-dependent manner. Human recombinant interferon-g (IFN-g) also
modulates cathelicidin expression in a time-dependent fashion. In addition, we have detected LL-
37 protein synthesis in response to IFN-? by dot blot analysis. Our preliminary data also implicate
bacterial lipopolysaccharide (LPS) as a positive signal for induction of LL-37 expression in HaCat.
To further study the regulation of cathelicidin expression, truncations of the 5¢ ¯anking region of
the murine cathelicidin CRAMP gene have been carried out. These constructs were cloned into a
luciferase reporter system and the luciferase activity determined in a variety of cell types.
Preliminary data indicate evolutionarily conserved regions of the CRAMP promoter that regulate
gene expression. In conclusion, we show that cathelicidin expression can be modulated in response
to in¯ammatory mediators. Since cathelicidins are versatile molecules with multiple functions in
protecting the skin, these results offer a system that has potential applications for the therapy of
human skin disorders.
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Altered Cutaneous Immune Parameters in Transgenic Mice Over-Expressing Viral IL-
10 in the Epidermis
W. Ding, S. Beissert,* L. Deng, C. Cassetty, K. Seiffert, Z. Yan,² J. Wagner,² J. Bluestone,² and
R. Granstein²
Dermatology, Weill Medical College of Cornell University, New York, New York; *Dermatology,
University of Muenster, Muenster, Germany; ²Medicine, University of Calif.ornia, San Francisco, San
Francisco, California
IL-10 is a pleiotropic cytokine that inhibits several immune parameters including Th1 cell-
mediated immune responses and cytokine production, antigen presentation, and antigen-speci®c T
cell proliferation. In some systems, IL-10 augments Th2-type responses. Recent data implicate IL-
10 as a mediator in the suppression of cell-mediated immunity induced by exposure to midrange
ultraviolet radiation (UVB, 280±320 nm). Viral IL-10 (vIL-10) is ~80% identical with human IL-
10 and also exhibits considerable sequence homology with mouse IL-10. To investigate the effects
of IL-10 on the cutaneous immune system, we developed transgenic mice over-expressing vIL-10
in the epidermis. Epidermal cells from vIL-10 transgenic mice produced vIL-10 in culture and vIL-
10 could be detected in serum. I-A-positive epidermal cells and dermal dendritic cells were
reduced in number although the density of epidermal ATPase-positive cells appeared to be normal
in epidermal sheets. After hapten painting of the skin, the number of I-A-positive, hapten-bearing
cells detected in regional lymph nodes was reduced in vIL-10 transgenic mice compared to
controls. CD80 and CD86 expression by I-A-positive epidermal cells was reduced in vIL-10
transgenic mice. After immunization with allogeneic cells, these mice demonstrated a signi®cantly
smaller delayed-type hypersensitivity (DTH) response to allogeneic cells upon challenge, but had
normal contact hypersensitivity to an epicutaneously applied hapten. Fresh EC from vIL-10
transgenic mice showed a decreased ability to stimulate allogeneic T cell proliferation. Our data
demonstrate the ability of vIL-10 to alter LC physiology and inhibit DTH. These ®ndings support
the concept that IL-10 is an important regulator of cutaneous immune function.
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Comparison of g-Interferon Signal Transduction in Monolayer and Scaffold-Based
Three-Dimensional Fibroblast Culture
J. Mansbridge, K. Liu, and A. Kern
Research, Advanced Tissue Sciences, La Jolla, California
When ®broblasts in monolayer culture are treated with g-interferon (IFN-g), HLA-DR is induced
and CD-40 is stimulated. By contrast, ®broblasts grown in three-dimensional culture on a scaffold
show a major nonresponsive cell population. We have found that other IFN-g-induced genes,
including HLA class I and ICAM-1, show monotonic induction by all the cells in three-
dimensional culture. We have investigated this system by immunoblot and by Taqman real time
PCR to determine to what extent the IFN-g-related signal transduction systems of the cells are
affected by three-dimensional scaffold-based culture. Examination of STAT-1 phosphorylation by
immunoblot has shown that this activity is essentially indistinguishable between monolayer and
three-dimensional culture, indicating that the early stages of the IFN-g signal transduction pathway
are intact. We have examined the induction of the transcriptional regulator CIITA, which controls
the expression of the HLA-DR region through interaction with DNA-binding proteins.
Quantitative estimation of mRNA for CIITA has demonstrated it is induced in three-dimensional
culture but only reaches a cellular concentration of a quarter that in monolayer. This may be
accounted for by the minority of cells that shows induction. Thus, inhibition of transactivator
expression is able to account for the lack of HLA-DR induction. In an examination of MAP
kinases, we have found that p38 is not activated in three-dimensional culture as it is in monolayer.
We conclude that the IFN-g signal transduction systems is intact as far as STAT-1 phosphorylation,
but inhibition of HLA-DR and CD40 induction is caused by lack of expression of CIITA. This
effect may, in part, explain the lack of rejection of allogeneic ®broblasts cultured in this way.
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Dietary Soy Oil Content, and Soy Oil Derived Genistein Affect Susceptibility to
Alopecia Areata in C3H/HeJ Mice
K. McElwee, S. Nijyama, E. Wenzel, P. Freyschmidt-Paul, J. Sundberg,* and R. Hoffmann
Dermatology, Philipps University Hautklinik, Marburg, Germany; *Dermatology, The Jackson Laboratory,
Bar Harbor, Maine
Alopecia areata (AA) is a suspected autoimmune disease expressed in humans and rodent models.
While oligogenetic susceptibility to AA is likely, epi-genetic factors may also affect AA expression.
Diet as a susceptibility and severity modi®er of AA in C3H/HeJ mice was examined. Prior to the
experiment, all mice received a standard commercial diet of 1% soy oil (4% total fat). Normal
haired C3H/HeJ mice were grafted with AA affected skin, a method previously shown to
successfully induce AA. Grafted mice were given one of three diets. Twenty-eight mice continued
to receive a 1% soy oil diet. Twenty-eight mice received a commercially available diet with 5% soy
oil (7.5% total fat). Eleven mice received a diet with 20% soy oil (23% total fat) formulated by the
animal diet manufacturer using the 1% soy oil diet as a base and additional soy oil from the same
source. In a second study, 10 grafted mice were injected with 1 mg of the phytoestrogen genistein
per week for 10 weeks and compared to 10 age matched mice receiving drug vehicle. Mice were
monitored for at least 20 weeks after skin grafting and then necropsied. Twenty of 28 mice (71%)
on the diet containing 1% soy oil developed AA hair loss by the time of necropsy whereas 11 of 28
mice (39%) on a 5% soy oil diet developed AA. Two of 11 mice (18%) fed a 20% soy oil diet had
hair loss. Four of 10 mice injected with genistein and all 10 control mice developed AA. Mice that
failed to develop AA typically regrew white hair from their skin grafts and histology revealed no
apparent in¯ammation. Of those mice that expressed AA, no signi®cant association was observed
between the extent of hair loss and diet. Mice with AA had hair follicle in¯ammation consistent
with observations for spontaneous mouse AA. The results suggest that soy oil may contain
compounds with indirect or direct immunomodulatory properties that modify susceptibility to AA
in mice and soy phytoestrogen genistein is a likely candidate.
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Characterizing C3H/HeJ Mice with Apparent Resistance to Alopecia Areata Onset
E. Zoller, K. McElwee, E. Wenzel, P. Freyschmidt-Paul, J. Sundberg,* and R. Hoffmann
Dermatology, Philipps University Hautklinik, Marburg, Germany; *Dermatology, The Jackson Laboratory,
Bar Harbor, Maine
Spontaneous alopecia areata (AA) develops in up to 20% of C3H/HeJ mice. The disease can also
be induced in normal haired mice by grafting AA affected skin to their dorsal surface. Dietary Soy
oil content and other environmental factors can reduce host susceptibility to AA onset after
grafting. Mice that failed to develop AA after grafting were characterized by gross observation,
adoptive transfer of lymphocytes, and FACS analysis of skin, lymph nodes and spleen cells. Sixteen
mice that received AA affected skin grafts but failed to develop AA, received further AA affected
skin grafts 15 or more weeks after the initial surgery of which 2 developed overt hair loss. In
contrast, 14 of 19 control mice developed AA. Subcutaneous injection of 107 lymph node or
spleen cells from grafted mice that failed to develop AA to 10 normal haired mice induced AA in 2.
AA affected skin revealed an increased percentage of CD4+ , CD8+ and sIgM+ cells, an increase
in IL-2, IL-4, IL-6, IL-10, IL-12, IFNg and TNFa cytokine production, and strong up-regulation
of the activation markers CD28, CD40L and their ligands CD80 (B7-1), CD86 (B7-2) and CD40.
In skin draining lymph nodes high numbers of monocytes and dendritic cells were present and
CD44v3, CD44v7 and CD44v10 were down regulated. In contrast, mice with failed AA induction
had high numbers of monocytes and dendritic cells in the skin, increased expression of IL-2, IL-4,
IL-10 and IFNg, and down-regulated expression of CD95L and CTLA4. The results suggest that
exposure to a variety of factors in AA affected skin grafts promotes disease onset or resistance to AA
depending on the environment in which the stimulatory factors are presented. The costimulatory
role of CD80, CD86 and their lymphocyte expressed ligands CD28 and CTLA4 may play a
signi®cant role in AA development. Examination of AA resistant mice may elucidate mechanisms
of disease tolerance induction and will identify new therapeutic targets.
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Melanocyte Antingens Induce Expression of Mediators of Apoptosis in Melanocyte
Speci®c T Cells in Vitiligo
R. Tackey, C. Walters, and R. Halder
Dermatology and Medicine, Howard University College of Medicine, Washington, District of Colombia
The immunological processes that mediate melanocyte destruction in vitiligo have recently been
under renewed study. In this study, the role of melanocyte speci®c T cells and the expression of
speci®c markers that mediate their response to melanocyte antigens were studied in vitro. Whole
blood or isolated peripheral blood lymphocytes (PBL) from vitiligo patients and normal controls
were exposed to melanocyte antigens for 18±96 h. Post activation cells were stained with
¯ourecein labeled anti-CD3, CD69, CD28, CD95L, CD25, CLA, HLA-DR, and Annexin V.
Flow cytometric analysis for activated cells, costimulatory molecules, skin homing receptor (CLA),
apoptosis inducing molecules and apoptosis showed that 13 of 18 patients had increased expression
of CD69 compared to controls. In this population, up-regulation of CD28 correlated with the
presence of large number of cells with increased expression of MHC Class-II antigen, an indication
that response to melanocyte antigens is a T cell receptor (TCR) mediated event. In addition, there
was a 2-fold increase in CLA+ cells expressing CD95L. Annexin V stain revealed 0.5±2.7%
increases in early apoptotic cells from vitiligo patients over normal control. These results suggest
that destruction of melanocytes in susceptible patients may involve costimulatory, activation, and
apoptotic molecules expressed by skin homing melanocyte-speci®c T cells.
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Osteopontin (OPN) De®cient Mice are Impaired in their Function to Attract Dendritic
Cells to Lymph Nodes which Correlates with a Reduced Cutaneous Contact
Hypersensitivity (CHS) Response
A. Renkl, J. Weiss, M. Kimmig, L. Liaw,² T. Ahrens, K. Thoma,* H. Hotta,* T. Uede,* and J.
Simon*
Department of Dermatology, University of Freiburg, Freiburg, Germany; *Institute for Genetic Medicine,
Hokkaido University, Hokkaido, Japan; ²Center of Molecular Medicine, Maine Medical Center Research
Institute, Portland, Maine
OPN is a chemotactic protein that attracts in¯ammatory cells. The sensitization phase of cutaneous
CHS is crucially dependent upon the migration of antigen-carrying Langerhans cells/dendritic cells
(LC/DC) from the skin to draining lymph nodes (LN). Investigating the expression of OPN in the
sensitization phase of CHS we found that OPN mRNA is up-regulated both in the TNCB hapten
sensitized skin and in LN draining such skin after hapten application. Within skin especially
endothelial cells expressed OPN. Speculating that OPN expression could be a crucial factor in
attracting DC to lymphatic organs, we investigated the role of OPN in DC traf®cking. Migration-
assays revealed that OPN-induced DC migration in a chemotactic manner. In vivo s.c. injected
OPN initiated LC emigration from the epidermis and OPN injected in close proximity to LN
draining the skin attracted DC into these nodes. The OPN receptors CD44 and avb3 integrin are
known mediators of OPN induced cell migration. We found both receptors on DC upon their
maturation in bone-marrow cultures. Antibodies against av and CD44 partially blocked OPN
mediated LC/DC migration in vitro and in vivo. When ultimately investigating OPN function in
vivo we found that OPN de®cient mice had a signi®cantly reduced CHS response to TNCB.
Furthermore, when wild type DC were injected into OPN de®cient mice, migration of DC to
regional LN was reduced dramatically compared to wild type mice. In conclusion we demonstrate
that OPN is a crucial factor in the initiation of CHS by guiding DC from skin into lymphatic
organs.
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IL-4 Inhibits TNF-a-Induced Vascular Endothelial Growth Factor (VEGF) Production
by Human Keratinocytes
K. Nakamura, M. Komine, and K. Tamaki
Dermatology, Univerrsity of Tokyo, Tokyo, Japan
Vascular endothelial growth factor (VEGF) promotes endothelial cell growth, lymphatic vessels
growth or leukocyte migration. Enhanced immunoreactivity of VEGF has been detected in the
lesional skin of psoriasis, metastatic melanoma or Kaposi's sarcoma. We investigated the effects of
various cytokines (IL-1b, TNF-a, IL-4, IL-6, IL-7, IL-8 and TGF-b) on VEGF production by
human keratinocytes (KCs) cell lines, HaCaT cells in vitro. Both IL-1b (10 ng per ml) and TNF-a
(10 ng per ml) signi®cantly enhanced VEGF production for 48 h culture to 901.1 6 102.2 pg per ml
and 1526.0 6 215.5 pg per ml, respectively. IL-4 (10 ng per ml) alone slightly inhibited VEGF
production by KCs (22.3 6 3.6%), but IL-6, IL-7, IL-8 or TGF-b did not signi®cantly change this
production. TNF-a (10 ng per ml)-induced VEGF production was signi®cantly inhibited when
HaCaT cells were cocultured with IL-4 (10 ng per ml) for 48 h to 37.4% (956.3 6 140.3 pg per ml
(IL-4 with TNF-a) v.s.1526.0 6 248.0 pg per ml (TNF-a alone)). This inhibitory effect of IL-4 on
TNF-a-induced VEGF production was observed at both dose and time dependent manner. RT-
PCR and Northern blot analysis revealed that TNF-a-induced-VEGF mRNA was inhibited by
IL-4 for 48 h culture, indicating that this inhibition occurred at mRNA levels. These data suggest
that VEGF production by KCs can be modulated by Th2 cytokines and this suggest the possibility
of future therapeutic approach for vascular proliferative disorders by selective cytokine such as IL-
4.
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The Role of Reactive Oxygen Species in the Expression of Endothelial Adhesion
Molecules in Allergic In¯ammation
K Lee, Y. Choi, and J. Ro*
Dermatology, Yonsei University College of Medicine, Seoul, South Korea; *Pharmacology, Sungkyunkwan
University School of Medicine, Suwon, South Korea
In the pathogenesis of allergic diseases, such as atopic dermatitis, the expression of adhesion
molecules and subsequent adhesion of in¯ammatory cells to endothelial cells is necessary. It is
known that reactive oxygen species (ROS) are important second messengers in this process. We
studied the effect of allergic reaction-related cytokines on production of ROS and the role of ROS
in the expression of adhesion molecules in human dermal microvascular endothelial cells
(HDMEC). ROS and adhesion molecules were determined by FACstar and ELISA, respectively,
after stimulation with IL-1a, TNF-a, IL-4 and IL-13. Stimulation of HDMEC with IL-1a, TNF-
a, IL-4 and IL-13 increased production of ROS. The expression of ICAM-1, VCAM-1 and E-
selectin was up-regulated or induced by IL-1a, TNF-a and the expression of VCAM-1 was
induced by IL-4, or IL-13. Stimulation of HDMEC with H2O2 up-regulated or induced the
expression of ICAM-1, VCAM-1 and E-selectin but there was no synergistic effect between
cytokines and H2O2. The expression of adhesion molecules up-regulated or induced by cytokines
was inhibited by antioxidants. These ®ndings suggest that ROS play an important role in the
expression of ICAM-1, VCAM-1 and E-selectin induced by allergic reaction-related cytokines and
pharmaceutical approaches manipulating reduction-oxidation mechanism would be a new
therapeutic approach for allergic diseases.
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CCR4 Expression on Human Dermal Microvascular Endothelial Cells
K. Ferenczi, G. Pinkus,* J. Pinkus,² and T. Kupper³
Harvard Skin Disease Reaserch Center, Brigham and Women's Hospital, Boston, Massachusetts;
*Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; ²Department of
Pathology, Brigham and Women's Hospital, Boston, Massachusetts; ³Harvard Skin Disease Research
Center, Brigham and Women's Hospital, Boston, Massachusetts
There is increasing evidence that the expression of certain chemokine receptors is not restricted to
leukocytes, suggesting that they may play a role in processes others than leukocyte chemotaxis.
Recently, it has been shown that certain chemokine receptors are expressed on endothelial cells.
Little is known, however, about the expression of chemokine receptors on microvascular
endothelial cells. In this study we show that the chemokine receptor CCR4, recently described as
being associated with skin homing T cells, is expressed on human dermal microvascular endothelial
cells (HDMEC). CCR4 expression in skin was demonstrated by immunohistochemistry. CCR4
immunostaining in normal skin and diseased skin (cutaneous T cell lymphoma) showed a
constitutive CCR4 expression by dermal microvessels in normal skin and strong expression in
lesional skin. Flow cytometric analysis con®rmed CCR4 expression and showed that around 15%
of cultured HDMEC are CCR4 positive. To gain more insight into the function of CCR4 on
HDMEC, we examined the effect of the two CCR4 ligands, TARC (thymus and activation-
regulated chemokine) and MDC (macrophage-derived chemokine) on the expression of adhesion
molecules that mediate leukocyte adhesion to endothelial cells. We found that addition of TARC
and MDC separately resulted in a twofold increase in baseline E-selectin expression on HDMEC.
When TARC and MDC were added together a threefold increase was seen. In contrast, addition
of TARC and MDC had no effect on the constitutive expression of ICAM-1 on HDMEC. These
data suggest that release of TARC and MDC in the dermis may enhance the af®nity of cutaneous
postcapillary venules for CLA + T cells.
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The Neuropeptide a-MSH Acts as a Human Dermal Microvascular Endothelial Cell
Survival Factor in Hypoxia
D. Kalden, T. Brzoska,* G. Burbach, T. Scholzen,* R. Lang, R. Swerlick, C. Armstrong, T.
Luger, and J. Ansel
Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia; *Ludwig Boltzmann
Institute of Cell Biology and Immunobiology of the Skin, Department of Dermatology, University of
Muenster, Muenster, Germany
Human dermal microvascular endothelial cells (HDMEC) play a key role in regulating cutaneous
homeostasis and in¯ammatory responses in the skin. Hypoxic stress activates endothelial cells (EC)
to release growth factors and pro-in¯ammatory mediators. In addition hypoxia may result in EC
death, which contributes to ischemia and tissue injury. Little is currently known about the
mechanism of EC death in response to hypoxia. a-MSH is a potent inhibitor of in¯ammation, and
HDMEC are known to be both an a-MSH target and source of a-MSH. The plasma
concentration of a-MSH is also raised during acute ischemia. Therefore, the aim of the present
study was to test the ability of a-MSH to in¯uence the survival of HDMEC under hypoxic
conditions. HDMEC were cultivated under hypoxic conditions (0.5% O2) for 24±36 h with
increasing concentrations of a-MSH (10-14±10-8 M). Cell viability was tested using a MTT based
assay, EC were also stained for apoptotic bodies and the a-MSH precursor proopiomelanocortin
(POMC) mRNA expression was determined by quantitative RT-PCR. Our results indicated that
hypoxia signi®cantly reduces cell viability and leads to the induction of apoptosis in HDMEC. In
contrast, treatment with a-MSH prevented hypoxia-induced cell death in a concentration
dependent manner, whereas TNF-a induced cell death is not affected by a-MSH. In addition, the
expression of HDMEC POMC mRNA was markedly increased under hypoxic conditions. These
data provide the ®rst evidence that a-MSH, in addition to its anti-in¯ammatory capacity, may
serve as a survival factor for HDMEC during hypoxic conditions and suggests that it could be used
therapeutically in various cutaneous ischemic conditions such as vasculitis and chronic ulcers.
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E-Selectin is Constitutively Expressed by Dermal Blood Vessels: A Targeting
Mechanism for Skin-Speci®c Immunosurveillance by CLA+ Memory T Cells
B. Chong,* J. Murphy, T. Kupper, and R. Fuhlbrigge
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; *School of Medicine, Johns Hopkins
University, Baltimore, Maryland
The mechanisms regulating recruitment of memory T cells to skin are of central importance in
immune surveillance for invading pathogens and developing malignancies. Induction of E-selectin
(CD62E) on the vessel endothelium in response to in¯ammation permits tethering and rolling of
skin-homing T cells expressing the Cutaneous Lymphocyte-associated Antigen (CLA), the
required ®rst step in leukocyte recruitment. While this process is well established for sites of
cutaneous in¯ammation, the role of this pathway in immunosurveillance has been subject to
controversy. Both E- and P-selectin are reported to be absent on routine immunohistochemistry of
nonin¯amed tissues. We have shown previously, using intravital microscopy, that CLA+ human T
cells and blood dendritic cells form spontaneous rolling interactions in the dermal postcapillary
venules of unmanipulated mouse ears. This has been shown to re¯ect constitutive expression of
selectins on mouse ear dermal microvessels. To determine if similar constitutive expression exists in
human skin, we stained sections of normal unin¯amed human skin for CD62E. Skin samples from
three separate donors (face, breast and abdomen obtained from cosmetic surgical specimens)
showed constitutive expression of E-selectin on a subset of vessels near the dermal-epidermal
junction. None of these patients had clinical evidence of an in¯ammatory skin condition, nor did
the skin samples show cellular in®ltrates indicative of a subclinical in¯ammatory process. Serial
sections stained with anti-CD31 showed numerous vessels throughout the sections that did not
stain with anti-CD62E. Comparison sections from a patient with mycosis fungoides revealed
numerous vessels staining with E-selectin within the tumor. Constitutive selectin expression in skin
microvessels provides a mechanism for recruitment of CLA+ memory T cells to unin¯ammed skin
and suggests an opportunity for selective inhibition or augmentation of normal and malignant T
cell recirculation through skin in the therapy of in¯ammatory and malignant skin disorders
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Agonists of Protease-Activated Receptor-2 Induce Secretion of Interleukin-1b and Up-
Regulation of Cell Adhesion Molecules in Human Dermal Microvascular Endothelial
Cells
M. Steinhoff, V. Shpacovitch, T. Brzoska, N. Bunnett,³ C. Sommerhoff,² J. Ansel,* and T. Luger
Dermatolgy, University of Muenster, Muenster, Germany; *Clinical Chemistry, University of Munich,
Munich, Germany; ²Dermatology, Emory University, Atlanta, Georgia; ³Surgery, University of California,
San Francisco, California
Protease-activated receptor 2 (PAR2) belongs to a new subfamily of G protein-coupled receptors
for serine proteases such as mast cell tryptase. Tryptase cleaves PAR2 and thereby induces
cutaneous in¯ammation and in®ltration of neutrophils. Recently we have shown that PAR2 plays
a crucial role in cutaneous neurogenic in¯ammation. However, the precise role of PAR2-induced
vascular responses during cutaneous in¯ammation is still uncertain. Therefore, we were interested
in whether or not human dermal endothelial cells (HDMEC) express functional PAR-2 and
whether agonists of PAR2 may regulate in¯ammatory responses in these cells. We detected
expression of PAR2 in HDMEC cells by immunohistochemistry, FACS analysis and Northern
blotting. Ca-mobilisation studies revealed that PAR-2 is functional in these cells. RT PCR
showed up-regulation of IL-1b at 6 h after stimulation with tryptase and PAR2 agonist SLIGKV.
ELISA experiments con®rmed these results. We also investigated cell adhesion molecule expression
after PAR2 activation by RT PCR and adhesion assay. ELAM-1 mRNA was up-regulated at 6 h
and 9 h, VCAM-mRNA was up-regulated at 9 h, and ICAM-1 mRNA was up-regulated at 3 h
after treatment with PAR2 agonists. In addition, cell adhesion assays demonstrated conclusive
results. PAR-2 like immunoreactivity was increased in endothelial cells of patients with atopic
dermatitis and urticaria indicating up-regulation of this receptor in endothelial cells during
cutaneous in¯ammation. Electro mobility shift assays revealed PAR2-induced activation of NFkB.
In conclusion, agonists of PAR-2 up-regulate IL-1b expression and release as well as expression of
cell adhesion molecules in human dermal microvascular endothelial cells. Thus, PAR-2 may play
an important role in cutaneous in¯ammation by mediating in¯ammatory responses of mast cell
tryptase on endothelial cells and activation of NFkB.
413
Expression of Toll Like Receptors in Human Keratinocytes
B. Vega-Diaz and S. Michel
In Vitro Studies, Galderma R & D, Sophia Antipolis, France
Members of the Toll like receptor (TLR) family are involved in host defense and in¯ammation and
are usually expressed by cells of the immune system such as macrophages. Since keratinocytes play a
role in the skin immune response, we have determined if they may express the different members
of the TLR family. The presence of mRNAs encoding TLRs was determined in cultured human
keratinocytes by using RT-PCR. TLRs 1, 2, and 3 were strongly expressed, while TLR 4 was
weakly detected. TLR 6 was undetectable. The positive expression of TLR2 in keratinocytes
prompted us to assess the functionality of this receptor by treating cells with one of its ligand, a
Gram + bacterial protein extract (SAC). After 8 h of treatment, we showed, by using an ELISA,
that keratinocytes secrete IL12, a cytokine known to be also produced by macrophages after SAC
treatment. Colonization of the skin surface with Staphylococcus aureus is a characteristic feature of
patients with atopic dermatitis. We therefore studied the expression of TLR2 in pooled epidermis
obtained from normal and atopic individuals. Expression of TLR2 was signi®cantly decreased in
disease as compared to normal epidermis. Our study showed, for the ®rst time, the expression of
Toll like receptors in human keratinocytes and that, after stimulation, TLR 2 is able to induce
secretion of IL12. Furthermore, the differential expression of TLR 2 in the epidermis of patients
with atopic dermatitis may indicate a role of this receptor in the pathogenesis of this disease.
414
IL-18 Induces IgE Production in Caspase-1 Transgenic Mice and Wild Type Mice:
Dependence on IL-4 and STAT6
H. Mizutani, K.Yamanaka, H. Konishi, T. Murakami, and K. Nakanishi*
Dermatology, Mie University Faculty of Medicine, Tsu, Japan; *Immunology & Zoology, Hyogo College of
Medicine, Nishinomiya, Japan
Overproduced IgE and Th2 cytokines are characteristic in atopic dermatitis and allergic disorders.
Although IL-4 is critical to the polarization of CD4+ T cells to a Th2 phenotype, the epidermis
derived factors that regulate IL-4 production and Th2 commitment in vivo are poorly understood.
IL-18 that can be produced by keratinocytes and be processed by caspase-1, has strong ability in
IFN-g production from lymphocytes. Paradoxically, IL-18 has capacity to induce IL-4 and/or IL-
13 secretion from NK cells, T cells and mast cells in vitro. To clarify the roles of IL-18 in vivo, we
investigated skin-speci®c caspase-1 transgenic mice (CASP1Tg). CASP1Tg develop severe itching
dermatitis with elevated serum IL-18 and IgE levels and the lesional IL-4 production. These
responses were entirely suppressed in CASP1Tg lacking IL-4, STAT6 or IL-18. Furthermore,
recombinant IL-18 injected into normal mice successfully elevated serum IgE levels. Results
described above indicate that CASP1Tg is a potent model for atopic dermatitis, and caspase-1/IL-
18 may be critically involved in regulation of IgE production in vivo, providing a potential
therapeutic target for atopic dermatitis.
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In Vitro Method for Screening Anti-Irritants on UV and Chemically Treated
Reconstituted Three Dimensional Human Skin
G. Majmudar and L. Fisher
R & D, Mary Kay Inc., Dallas, Texas
A great need exists in the cosmetic, pharmaceutical and biochemical industries for in vitro methods
to screen ingredients, to provide a quick and economical preclinical safety assessment, and to
develop effective products. In the present study we utilized Epiderm(tm), a human skin equivalent
culture, to test anti-irritants in a nonionic cream base. Treating Epiderm with known skin irritants
such as UVA, UVB, SLS and croton oil resulted in a decrease in cell viability and an increase in the
release of IL-1a. Cell viability (MTT) and IL-1a assays were conducted after application of the
irritant or application of an anti-irritant followed by the irritant. A variety of tea extracts, rosemary
extract,carnosic acid and rosemarinic acid (carnosic acid and rosemarinic acid are components of
rosemary) showed protection of the cells against UVB, SLS and croton oil, although to different
degrees. Rosemary extract reduced the release of IL-1a about 80% from the UVB treated
Epiderm. However, carnosic and rosemarinic acids showed 50% inhibition of IL-1a. Green tea
reduced 60% of IL-1 against UVB. Our results also suggest that green tea, rosemary extract,
rosemarinic acid and carnosic acid are able to provide dose related protection against SLS and
croton oil. These in vitro results showed good agreement with previously published and concurrent
clinical tests using anti-irritants in the presence of known irritants. Our results demonstrate the
usefulness of the living skin equivalent and of cell viability and IL-1a as biological markers for the
screening of anti-irritants.
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Immunologic and Histopathologic Characterization of Active Disease Model Mouse for
Pemphigus Vulgaris
M. Ohyama, M. Amagai,* K. Tsunoda,* T. Ota,² S. Koyasu,² J. Hata, A. Umezawa, and T.
Nishikawa
Division of Dermatology, Tokyo Electric Power Company Hospital, Tokyo, Japan; *Department of
Dermatology, Keio University, Tokyo, Japan; ²Department of Microbiology and Immunology, Keio
University, Tokyo, Japan; ³Department of Pathology, Keio University, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease of skin and mucous membranes
caused by antidesmoglein 3 (Dsg3) IgG autoantibodies. Recently, we have generated an active
disease mouse model for PV by adoptive transfer of splenocytes from immunized Dsg3±/± mice to
Rag2±/± mice. Recipient mice stably produced anti-Dsg3 IgG and inhibited adhesive function of
Dsg3 with resultant blister formation. In this study, we performed immunologic and
histopathologic characterization of this model mice and compared histologic features of PV
model mice with those of Dsg3±/± mice. Direct immuno¯uorescence staining showed strong IgG
as well as weak IgA deposition on cell surfaces of keratinocytes in vivo in PV model mice. Enzyme-
linked immunosorbent assay revealed that IgG in PV mice speci®cally recognized mouse Dsg3, but
not mouse Dsg1. The predominant subclass of anti-Dsg3 IgG was IgG1 both in vivo and in vitro.
Suprabasilar acantholysis, typical histologic ®nding of PV, was similarly distributed in oral mucous
membranes as well as on the skin around the eyes, nose, ears, limbs and tails in both PV model
mice and Dsg3±/± mice. Acantholysis in telogen hair club caused patchy alopecia in both mice.
However, microscopic blisters in esophagus and forestomach were only observed in PV model
mice. Furthermore, some PV model mice developed severer phenotype with larger number of
affected sites than Dsg3±/± mice. In addition, eosinophilic spongiosis, which is often found in PV
patients, was occasionally observed only in the skin of PV model mice. These ®ndings indicated
that our PV model mice are valuable to investigate immunopathological mechanisms of blister
formation as well as to evaluate various therapeutic strategies for PV.
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Search for T Cell Epitopes in Pemphigus Vulgaris
C. Willis, A. Moesta, and A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York
Pemphigus vulgaris (PV) is an autoimmune blistering skin disease mediated by autoantibodies
directed against desmoglein 3 (Dsg3), a transmembrane protein involved in keratinocyte adhesion.
Although tissue damage is ultimately mediated by anti-Dsg3 antibodies, an initial T-cell response is
presumably required for autoantibody generation. The strong HLA association of PV to
DRB1*0402 and DQB1*0503 reinforces the hypothesis that T-cell recognition of self and/or
foreign peptides presented by self HLA molecules is a crucial initial step in disease development. A
major focus of autoimmune research has been the precise identi®cation of disease related T-cell
epitopes. To de®ne these epitopes in PV, we have designed a novel strategy which takes advantage
of intracellular processing and presentation events to better capitulate natural ligands. Dsg3 has
been targeted to the class II pathway of antigen presenting cells by transfecting chimeric vectors
encoding intracellular traf®cking signals. For this purpose, we have stably transfected the human
melanoma cell line Mel JuSo (known to have a functional MHC class II antigen processing,
presentation system) to express the disease susceptibility allele DRB1*0402. Additionally, we have
constructed and transfected into DRB1*0402 expressing Mel JuSo cells 4 unique chimeric Dsg3
targeting vectors which utilize one of the following intracellular traf®cking signals to ensure
targeting to the appropriate intracellular compartments: (1) LAMP1 (lysosomal compartment), (2)
LSYTRF (early endosome), (3) Mb (MIIC/late endosomal compartment), and (4) MSSSD
(mutagenized-Mb tail targeting to the cell surface). Expression of these chimeric proteins in Mel
JuSo cells has been con®rmed by RT-PCR and Western blotting. Transfectant cell lines able to
functionally stimulate T cell clones and PBMCs from PV patients will be grown in bulk in order to
biochemically isolate MHC-peptide complexes by immunoaf®nity column puri®cation, followed
by elution of bound peptides. Precise delineation of the presented epitopes will be con®rmed by
mass spectrometry and pooled peptide sequencing.
418
The Distribution of IgG Subclasses in Pemphigus Vulgaris Patients in Active Disease
and in Remission  Comparison of Direct Immunostaining (DIS), ELISA and Western
Blot Data
Y. Milner, M. Frusic-Zlotkin, D. Mimouni,* L. Maron,* D. Goldshmit, and M. David*
Myers Skin Biochemistry Laboratory, Hebrew University of Jerusalem, Jerusalem, Israel; * Rabin Medical
Center, Beilinson Campus, Faculty of Medicine, Tel-Aviv University, Petach Tikwa, Israel
Several investigations on the role of pemphigus vulgaris pathogenic antibodies (PV-IgG) subclasses
revealed a high frequency of apparently pathogenic IgG1 and IgG4 subclasses in patients' sera (Bhol
et al, PNAS 92:5239, 1995; Kricheli et al, Br J Dermatol 143:337, 2000). The aim of this study was
to determine whether their differential distribution in active and remission phases of the disease
might further help in elucidation of the subclasses' pathogenicities. The study group comprised
pairs of active/remission sera of 17 PV patients. The IgG subclasses pro®le was determined using
direct immunostaining (DIS) with peroxidase-conjugated antihuman IgG of perilesional patients'
skin, Dsg 3 ELISA (recombinant desmoglein 3) and Western blot (WB) reactivity with Dsg 3 in
epidermal membrane extracts. Blood and skin biopsies were taken from the patients õÂn the same
day. By ELISA/WB circulating PV-IgG 1 antibodies were found in the sera of 75% patients with
active disease and in the sera of 33% of those in remission. In perilesional skin of PV patients in
remission as well, the occurrence of tissue-®xed IgG1, determined by DIS, was lower (31%) as
compared to their detection in patients with active disease (80%). On the other hand, circulating
IgG4 antibodies were detected in sera of 80% patients with active PV and in sera of 50% patients in
remission. By DIS, 100% of the patients with active PV had IgG4 ®xed to perilesional epidermis,
which was still detectable in 71% of patients in remission. In most of the cases when IgG was
present in a remission counterpart of an active phase sample, it was with much reduced reactivity.
Comparison of ELISA and WB data con®rmed the sensitivity of the latter which, although reacting
with denatured antigens, correlated in 90±100% of the cases to ELISA test which detects native
antigens. The three techniques taken altogether showed a larger decrease in IgG1 occurrence (a
drop of 57%) as compared to IgG4 (a drop of 33%) upon patients' remission. This might indicate
the higher pathogenicity of IgG1 (a complement-®xing antibody). The signi®cance of this ®nding
is being further addressed to in our lab, by an ongoing study of in vitro pathogenicity of isolated
IgG1 and IgG4 PV autoantibodies.
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Production of Human Monoclonal antibodies to Desmoglein 3 from Pemphigus
Vulgaris patient
K. Bhol and A. Ahmed
Department of Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts
Pemphigus vulgaris is a potentially fatal autoimmune mucocutaneous disease associated with
production of IgG autoantibodies to desmoglein 3 (130-kDa protein). To further characterize the
epitope (s) of pemphigus antigen we established two human-human hybridoma by fusion of the
peripheral blood mononuclear cells with a human 3 mouse heterohybridoma. These hybridoma
designated as RP06 and RP10 and stable in culture and demonstrated yield of monoclonal
antibodies speci®c for pemphigus vulgaris. Immuno¯uorescence, immunoblot, ELSA assays
demonstrated that both the monoclonal antibodies bind to the intercellular cement substance and
to 130 kDa protein present in the epidermal lysate and speci®cally binds to recombinant
desmoglein 3 protein, not to desmoglein 1 protein. The epitope mapping experiment using 12
peptides spanning the extracellular domain of pemphigus vulgaris antigen demonstrated that both
the antibodies recognized the Bos 6 peptide and are of IgG1 subclass in nature. Both the
monoclonal antibodies failed to produce acantholysis in normal human skin and unable to induce
disease in neonatal BALB/c mice used in in-vitro and in vivo experiments, respectively. The
relevance of these monoclonal antibodies in the pathogenesis of pemphigus vulgaris is discussed.
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Computer-Driven Individuation of Mouse Monoclonal Antidesmoglein 3 Antibody
De®ned Epitopic Peptide Sequence
D. Kanduc, A. Lucchese, and A. Sinha*
CARSO Cancer Research Center, University of Bari, Bari, Italy; *Dermatology, Weill Medical College of
Cornell University, New York, New York
Utilizing computational biology, we have identi®ed the antigenic linear determinant recognized by
5H10, a mouse monoclonal antibody (mAb) raised against the EC1/EC2 domains (aa1±212) of
desmoglein-3 (Dsg3), the target of autoantibodies in pemphigus vulgaris. The computer-assisted
search for the EC1/EC2 Dsg3 epitope was based on the analysis of (i) the capability of Dsg 3 15-
mer peptides to bind to major histocompatibility complex (MHC) class II molecules and (ii) the
similarity level of the human desmosomal adhesion protein to the mouse proteome. Among the
peptides tested as possible antigenic determinants in dot immunoassay experiments, the anti-EC1/
EC2 Dsg3 mAb 5H10 recognized the peptide having both high binding potential to MHC II
molecules and low level of molecular mimicry to mouse proteome. These data validate previous
results obtained in other disease models (breast cancer-associated-Her2/neu and cervical cancer-
associated-HPV16 E7) and con®rm the concept that peptide ability to bind to MHC molecules
appears a condition necessary but not suf®cient to determine peptide immunodominance, by
needing to be supported by a low degree of similarity to the host's proteome.
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Isotype and Epitope Pro®les of Anti-Desmoglein-1 Autoantibodies in Patients and
Normal Subjects in an Endemic Focus of Fogo Selvagem
M. Lin, L. Arteaga, P. Prisayanh, S. Warren, Z. Liu, and L. Diaz
Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Fogo selvagem (FS) is characterized by subcorneal blisters and antidesmoglein-1 (aDsg1)
antibodies. Disease activity and remission correlate well with levels of IgG4 aDsg1 but not with
levels of IgG1 aDsg1 antibodies (Warren et al Abstr.). IgG1 aDsg1 antibodies are detected in certain
normal individuals and in preclinical stages of FS. The aim of this study was to investigate the
epitope pro®les of aDsg1 IgG isotypes present in FS (n:7) and control sera (n:8) using ELISA,
immuno¯uorescence (IF), immunoblotting (IB) assays and monoclonal subclass-speci®c antihuman
IgG antibodies. Recombinant Dsg1 (rDsg1) was used throughout for ELISA and IB studies and
three tissue substrates, i.e. human (H), monkey (M) and mouse (Mus) for IF assays. The passive
transfer mouse model of FS was also employed. All FS sera (n:7) tested contained IgG1 and IgG4
aDsg1 antibodies but normal control sera (n:8) contained only IgG1 aDsg1 antibodies by ELISA
and IF analysis. IgG1 aDsg1 antibodies from FS sera bound epidermal cell surfaces from H, M, but
not Mus by IF; whereas, control IgG1 aDsg1 bound only M esophagus. Further, FS IgG4 aDsg1
antibodies bound all 3 substrates by IF. IgG1 aDsg1 antibodies from patients (n:7) and controls
(n:8) bound rDsg1 by IB; however, IgG4 aDsg1 antibodies were not reactive with rDsg1 by this
assay. Af®nity-puri®ed aDsg1 antibodies from a control serum were ineffective in inducing skin
disease in mice in a dose 10 times higher than those of pathogenic IgG4 aDsg1 antibodies. These
results strongly suggest that IgG4 aDsg1 antibodies recognize a conformational epitope(s) on Dsg1
and IgG1 aDsg1 antibodies bind sequential and species-speci®c epitopes. The autoimmune
response in FS may undergo epitope spreading during isotype switching from nonpathogenic IgG1
in the preclinical stages to pathogenic IgG4 when FS is clinically apparent.
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Analysis of T-Cell Receptor Vb and Jb usage in Pemphigus Foliaceus
A. Moesta, M. Lin,* L. Diaz,* and A. Sinha
Dermatology, Weill Medical College of Cornell University, New York, New York; *Dermatology,
University of North Carolina, Chapel Hill, North Carolina
Analysis of T-cell receptors (TCR) is critical to further our understanding regarding mechanisms of
T-cell epitope selection and autoimmune initiation and progression. Pemphigus foliaceus (PF) is an
autoimmune skin disease characterized by intraepidermal blisters and circulating autoantibodies
directed against desmoglein 1 (Dsg1), a 160 KD transmembrane desmosomal molecule expressed in
keratinocytes. Although tissue damage is mediated by anti-Dsg1 antibodies, an initial T-cell
response is a likely requirement for autoantibody generation in this disease. To further elucidate the
role of pathogenic T-cells in autoimmunity, we have directly characterized the TCR of T-cells
derived from PF patients. Complimentary DNA (cDNA) was isolated from 17 Dsg1 speci®c T-cell
clones generated from PF patients by clonal expansion in vitro. To analyze the T-cell repertoire, a
panel of primers, collectively speci®c for the known human TCR b variable region families were
paired with a constant region primer to PCR amplify one distinct Vb allele for each T-cell clone
studied. PCR products were sequenced to determine exact b chain gene usage. Overall, 10
different Vb gene segments were used. Five of 17 T-cell clones were found to utilize the same Vb
gene segment-Vb5.1. However, no other particular Vb subfamily was expressed more than twice.
Nine different Jb segments were utilized; Jb2.5 was found in 4 of 16, and Jb1.6 was found in 3 of
16 T-cell clones. While the selection of V and J gene segments was not randomly distributed, there
was not exclusive usage of any single Vb or Jb segment. Instead, we demonstrate oligoclonality.
Moreover, TCR gene usage varies within a given patient, indicating that disease induction and/or
progression is not dependent on only one set of TCR gene segments.
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A Subset of Pemphigus Foliaceus Patients Possess Both Pathogenic Anti-Desmoglein-1
and Anti-Desmoglein-3 Antibodies
L. Arteaga, J. Warren, P. Prisayanh, Z. Liu, L. Diaz, and M. Lin
Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are distinct cutaneous autoimmune diseases
characterized by intraepidermal blisters and antidesmoglein-1 (aDsg1) and antidesmoglein-3
(aDsg3) antibodies, respectively. PV patients exhibit aDsg3 antibodies, which in 50% of the
patients are mixed with aDsg1 antibodies. We have shown that af®nity-puri®ed aDsg1 and aDsg3
antibodies from PV patients are pathogenic, inducing features of each disease in mice. Moreover,
clinical and serological transition from PV to PF has been reported in few patients. The majority of
PF patients; however, show mainly aDsg1 antibodies. A recent report describes a transition from
PF to PV in a single patient. The aim of this study was twofold: (a) to investigate the presence of
aDsg1 and aDsg3 in a large group of PF patients (n:276) by a highly sensitive ELISA and
immunoprecipitation (IP) assays and (b) to test the pathogenicity of aDsg1 and aDsg3 antibodies in
the mouse model. Puri®ed soluble fractions comprising either the ectodomain of rDsg1 or rDsg3
were generated in the baculovirus system and used in the assays. We detected aDsg1 antibodies in
all PF sera tested (100%) and aDsg3 antibodies in 19 PF sera (7%) using ELISA and IP tests. To
further verify the speci®city of both autoantibodies, an inhibition ELISA was employed using
known amounts of puri®ed rDsg1 and rDsg3. The rDsg3 was able to inhibit the binding of only
aDsg3 antibodies in a dose-dependent manner, whereas rDsg1 blocked only the binding of aDsg1
in a dose-dependent manner. Passive trasfer experiments of af®nity-puri®ed aDsg1 antibodies from
3 PF patients induced subcorneal acantholysis in mice and aDsg3 antibodies induced suprabasilar
acantholysis in these animals. These studies suggest that in a subset of PF patients there is a dual and
independent pathogenic autoantibody response against Dsg3 and Dsg1.
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The Role of IgG Subclass Switch in the Pathogenesis of Fogo Selvagem
S. Warren, L. Arteaga, E. Rivitti,* V.Aoki,* G. Han-Filho,² G. Giudice, L. Diaz, and M. Lin
Dermatology, UNC-CH, Chapel Hill, North Carolina; *Dermatology, U Sao Paulo, Sao Paulo, Brazil;
²Dermatology, U Federal de Mato Grosso do Sul, Campo Grande, Brazil; ³Dermatology, Medical Coll.
Wisconsin, Milwaukee, Wisconsin
Fogo Selvagem (FS) is characterized by subcorneal blisters and antidesmoglein 1 (aDsg1)
antibodies. The endemic focus of FS in Limao Verde (LV), Brazil shows a disease prevalence of
3.4%. In LV, we found aDsg1 antibodies in 97% of the FS (n:31) and in 55% of normal subjects
(n:93). In this study, we have determined the IgG subclass aDsg1 response in patients (n:31)
[preclinical (n:5) and remission stages (n:8)] and normal subjects known to have high levels of
aDsg1 antibodies (n:31). We detected IgG1 aDsg1 antibodies in 25 of 31 patients (mean ELISA
value 4.8), and IgG4 aDsg1 antibodies in 24 out of 31 (mean ELISA value 112.53). The 31 normal
subjects showed a mean value of IgG1 aDsg1 antibodies of 4.74; this value was very close to the
mean value of IgG1 found in FS patients. However, the mean value of IgG4 aDsg1 antibodies in
this normal group was 5.82, which is 19.3 fold lower than in the FS group. IgG1 aDsg1 antibodies
were detectable 1±4 years before the onset of FS in 5 patients. Onset of clinical FS in this group was
associated with a mean 1.95 fold increase in IgG1 aDsg1 antibody and a 9.54 fold increase in IgG4
aDsg1 antibody levels. Finally, the level of IgG4 aDsg1 antibodies also correlated closely with
activity and remission of FS. A positive IgG4 aDsg1 antibody test was associated with active disease
in 22/23 patients, whereas a negative IgG4 aDsg1 antibody test was associated with clinical
remission in 7/8. These correlations were not observed with the level of IgG1. These results
suggest that progression of FS from preclinical to clinical disease is associated with a switch from
IgG1 aDsg1 antibody to an IgG4 autoantibody response. IgG1 aDsg1 antibodies may not be
pathogenic.
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Serum IgG from Pemphigus Foliaceus Patients Reacts Against Maxadilan
A. Roselino, J. Figueiredo, K. Kounga,* V. Reddy,* and E. Lerner*
Internal Medicine, University of SaÄo Paulo, Faculty of Medicine, RibeiraÄo Preto, SP, Brazil; *Dermatology,
Cutaneous Biology Research Center, Harvard Medical School, Boston, Massachusetts
Endemic Pemphigus Foliaceus (EPF) is an autoimmune skin disease caused by autoantibodies
against desmoglein 1, the transmembrane glycoprotein of desmosomes. Vieira reported in the
1940s that two thirds of the State of SaÄo Paulo was affected by EPF, with the highest incidence of
disease in the north-east region, from Franca to RibeiraÄo Preto, extending to the margins of the
Grande River. He noted that the Simulium ¯y (black ¯y, ``borrachudo'' in Portuguese) was
common in the areas most affected by EPF. Maxadilan is a potent vasodilator peptide present in
salivary glands of the sand ¯y Lutzomyia longipalpis, a vector of leishmaniasis. In that region,
pemphigus foliaceus and cutaneous leishmaniasis are endemic. The purpose of this study was to
determine if serum antibodies against maxadilan are present in EPF patients. Serum obtained from a
total of 38 people from this region including 23 patients with EPF, 4 with pemphigoid and 11
controls were incubated with maxadilan [143 mg per ml] followed by incubation with human anti-
IgG in an ELISA test. Optical densitometry was obtained at 492 nm in a spectrophotometer. The
results with EPF serum varied from 0.060 to 0.804; of pemphigoid serum from 0.039 to 0.282, and
of control serum from 0.060 to 0.219, with signi®cance, p < 0.01, between EPF and control
groups. There was no statistical difference between localized (median, 0.360) and generalized
(median, 0.522) forms of EPF. There was no correlation (r = ±0.2414) between serum IgG
antimaxadilan (ELISA, median 0.304) and serum IgG antidesmoglein (indirect immuno¯uores-
cence, median 1:1024) in 16 EPF samples. These results demonstrate that patients with EPF have
antibodies against maxadilan. The relationship between the antibodies to maxadilan and the
autoantibodies that react against desmoglein 1 in HLA susceptible individuals for EPF needs to be
clari®ed.
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IgG, IgG1, IgG4 and IgE Antibodies to Three Domains of a 230-kDa Bullous
Pemphigoid (BP) Antigen in BP Sera
M. Dmochowski, M. Bowszyc-Dmochowska, T. Hamada,* Y. Nagata,* and T. Hashimoto*
Department of Dermatology, University School of Medicine, Poznan, Poland; *Department of Dermatology,
Kurume University School of Medicine, Kurume, Japan
It is known that IgG1 and IgG4 subclasses of IgG autoantibodies predominate in bullous
pemphigoid (BP) sera. It has also been reported that IgE antibodies target both 230 kDa (BP230)
and 180 kDa BP antigens. The aim of this study was to examine BP sera for the presence of IgG,
IgG1, IgG4 and IgE antibodies to the three bacterial recombinant GST-fusion proteins of C-
terminal (BP230-C), middle (BP230-M), and N-terminal (BP230-N) domains of BP230, which
encompass the entire molecule of BP230. Sixteen sera from BP patients showing typical
immunological features of BP, 1 pemphigus vulgaris serum and 3 linear IgA bullous dermatosis sera
were examined by immunoblotting. There were 8, 3, 6 and 2 BP sera with IgG, IgG1, IgG4 and
IgE antibodies, respectively, reactive with BP230-C. There were 6, 4, 6 and 2 BP sera with IgG,
IgG1, IgG4 and IgE antibodies, respectively, reactive with BP230-N. There were 2 BP sera with
IgG, but not with IgG1, IgG4 or IgE antibodies, reactive with BP230-M. None of the control sera
had antibodies of any class/subclass to any of the recombinant proteins of BP230. These results
suggest that the production of IgG4 and IgE antibodies to BP230 might not be signi®cantly
correlated in patients with BP at blistering stage of their disease.
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A Transgenic Approach For Model Immune Responses Against Bullous Pemphigoid
Antigen 2 (BPAG2)
J. Roh, C. Yee, J. Vogel, and K. Yancey
Dermatology branch, NCI, NIH, Bethesda, Maryland
BPAG2, a 180-kDa, type II transmembrane protein associated with hemidesmosomes in basal
keratinocytes, is targeted by autoantibodies in patients with various blistering diseases. To elucidate
the primary pathophysiology of these autoimmune diseases, C57BL/6 transgenic (Tg) mice
expressing human BPAG2 in murine epidermis under the control of a human keratin 14 promotor
were produced. Four phenotypically normal founders were identi®ed and bred. Monoclonal and
polyclonal anti-BPAG2 IgG identi®ed human BPAG2 in murine epidermal basement membranes
(BMs) in 3 of 4 founder lines; expression was greatest in mice homozygous for the transgene. Grafts
of trunk or tail Tg skin placed on otherwise syngeneic C57BL/6 mice (wt) were lost in 3 weeks; wt
mice grafted a second time with Tg skin showed graft loss within 1 week. Sera from mice grafted
with skin from 2 different Tg founder lines contained IgG that: (1) bound epidermal BM in human
and Tg skin; (2) immunoblotted human BPAG2; and (3) showed no reactivity to epidermal BM or
BPAG2 in wt C57BL/6 mice. Immune splenocytes of grafted wt mice generated B-cell
hybridomas producing monoclonal IgGs that speci®cally bound human epidermal BM and
BPAG2. Adoptive transfer of immune splenocytes from grafted wt mice to naive Tg mice
expressing human BPAG2 sustained production of circulating anti-BM IgG in vivo for more than
28 days (the longest period of observation to date). This transgenic approach yielded an animal
model in which primary immune responses against a known autoantigen can be elicited,
characterized, and potentially modulated or blocked in vivo. This animal model may elucidate the
primary pathophysiology of autoimmune blistering diseases.
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Development of an Active Autoimmune Disease Model for Bullous Pemphigoid
M. Zhao, M. Lin, R. Fritz,* L. Diaz, and Z. Liu
Dermatology, University of North Carolina, Chapel Hill, North Carolina; *Immunology, Medical College of
Wisconsin, Milwaukee, Wisconsin
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by
deposition of IgG and complement components at the basement membrane zone (BMZ) and
in¯ammatory in®ltration at the dermis. BP autoantibodies recognize two hemidesmosomal
proteins ± BP230 and BP180. The current IgG passive transfer animal model for BP reproduces
key immunohistological features of human BP. We have used this model to systematically dissect
the in¯ammatory cascade and demonstrate that subepidermal blistering is triggered by anti-BP180
IgG and depends on complement activation, mast cell degranulation and neutrophil in®ltration.
Activated neutrophils release proteolytic enzymes and reactive oxygen species, causing
subepidermal blistering. To understand the molecular and cellular interactions between T and B
lymphocytes leading to the production of pathogenic anti-BP180 IgG, we have attempted to
develop an BP model by active immunization of mice with murine BP180 antigen. Three strains of
mice BALB/c (H2d), C57BL/6 J (H2b), and SJL/J (H2s) were immunized with recombinant
mBP180 antigen (mBP180ABC) and compared for BP-susceptibility and immune-responsiveness
to the autoantigen. Although all three strains of mice produced antimBP180 IgG as determined by
immunoblotting, ELISA and indirect immuno¯uorescence, only C57BL/6 J mice are susceptible
to BP. We found that approximately 20% immunized mice developed skin lesions. Histological
examination of the lesional sites in these mice revealed a BP-like dermal-epidermal separation with
in¯ammatory cell in®ltration. In vivo deposition of IgG and C3 was found at BMZ. Further, about
80% immunized C57BL/6 J produced pathogenic anti-BP180 IgG as determined by passive
transfer experiments. This model will allow us to investigate T and B-cell responses that modulate
BP and develop novel therapeutic strategies for this disease.
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IgG Auto-Antibodies to BP180 are Directly Pathogenic in Human Skin and Induce Sub-
Epidermal Blisters: Evidence Using Skin Explant Culture and SCID Mouse Grafted with
Human Skin
R. Ghohestani, S. Joubeh, M. Cacciapuoti, and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Previous studies had suggested that antibodies to the 180 kDa bullous pemphigoid (BP180) antigen
can induce subepidermal blisters only in the presence of complement and PMN/eosinophils. We
here provide evidence that anti-BP180 antibodies are pathogenic and induce subepidermal splits
without presence of complement or PMN/eosinophils in vitro in a skin explant culture model and
in vivo in SCID mouse grafted with normal human skin. IgG4 deposits were found along the
dermal-epidermal junction and localized to the epidermal side of the split. C3 deposits were
insigni®cant and there were no major eosinophilic in®ltrates in the split area. Clinically, a
correlation was found between the presence of IgG4 antibodies to BP180 and disease severity in 20
patients with bullous pemphigoid (BP) (p < 0.001). Sera from patients with severe forms of the
disease contained high titer anti-BP180 antibodies. We further sought to determine the mechanism
by which the anti-BP180 antibodies may mediate their pathogenic effect by using a keratinocyte
culture system and a rabbit antibody raised against the extracellular part of BP180. Pre-incubation
of cultured keratinocytes with the anti-BP180 antibody induced re-distribution of BP180
ectodomains from the cell membrane into the cytoplasm. This change was accompanied by BP180
phosphorylation. The present study demonstrates the direct pathogenic role of anti-BP180
antibodies in human skin in both in vitro and in vivo models.
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Detection of BP180 Speci®c IgE Antibodies in Bullous Pemphigoid and Identi®cation of
a Potential Effector Function
O. Dimson, C. Fu, M. Janson, G. Giudice,* and J. Fairley
Dermatology, Medical College of Wisconsin and VA Medical Center, Milwaukee, Wisconsin; *Dermatology
and Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin
Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by the presence of
autoantibodies directed against two hemidesmosomal proteins in the skin: BP180 and BP230.
Animal models have provided strong evidence that IgG antibodies reactive with the NC16A
domain of BP180 play a direct role in disease pathogenesis. Recent studies have indicated that anti-
BP180 IgE class antibodies are also present in BP sera; however, the pathologic relevance of the
IgE response has not been established. The present studies were designed to further characterize the
role of IgE antibodies in BP. Seventeen BP patients well characterized by clinical, histological, and
immunological criteria were used in these studies. By immunoblotting, IgE reactivity to NC16A
was detected in 6 of 7 (86%) new, untreated BP patients and in an additional 5 of 10 BP patients at
various stages of treatment. By indirect IF 5/17 sera contained IgE antibodies that bound the
basement membrane zone (BMZ). Of the 13 patients' skin biopsies that were available for testing,
none had detectable IgE bound to the BMZ in vivo; however, 9 of the 13 samples showed IgE-
positive cells in the papillary and reticular dermis. These IgE-positive cells were identi®ed as mast
cells by double labeling with Texas-Red conjugated antihuman mast cell tryptase. Basophils from
freshly drawn blood of 5 BP patients were challenged with varying amounts of recombinant
NC16A and the release of histamine was measured using a competitive histamine immunoassay.
Cells from 4 of the 5 BP patients exhibited NC16A-dependent histamine release. The one patient
that showed no response was in remission on steroids and dapsone. Basophils from 6 controls were
assayed and none showed a response to NC16A. These data suggest that IgE class antibodies may
have a role in the pathogenesis of BP.
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Antibody to an Intracellular Domain of Human b4 Integrin is Pathogenic in Mucous
Membrane Pemphigoid
S. Kumari, J. ColoÂn, K. Bhol, M. Razzaque, and A. Ahmed
Department of Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts
Mucous membrane pemphigoid (MMP) is a mucocutaneous autoimmune blistering disease
characterized by the presence of an autoantibody to the basement membrane zone (BMZ). We
identi®ed human b4 to be the target antigen recognized by these anti-BMZ antibodies. We have
previously demonstrated that MMP autoantibody reacts with the intracellular and not the
extracellular domain of human b4 integrin molecule. We produced 3 essential fragments of the
intracellular region of b4 (IC1.0, IC2.0 and IC3.0). Majority of the MMP sera demonstrated strong
binding to IC3.0. The binding of the MMP sera to IC3.0 is entirely due to its binding to IC3.4
containing 85 aa. This region may have multiple antibodies binding sites. We incubated MDA-435
cell line (human b4 expressing cell line) with rabbit antibody to IC 1.0, IC2.0, IC3.0, IC3.4, MMP
sera, normal human sera and preimmune rabbit sera. Using immunoperoxidase staining binding of
MMP sera, and rabbit antibodies to different intracellular fragments of b4 integrin to the cytoplasm
of MDA-435 cells was observed. No binding of preimmune rabbit sera or normal human sera to
the cell lines was observed. These experiments clearly indicate that these antibodies can penetrate
the cells and bind to relevant antigens. Rabbit antibody to IC3.0 and IC3.4 produced separation of
BMZ when incubated with normal human buccal mucosa in an in vitro organ culture model.
Similar BMZ separation of oral mucous membrane is observed in cultures incubated with MMP
patient sera and antibodies to ?4 integrin, but not with normal human sera. These observations
identify IC3.4 or CP1 as the possible antibody binding site for sera of MMP patients and suggests a
possible role for it in blister formation. The observations in this study provide a model that allows
the use of normal human buccal mucosa in studying the pathogenesis of MMP, blister formation,
hemidesmosomal and basement membrane biology.
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Immunomapping of EBA Sera to the NC-1 Domain of Collagen VII: Further Evidence
that Anchoring Fibrils Originate and Terminate in the Lamina Densa
J. McMillan, T. Matsumura, T. Hashimoto,* H. Schumann,² L. Bruckner-Tuderman,² and H.
Shimizu
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan;
*Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan; ²Department of
Dermatology, University of Munster, Munster, Germany
Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease with circulating
antibodies to type VII collagen, a major component of anchoring ®brils located in the epidermal
basement membrane. We assessed the ultrastructural localization of sera from two Japanese patients
with clinically typical forms of EBA and compared this with two EBA patients who predominantly
presented with oral lesions initially and mild cutaneous involvement. Immunoblotting of whole
dermal extracts showed labelling of a 290-kDa target in both typical and mucosal EBA forms,
consistent with that of type VII collagen. The blotting target for the EBA sera was further
identi®ed using the NC-1 domain fusion protein of collagen VII and the central collagenous
portion of collagen VII. Postembedding immunoelectron microscopy (IEM) using Lowicryl
K11M embedded normal human skin and patient's sera demonstrated the majority (80%) of
labelling over the lamina densa, not below the lamina densa. This labelling pattern was similar to
that observed when using the mouse monoclonal LH7 : 2 against the NC-1 domain of collagen VII
but was distinct from the NC-2 domain labelling. The majority of EBA sera blotted to the NC-1
domain (3/4 sera). One typical EBA serum reacted with both NC-1 and the collagen VII triple
helical domain, con®rming the latter as a less frequent binding epitope. We conclude that the
majority of EBA sera bind to the NC-1 domain of collagen VII situated in the lamina densa of the
epidermal basement membrane. This further con®rms previous reports that anchoring ®brils
originate and terminate in the lamina densa. The presence of multiple EBA epitopes on the
collagen VII molecule shows no correlation with disease phenotype and therefore an individual's
immune response is more likely to determine the clinical features of this disease.
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The a5 and a6 Chains of Type IV Collagen are the Target of Autoantibodies in a Novel
Autoimmune Disease Characterized by Subepidermal Blisters and Glomerulonephritis
G. Zhang, S. Rotunda, G. Webster, J. Uitto, and R. Ghohestani
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Type IV collagen is a heterotrimeric complex of proteins composed of a1(IV)-a6(IV) chains. The
a5(IV) and a6(IV) chains are expressed at the dermal-epidermal junction, but their precise
function is as yet unknown. We here describe a novel autoimmune disease with IgG or IgA
autoantibodies directed against the NC1 domain of the a5(IV) or a6(IV) type IV collagen chain.
Clinically, the patients presented with severe subepidermal bullous eruptions and glomerulone-
phritis. In vivo deposits of IgG or IgA were found along the dermal-epidermal junction and
glomerular basement membrane zone. The identity of the target antigen was determined by
immunochemical analyses of candidate antigens using the patients' autoantibodies. These
autoantibodies reacted with a 185±190 kDa band from human dermal extracts that was
distinguished from the known 180 kDa or 230 kDa bullous pemphigoid antigens, the 290 kDa
(type VII collagen) epidermolysis bullosa antigen or the a3, b3 and g2 chains of laminin 5
cicatricial pemphigoid antigen. Af®nity puri®ed IgG and IgA antibodies from the 185±190 kDa
nitrocellulose band speci®cally reacted with recombinant NC1 domain of a5(IV) or a6(IV),
among the six NC1 domains of type IV collagen, by ELISA. This study provides evidence for the
a5(IV) and a6(IV) chains as target antigens in a novel autoimmune disease characterized by severe
skin blistering and glomerulonephritis.
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IQGA Human Ras GTPase-Activating-Like Protein IQGAP1 is Expressed by Human
Keratinocytes and Recognized by Circulating Autoantibodies
S. Presslauer, G. Hinterhuber, R. Horvat,* K. Wolff, and D. Foedinger
Dermatology, University of Vienna, School of Medicine, Vienna, Austria; *Clinical Pathology, University of
Vienna, School of Medicine, Vienna, Austria
Autoantibodies in patients with bullous skin diseases are of diagnostic value and suspected to play a
role in the initial pathogenic scenario. We screened serum samples from patients with bullous
pemphigoid, pemphigus, erythema multiforme and erythema multiforme like bullous eruptions for
the presence of circulating autoantibodies. Immunoblotting and immunoprecipitation of lysates
from cultured human keratinocytes revealed a sofar unrecognized distinct protein band of 190 kDa
in a small number of patients (4 out of 120). For characterization aminoacid sequence analysis of
peptide fragments derived from the respective protein after preparative SDS-gel electrophoresis
was performed showing 100% sequence homology to IQGAP1 (IQGA Ras GTPase activating-like
protein), a recently described protein suspected to act as an effector molecule for Cdc42 and Rac1,
members of the Rho small GTPase family and to play a key role in regulating E-cadherin mediated
cell-cell adhesion. The protein is also selectively recognized by a boni®ed anti-IQGAP1
monoclonal antibody on Western blots and immunoprecipitates from cultured human
keratinocytes and epidermal extracts. Indirect immuno¯uorescence locates IQGAP1 within
individual keratinocytes in a perinuclear, vesicular pattern and in the periphery of the cell close to
the inner part of the cell membrane. In conclusion, our results demonstrate that IQGAP1, a newly
described multifunctional protein, is constitutively expressed in human keratinocytes where it may
contribute to the integrity of the epidermal layer. At the same time IQGAP1 appears as target for
circulating autoantibodies in a small number of patients exhibiting erythema multiforme like
eruptions.
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NPY Suppresses Induction of Contact Hypersensitivity
I. Friedman, K. Seiffert, and R. Granstein
Dermatology, Weill Medical College of Cornell University, New York, New York
An anatomical association between epidermal Langerhans cells (LC) and peripheral nerves has
recently been discovered. It has been hypothesized that the nervous system regulates the function
of LC via release of neuron-derived factors, resulting in modulation of cutaneous immune
responses. Neuropeptide Y (NPY) and peptide YY (PYY) are structurally related peptides with a
variety of known functions, including regulation of cardiovascular tone and and food/water-
intake. NPY has been found in nerve endings in immunocompetent organs, including the
epidermis. Several authors have described an effect of NPY and PYY on immunocompetent cells,
suggesting a role for these neuropeptides in immune functions. In this study we wished to
determine whether NPY and PYY affect the antigen presenting capability of murine LC. We
utilized a contact hypersensitivity (CHS) model in which CAF1 (BALB/c 3 A/J) F1 (H-2d/a)
mice (female, 8±10 weeks) were injected i.d. with 500 pmol of NPY or PYY or diluent alone
15 min prior to sensitization with 5 ml of 1% DNFB at the same site. Seven days later mice were
challenged by application of 5 ml of 0.2% DNFB to both sides of their ears and 24 h ear-swelling
was assessed. Injection of NPY signi®cantly reduced CHS by 73% (p < 0.01) (NPY injected group:
2.9 mm-2 vs. positive control/no NPY: 10.65 mm-2; negative controls received vehicle without
DNFB before injection of NPY or diluent: 0.2 and 0.04 mm-2, resp.; data pooled from two
independent experiments, n = 10). In contrast, PYY and substance p had no signi®cant effect on
the DNFB-induced ear swelling response. We wished to determine whether the above ®ndings
could be explained by a direct effect of NPY on LC. However, RT-PCR failed to demonstrate
NPY 1-, 2- or 5-receptors, speci®c for NPY and PYY, on fresh murine LC and the LC-cell lines
XS52 and XS106. Thus, NPY might not affect LC antigen presenting capability and function
directly. We can infer, however, that the observed effect of NPY is unrelated to its known
vasoconstrictive function, since PYY, equipotent as a vasoconstrictor, did not affect CHS-
induction at the same dose in this model. We plan to further elucidate the exact mechanisms
involved (e.g. stimulation/inhibition of T-cell and/or keratinocyte cytokine production) in future
experiments.
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Repeated Hapten Application Induces Th1 Deviation in NC/Jic Mice (Subspecies of NC
Atopic Model Mice)
H. Terao, T. Koga, Q. Chen, K. Morita, H. Duan, H. Hara, and M. Furue
Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
NC/Nga mice show atopic dermatitis-like eruption and increase in serum IgE in conventional
conditions but not in speci®c pathogen-free (SPF) conditions. It has been reported that NC/Nga
mice also show a high serum IgE level and dermatitis after repeated trinitrochlolobenzene (TNCB)
application in SPF conditions. We applied TNCB to another NC mice strain, NC/Jic, once a
week for 4 weeks in SPF conditions. After the last application of TNCB, we studied immune
reactions, including serum IgE level, delayed type hypersensitivity (DTH) reaction and cytokine
pro®le in regional lymph node. Non-treated NC/Jic mice showed a serum IgE level higher than
those of the control BALB/c mice in coventional conditions, but after the application of TNCB,
the NC/Jic mice showed more severe dermatitis, lower serum IgE level and higher serum IgG2a
level than did the control BALB/c mice in SPF conditions. Moreover, NC/Jic mice showed
stronger DTH reaction, higher IFN-g level and lower IL-4 level in regional lymph nodes
compared to control BALB/c mice in SPF conditions. The results indicate that the NC/Jic mice
showed a Th2 type response in conventional conditions but a Th1 type response after repeated
hapten application in SPF conditions compared to control BALB/c mice. It is thought that this
difference in T cell deviation in NC/Jic mice may be due to antigens or antigen routes.
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Th2 Memory in a Mouse Allergic Asthma Model
N. Mojtabavi, G. Dekan, G. Stingl, and M. Epstein
Department of Dermatology University of Vienna Medical School,VIRCC, Division of Immunology Allergy
and Infectious Diseases, Vienna, Austria
Immunological memory is one of the features of immune system to react more rapidly and more
effectively to the second exposure of antigen. Whereas life long protection against pathogen is
bene®cial vigorous and long immune responses against allergen is not. Several studies examined the
CD8 and Th1 memory but the Th2 memory is not well understood. To study the Th2 memory
response we generate a mouse allergic asthma model in the absence of adjuvant and
microorganisms. BALB/c female mice were immunized intraperitoneally with either 10 mg of
ovalbumin (OVA) or PBS on days 0 and 21, 7 days later they were nebulized with 1% OVA
dissolved in PBS or PBS alone twice a day for 2 days. To study the generation and maintenance of
Th2 memory in this mouse allergic asthma model OVA sensitized mice were nebulized with OVA
or PBS and mice were assessed on day 60, 90, 143, 170, 220, 260 and 433. Mice, which were
aerosol challenged with OVA showed BAL Eosinophilia and airway hyperresponsiveness, high
level of mucus production and peribronchial and perivascular in®ltration, high level of IL5
production less amount of IL4 whereas OVA sensitized mice which were aerosol challenged with
PBS showed no Eosinophilia and airway hyperresponsiveness and no mucus production but they
show peribronchial lymphocytes in®ltration. Splenocytes from PBS challenged mice are producing
lower amount of IL4 and IL5 compared to OVA challenged mice. In summary, we generate a
mouse allergic asthma model in the absent of adjuvant and microorganisms to study a th2 memory
in this model. Th2 memory cells are generated and maintained until 400 days after sensitization.
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CC Chemokine Receptor (CCR4) Expression on Peripheral Blood CD4+ T Cells
Re¯ects Disease Activity of Atopic Dermatitis
M. Wakugawa, K. Nakamura, T. Kakinuma, K. Matsushima,* and K. Tamaki*
Dermatology, University of Tokyo, Tokyo, Japan; *Molecular Preventive Medicine, University of Tokyo,
Tokyo, Japan
Th1 and Th2 cells differ in their chemokine receptor expression and their responsiveness to various
chemokines. CC chemokine receptor (CCR) 4 is selectively expressed on Th2 cells, whereas
CXC chemokine receptor (CXCR) 3 is selectively expressed on Th1 cells. We examined CCR4
and CXCR3 expression on peripheral blood CD4+ and CD8+ T cells in atopic dermatitis (AD)
(n = 17), psoriasis vulgaris (Ps) (n = 9) and healthy subjects (n = 9). CCR4 expression on CD4+ T
cells from AD subjects (22.4 6 18.1%) was signi®cantly higher than that in healthy subjects
(5.3 6 3.5%, p < 0.005) and Ps subjects (6.5 6 5.0%, p < 0.05). CXCR3 expression on CD4+ T
cells in AD, Ps and healthy subjects were 9.1 6 5.1%, 25.6 6 8.5% and 9.2 6 5.5%, respectively.
Intracytoplasmic IL-4 or IFN-g staining in CCR4+ or CXCR3+CD4+ T cells of AD subjects
after PMA and ionomycin stimulation revealed that 43.4 6 7.5% of CCR4+CD4+ T cells were
positive for IL-4, but virtually negative for IFN-g and that 29.4 6 5.4% of these cells were positive
for both IL-4 and IFN-g, suggesting that most of these cells were Th2 or Th0 cells. CCR4
expression on CD4+ T cells in severe AD subjects decreased by improvement of disease activity.
CD25 was preferentially expressed on CCR4+CD4+ T cells (20.1 6 7.2%) but not
CXCR3+CD4+ T cells (6.7 6 1.7%) in AD subjects. Cutaneous lymphocyte-associated antigen
(CLA) was preferentially expressed on CCR4+CD4+ T cells (24.9 6 8.4%) but not
CXCR3+CD4+ T cells (1.3 6 0.8%) in AD subjects. Immunohistochemical analysis indicated
that CD4+ T cells in AD skin lesion were predominantly CCR4+ cells. These data strongly
suggest that CCR4 expression is important for T cell in®ltration into AD lesions.
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Thymus and Activation-Regulated Chemokine (TARC) in Atopic Dermatitis: Serum
Level of TARC is Closely Related with Disease Activity
T. Kakinuma, K. Nakamura, M. Wakugawa, H. Mitsui, Y. Tada, H. Saeki, H. Torii, A. Asahina,
and K. Tamaki
Dermatology, Univerrsity of Tokyo, Tokyo, Japan
Thymus and activation-regulated chemokine (TARC/CCL17) is a chemokine that attracts CC-
chemokine receptor 4 positive (CCR4+) or CCR8+ cells. We have previously demonstrated that
TARC is produced by epidermal keratinocytes (KCs) using NC/Nga mouse, regarded as a mouse
model of atopic dermatitis (AD) (J Clin Invest 104:1097, 1999). In order to investigate the
participation of TARC in AD, we examined the serum TARC levels of AD (n = 40), healthy
controls (n = 20) and psoriasis vulgaris (Ps) (n = 20). The serum TARC levels of AD patients
(2338.70 6 302.83 pg per ml) were signi®cantly higher than those of healthy controls
(215.3 6 26.79 pg per ml) and Ps patients (256.30 6 113.10 pg per ml). The serum TARC levels
of AD decreased after the treatment in accordance with the improvement of clinical symptoms.
The serum TARC levels in AD signi®cantly correlated with eosinophil number (coef®-
cient:r = 0.61), serum sE-selectin levels (r = 0.58) and weakly correlated with serum sIL-2R levels
(r = 0.34). CCR4 positivity of CD4+CD45RO+ cells in PBMCs of AD patients (25.61 6 6.08%)
was signi®cantly higher than that of healthy controls (5.24 6 1.15%) and Ps patients (3.72 6 1.97%)
by FACS analysis. The strong immunoreactivity for TARC was detected in epidermal KCs,
vascular endothelial cells and dermal in®ltrating cells in the lesional skin both in the acute and
chronic phase of AD. Immunoreactivity for TARC was virtually negative in normal skin and
weakly positive in the lesional epidermal KCs of Ps. Taken together, these results demonstrates that
the serum TARC level is closely associated with disease activity of AD and that TARC may play
an important role in the pathogenesis of AD.
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Altered Cytokine Production and Expression of Costimulatory Molecules in Monocytes
and Monocyte-Derived Dendritic Cells from Atopic Dermatitis Patients
H. Manome, S. Aiba, Y. Yoshino, and H. Tagami
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
Atopic dermatitis (AD) is associated with a bias of T helper cells to show increased IL-4 and
reduced IFN-g production. Antigen presenting cells (APC) such as monocytes (MO) and dendritic
cells (DC) strongly in¯uence Th1/Th2 deviation by changing their production of cytokines and
their expression of costimulatory molecules. In this study, we examined whether atopic MO or
DC differ from those of healthy controls in the production of cytokines and expression of
costimulatory molecules. We studied 12 AD adult patients demonstrating more than 2000 U per ml
of IgE. Controls were 12 age-matched nonatopic healthy adults. We examined the production of
GM-CSF, IL-1b, IL-10, IL-12p40, and IL-12p70 and the expression of CD23, CD40, CD54,
CD80, CD86, and HLA-DR by MO stimulated by SEA, streptococcal pyrogenic exotoxin A
(SPEA), LPS, PHA, IL-4, IL-1/TNF-a, or IFN-g. We also examined the production of IL-1b, IL-
10, IL-12p40 and IL-12p70, and the expression of CD23, CD86, and HLA-DR by monocyte-
derived DC stimulated by LPS, agonistic anti-CD40 antibody, or IFN-g. Statistical analysis of the
obtained data demonstrated (1) increased production of IL-10 and decreased production of GM-
CSF by AD MO stimulated with LPS, and decreased IL-12p40 production by AD MO with
various stimulations (2) increased CD23 up-regulation by AD MO stimulated with IL-4, increased
CD54 up-regulation by AD MO stimulated with IL-1/TNF-a or SEA, and decreased CD86 up-
regulation by AD MO stimulated with IL-1/TNF-a (3) decreased production of IL-12p40 and IL-
12p70 by AD DC stimulated with LPS or anti-CD40 antibody, and (4) decreased CD86 up-
regulation of AD DC stimulated with anti-CD40 antibody. These data suggest that APC from AD
patients play a role in their Th2-deviated pathogenic phenotype expression of helper T cells.
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The Role of Neutralizing Antibody to Staphylococcal Superantigen in Patients with
Severe Atopic Dermatitis
H. Asada, H. Fujii, S. Inui, S. Itami, and K.Yoshikawa
Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Japan
Our previous studies demonstrated that T cells from the patients with severe atopic dermatitis (AD)
were prone to undergo apoptosis following staphylococcal enterotoxin B (SEB) stimulation. In
contrast to this in vitro phenomenon, we observed only few apoptotic T cells at the AD lesions with
staphylococcal infection. To clarify this discrepancy, we hypothesized that antiapoptotic activity
was present in the serum of the patient. Here we examined whether or not sera of AD patients had
any in¯uence on T-cell response to SEB. Sera from 27 severe AD patients (IgE5000 U per ml), 9
patients with psoriasis vulgaris and 15 healthy controls were used for this study. Normal peripheral
blood mononuclear cells (PBMC) were cultured in the presence of serially diluted sera, followed
by stimulation with SEB (0.1 mg per ml). [3H]-thymidine incorporation was measured after three-
day culture. In 13 of 27 AD patients, serum titers (expressed as the reciprocal of the highest serum
dilution resulting in 50% suppression of PBMC proliferation) were more than 10, while sera from
psoriasis patients and healthy controls demonstrated no suppression or very low titers. Depletion of
IgG from AD sera by protein G sepharose abrogates the suppressive effect on PBMC proliferative
response, whereas eluted IgG fraction had a suppressive activity. Western blotting analysis
demonstrated the presence of anti-SEB IgG in sera of AD patients. To examine the role of anti-
SEB IgG in vivo, NC/Nga mice (as model mice for AD) were treated with AD sera before
intracutaneous injection with SEB producing strain of S. aureus (SEB-S. aureus) which cause severe
dermatitis in these mice. AD sera, but not normal sera, prevented SEB-S. aureus inducing severe
dermatitis. Our ®ndings suggest that severe AD patients had high titers of anti-SEB neutralizing
antibody that may down-regulate in¯ammatory responses induced by SEB in the patients.
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Production of Soluble Mediators by Inhalant Allergen-Stimulated Human Blood-
Derived Dendritic Cells from Atopic vs. Nonatopic Individuals
M. Grewe, N. Gross, J. Krutmann, M. Klammer, and T. Ruzicka
Department of Dermatology, University of Duesseldorf, Duesseldorf, Germany
To elucidate pathophysiological functions of antigen-presenting cells (APC) in atopic diseases, the
present study compared the capacity of human blood-derived dendritic cells (DC) from atopic and
nonatopic individuals to produce immunologically key-mediators upon treatment with inhalant
allergens. Treatment of differentiated, immature, 98% pure, T-cell-free preparations of DC with
various concentrations of house dust mite or grass pollen extracts for up to 72 h dose-dependently
induced DC maturation, release of MCP-1 and induction of IL-12p35 mRNA, but no release of
IL-12 and IL-10. Full cytokine release was achieved by treatment of DC with either endotoxin
(LPS) or a cytokine cocktail consisting of IL-1b, TNFa and IL-6. Remarkably, in 7/8 paired
investigations of age and sex-matched individuals, maximum production of IL-10 and MCP-1 was
1.5±2-fold higher in atopic vs. nonatopic DC, whereas IL-12 production did not show signi®cant
differences. LPS- as well as cytokine cocktail-induced cytokine production was modulated by 48 h
pretreatment of DC with inhalant allergens, resulting in dose-dependent super-production of IL-
10 and MCP-1. In contrast, IL-12 production was inhibited by very high and very low
concentrations of inhalant allergen pretreatment, resulting in a bell-shaped dose±response curve of
IL-12 release. As a more physiologic model for DC activation in human skin, untreated as well as
inhalant allergen-primed DC were challenged with supernatants from untreated or activated
cultured normal human keratinocytes (HNK). DC responded upon supernatants from HNK with
signi®cant cytokine production (MCP-1, IL-10). This cytokine production could be increased,
either if DC were pretreated with inhalant allergens for 48 h or if HNK were activated by e.g. UV-
irradiation. Our data demonstrate differential regulation of inhalant allergen-induced DC cytokine
production and they suggest geniune DC-dependent differences in the release of Th2-like
cytokines in atopic vs. nonatopic individuals. In human skin, DC activation may be modulated by
cells of the surrounding microenvironment, i.e. keratinocytes. Taken together, it may be
speculated that the pathophysiological basis for atopic diseases is found in cells of the unspeci®c
branch of the human immune system rather than in cell types determining speci®city of immune
responses.
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Phorbol Ester-Induced Apoptosis Associated with Syncytia Formation in Human
Monocytic Cell Lines Established from Peripheral Blood of Patients with Atopic
Dermatitis and Psoriasis
Y. Hamamoto, K. Nagai, Y. Ogasawara, K. Inoue, M. Ichimiya, and M. Muto
Dermatology and Biomolecular Sensing, Yamaguchi University School of Medicine, Ube, Japan
12-O-tetradecanoylphorbol-13-acetate (TPA) known as a tumor promoter and protein kinase C
activator, induces apoptosis which is mediated by tumor necrosis factor (TNF)-a as in human
monocytic cell line U937cells. We studied the regulation of apoptosis by TPA in YAA and YAP
cells established from peripheral blood of patients with atopic dermatitis and psoriasis, respectively.
When YAA, YAP and U937 cells were treated with 1 ng of TPA for 24 h, the cell growth of each
cell line was inhibitted and the viability of YAP, YAA, and U937 cells were 18%, 35%, and 90%,
respectively. TPA-treated cells stained with 4¢,6¢-diamino-2-phenylindole dihydrochloride (DAPI)
showed morphologically apoptotic change. However, the amount of TNF-a in the culture
supernatants was not signi®cantly different. Interestingly, TPA induced remarkable syncytia
formation in YAA and YAP cells, but not in U937 cells. These syncytia were also associated with
apoptotic cells as judged by the DAPI stainning. These results suggest that YAA and YAP cells
seem to be usuful for investigation of giant cell formation as well as apoptosis in human monocytic
cells. Our data also suggest that these cells might be usuful for basic researches in treatments of
lymphoma and in granulomatous skin diseases.
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SB239063, a p38 Map Kinase Inhibitor, Inhibits Development of Psoriatic Lesions as
Effectively as Cyclosporin A in C.B-17 SCID Mice Adoptively Transferred with NaõÈve T
Cells from B10.D2 Splenocytes
H. McAdams, A. Truneh, J. Kou, C. Eichman, and C. Davenport
Immunology, SmithKline Beecham, King of Prussia, Pennsylvania
We have previously reported that adoptive transfer of naõÈve T cells isolated from B10.D2 donors
into C.B-17 SCID (SCID) mice, produced symptoms of disease similar to psoriasis. Here we
evaluated the ability of SB239063, a novel p38 MAP kinase inhibitor, to prevent onset or reduce
symptoms of disease. SCID mice were injected IV with 0.33 3 106 naõÈve T cells from B10.D2
donors, and evaluated weekly for signs of disease for a duration of 8 weeks. Our results showed that
SB239063 signi®cantly inhibited the onset of psoriatic lesions by 62.5%, while Cyclosporin A and
CTLA4-Ig had 66.7% and 100% reduction in development of lesions, respectively. Our compound
also reduced the number of absolute number of granulocytes in blood by 72.8% as determined by
CBC analysis, while Cyclosporin A and CTLA4-Ig reduced the number by 30.3% and 80.9%,
respectively. Cytokine analysis of supernatants of skin homogenates revealed that SB239063 had a
54.9% inhibition of IL-1b, a 39.4% inhibition of IFN-g, a 64.7% inhibition of TNF-a, and no
effect on IL-4 levels. Cyclosporin A demonstrated a 61.2% inhibition of IL-1b, a 59.9% inhibition
of IFN-g, a 21.6% inhibition of TNF-a, and also had no effect on IL-4 levels. CTLA4-Ig
demonstrated a 90.8% inhibition of IL-1b, an 88.4% inhibition of IFN-g, a 96% inhibition of
TNF-a, and also had very little effect on IL-4 levels. Taken together, these data show that
SB239063 reduced symptoms of psoriasis as effectively as Cyclosporin A, however, neither
compound was as effective as CTLA4-Ig.
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LFA3TIP Affects Epidermal CD8+ T Cells In Vivo and Down-Regulates Keratin 16 and
Ki-67 Expression in the Psoriatic Plaque
K. Gordon, L. Nair, M. Di, D. Shrager,* and A.Vaishnaw*
Department of Dermatology, North-western University Medical School, Chicago, Illinois; *Biogen, Inc.,
Cambridge, Massachusetts
Six patients received 12 weekly doses of LFA3TIP, a fully human LFA-3/IgG1 fusion protein. 6
mm biopsies were performed at baseline and weeks 7 and 13 (1 week after ®nal dose). Biopsies
were snap frozen and analyzed for immunohistochemical markers (CD3, CD4, CD8, and CD2),
Ki67, keratin 16, and epidermal thickness. Pan-T cell staining with CD3 demonstrated a decrease
in the numbers of epidermal T cells present in 4/6 patients while dermal T cells decreased in 3/6.
Staining for CD2 was similar to the CD3 data and results were also consistent with staining for
CD4 and CD8. CD4 staining was primarily in the dermis and was only slightly decreased in 3/6
samples at week 13, while CD8 staining was primarily in the epidermis and showed signi®cant
decreases in 4/6 patients by week 7. Notably, the epidermal effects at the week 7 biopsy antedated
the dermal changes. Dermal changes including reduction in Ki67 staining (5/6 samples) and a
diminution of keratin 16 expression (4/6 patients) were of lesser magnitude and were evident
between week 7 and 13. These data suggest a differential sensitivity between dermal CD4+ T cells
and epidermal CD8+ T cells to LFA3TIP. By having a signi®cantly greater effect on epidermal
CD8+, most of which are likely to be CD45RO+, LFA3TIP may preferentially reduce the
activated cells directly interacting with keratinocytes in psoriasis, while relatively sparing CD4+.
Moreover, since changes in epidermal T cells preceded other immunohistochemical changes (e.g.
Ki-67 and keratin 16), the data provide in vivo proof of the proximal nature of CD8+ T cells in the
psoriatic lesion. Altering CD8+ T cells speci®cally with relative sparing of dermal CD4+ T cells
appears to reduce the activity of psoriasis. Biologics (e.g. LFA3TIP) capable of targeting speci®c
lymphocyte subsets can give important insights into the pathogenesis of T cell-mediated
autoimmune disorders.
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Role of Transforming Growth Factor-b-1 in the Th1/Th2 Mechanisms of Vasogen's
Immune Modulation Therapy: Potential Role in Psoriasis
I. Freed, S. Shahid, B. Wang, A. Mandel,* A. Bolton,* and D. Sauder
Dermatology, Sunnybrook & Women's College Health Sciences Centre, Toronto, Ontario, Canada;
*Vasogen Inc., Mississauga, Ontario, Canada
Transforming Growth Factor-b-1 (TGF-b1) is known to play a major role in the modulation of
immune responses and the down-regulation of in¯ammation. Increased TGF-b1 production
correlates with protection and/or recovery from in¯ammatory and autoimmune diseases. It is
proposed that there are populations of regulatory T cells that exert their action primarily by
secreting this cytokine. Recently, Vasogen's Immune Modulation Therapy (IMT) has been
introduced in the treatment of a number of in¯ammatory and autoimmune disorders. IMT is
believed to down-regulate T cell- mediated in¯ammatory responses by suppressing the Th1 arm of
the immune system. IMT involves modifying autologous blood by controlled exposure to an
oxidizing agent and UVC, at an elevated temperature ex vivo and then administered by
intramuscular injection. The initial randomized, double blind clinical trial in patients with
moderate to severe psoriasis has shown that 40% of patients receiving IMT experienced a clinically
signi®cant bene®t (greater than 50% improvement in maximal PASI score), double that seen in the
placebo group. The objective of this present study was to evaluate the role of TGF-b1 in the
mechanisms of the immune modulating effect of IMT using contact hypersensitivity (CHS) as a
model. Mice treated with IMT-processed blood demonstrated a signi®cantly lower CHS response
than controls. RT-PCR demonstrated that IMT treatment induced a signi®cant up-regulation of
TGF-b1. This was associated with a two-fold down-regulation of IFN-g and IL-6. We have
previously shown that IMT works through an IL-10 dependent mechanism. The results of these
studies suggest that bene®cial effects of IMT on psoriasis are mediated through modulation of
cytokines.
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IFN-g+ Epidermal T Cells and IL-8+ Neutrophils in Psoriasis
H. Duan, T. Koga, F. Kohda, H. Hara, K. Urabe, and M. Furue
Dermatology, Kyushu University, Fukuoka, Japan
IFN-g and IL8 are believed to be important mediators in the cytokine cascade of psoriasis. It is not
known (1) wether epidermal T cells produce IFN-g within the lesion and (2) whether the elevated
levels of IL8 in psoriatic scales are predominantly of keratinocyte origin or whether they are
derived from other cells within psoriatic skin. We performed immunohistochemical studies to try
to determine in situ localization of IFN-g+ cells and IL-8+ cells in psoriatic lesions by using
formalin-®xed, paraf®n-embedded sections. Considerabe amounts of IFN-g+ cells were detected
in in®ltrateds of the papillary dermis. IFN-g+ cells were found to be present in the epidermis. The
pattern of IFN-g+ staining appeared to be a combination of intracellular staining in lymphoid cells
and extracellular depostion in the surrounding areas. IL-8 was positively stained in the vast majority
of neutrophils but not in the mononuclear cells, macrophages, or keratinocytes. IL-8+ neutrophils
were seen both in Munro's microabcesses in cases of psorisis vulgaris and in a small spongiform
pustule and much larger macropustules of Kogoj in cases of pustular psoriasis. Some IL-8-positive
neutrophils were observed in the upper dermis of pusrular psoriasis. Our data suggest that (1)
psoriatic epidermal T cells produce and secrete IFN-g within the lesion and these T cells are
involved in the pathogenesis of psoriasis, and that (2) neutrophils are one of the sources of IL-8 in
psoriasis and the IL-8 autocrine and/or paracrine system functions in the formation of the
microabcesses and pustules in psoriasis.
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Use of Expression Cloning to Identify Autoantigens in Psoriasis
D. Jones, N. Yawalkar, and T. Kupper
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
Psoriasis is a very common disease, affecting approximately 2% of the world's population. Severity
ranges from a minor cosmetic concern to a severe skin disease with life-threatening ¯ares and
disabling arthritis. There is strong evidence that the disease is driven by a T cell mediated immune
response in the skin. However, the antigen or antigens to which these T cells react have not yet
been de®ned. In this project, we plan to identify these antigens using the SEREX method, which is
an expression cloning method widely used in the study of tumor antigens. This method does not
make any assumptions about the nature of the antigens and is signi®cantly more rapid than other
methods used to directly characterize T cell antigens. It is based on the observation that cell
mediated immune responses can be associated with parallel humoral responses to the same antigens.
Although the humoral component is not necessarily an effective component of the immune
response, the presence of these antibodies has proven useful in the SEREX method by allowing
immunoscreening of a cDNA library with autologous serum to identify antigens which are also
recognized by T cells. The ®rst aim of this project is to create cDNA expression libraries from
psoriatic epidermis, screen these with autologous serum, sequence cDNAs encoding antigens, and
analyze the sequences for possible functions, homologies, and mutations which may be relevant in
the pathogenesis of psoriasis. We have created four of these libraries and have started work
screening. At this point, none of the autoantigens identi®ed has an obvious clear relationship to the
pathogenesis of psoriasis, such as homology to a streptococcal protein. The next aim is therefore to
assess which antigens most commonly elicit a humoral immune response in psoriasis patients
compared with normal controls using a dot blot assay. We conclude that this work demonstrates
the feasibility of applying the SEREX method to the study of psoriasis. This technique should also
be applicable in the study of other T cell mediated skin diseases such as lichen planus, vitiligo, and
alopecia areata. With continued progress, we expect this approach will signi®cantly improve
understanding of the pathogenesis of psoriasis and may provide new targets for treatment in the
future.
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Analyzing of Lesional T-Cells in Psoriasis by Flowcytometry
M. Friedrich, S. Krammig, M. Henze, W. Doecke,* W. Sterry, and K. Asadullah
Dermatology and Allergy, Charite, Humboldt University, Berlin, Germany; *Immunology, Charite,
Humboldt University, Berlin, Germany
The cellular in®ltrate in psoriasis has been characterised extensively by immunohistology and
revealed a T-cell predominance. The aim of the present study was to further characterise these cells
by multiparameter analyses. We determined phenotypic markers and performed short-term
functional assays with T-cells using a novel protocol for mechanic disaggregation of skin
specimens. Skin biopsies and venous blood samples were obtained from 10 patients with currently
untreated psoriasis. The cellular composition of the lesional lymphocytic in®ltrate showed a T-cell
predominance. The higher frequency of CD4+ than CD8+ cutaneous T-cells resulted in a high
CD4+/CD8+ T-cell ratio. Our immunophenotypic characterisation revealed a high proportion of
activated, proliferating (HLA-DR+, Transferrinreceptor (CD71)+) memory/effector (CD45RA±,
CD45RO+) CD4+ and CD8+ T-cells in psoriatic plaques. The higher frequency of such cells
compared to that in peripheral blood indicates their selective cutaneous accumulation. The
majority of lesional T-cells expressed the adhesion molecule CD11a and the chemokine receptor
CXCR3. Finally, we determined the intracellular cytokine formation in cutaneous T-cells from 4
patients after short-term stimulation. A high number of CD4+ and in particular CD8+ T-
lymphocytes expressed IFN-g and TNF-a, whereas IL-2 and IL-4 producing T-cells were only
rarely detected. Consequently, the IFN-g/IL-4 ratio was high, indicating a type 1 cytokine
predominance. This is of particular interest since activated T-cells and type 1 cytokines are
considered to be key players in psoriasis. Our investigations demonstrated a activated, memory/
effector type 1 immunophenotype in psoriasis and indicated that the mechanic disaggregation
followed by ¯ow cytometric analysis is a fast and useful approach for multiparameter
characterisation of skin-in®ltrating lymphocytes.
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Induction of Psoriasiform Histology by NK Cells is a General Phenomenon of both
Psoriatics, and Non-Psoriatics
R. Kalish, A.Gilhar,* Y. Ullmann,* B. Assy,* R. Shalaginov,* and S. Sera®movich*
Dermatology, SUNY @ Stony Brook, Stony Brook, New York; *Skin Research Laboratory, Technion
Institute of Technology, Haifa, Israel
This study was performed to ask whether psoriasis is a unique pathological response of epidermis of
psoriatic patients, or whether NK cells can induce psoriatic changes in skin from nonpsoriatic
donors. Human, and animal protocols were approved by the appropriate institutional review
committees. Human nonlesional skin from 3 psoriatics (NP), as well as from 7 nonpsoriatics (NN)
was grafted onto SCID mice (CB-17 Prkdc-scid). Lymphocyte lines with NK activity were
generated by culture of PBMC in IL-2100 U per ml for 14 days. Cells were phenotyped, and tested
for INF-g production, and NK activity by CTX against K562 cells, then injected into the human
skin grafts. The following permutations were tested: (1) autologous psoriatic NK cells in NP skin,
(2) allogeneic normal NK cells in NP skin, (3) autologous normal NK cells in NN, skin (4)
allogeneic normal NK cells in NN skin, (5) allogeneic psoriatic NK cells in NN skin. After 6
weeks, the grafts were harvested and analyzed for histology, immunohistochemistry, epidermal
thickness, proliferation (Ki-67), and K16. Injection of autologous psoriatic NK cells into NP skin
resulted in classic psoriasis histology with signi®cant (p < 0.05) increase in epidermal thickness, and
proliferation. NK cells also induced expression of epidermal HLA-DR, ICAM-1, CD1d, and K-
16. Injection of normal NK cells into autologous NN skin, and allogeneic NK cells into NN or
NP skin, induced psoriasiform changes, with less elongation of the rete ridges. The ability of NK
cells to induce psoriasiform changes is a general phenomenon. NK cells from both autologous, and
allogeneic donors were able to induce psoriasiform changes in normal skin from both psoriatics and
non-psoriatics. Superantigen stimulation was not necessary. Psoriasiform changes are part of the
normal response repertoire of normal skin from non-psoriatics.
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Interleukin-17 Production by Isolated Circulating Skin-Homing T Cells from Psoriasis
Patients
L. Santamaria, M. Pont, A. Gimenez,* J. Camarasa,* J. Palacios, and J. Beleta
Pharmacology, Almirall Prodesfarma S.A., Barcelona, Spain; *Dermatology, Hospital del Mar, Barcelona,
Spain
The T cell±keratinocyte interaction plays a relevant role in the pathogenesis of psoriasis. IL-17 is a
proin¯ammatory cytokine produced by T cells that is involved in keratinocyte activation. The
subset of circulating memory T cells with cutaneous tropism (CLA) positive cells in psoriasis
contains increased percentage of activation markers like HLA-DR, CD25 and CD69. This is an
indication that circulating memory CLA positive cells may traf®c between blood and psoriasis
lesions and may be implicated in the pathological mechanisms. The purpose of this study was to
determine the production of IL-17 by puri®ed CLA positive and CLA negative cells memory T
cells from individuals with psoriasis (n = 4), atopic dermatitis (n = 3) and healthy controls (n = 3).
Cell isolation of both CLA positive and negative memory T subsets was performed by an
immunomagnetic procedure and cells were activated with anti-CD3 and anti-CD28 after 5 days in
culture. IL-17 was analyzed by ELISA in the 48 h supernatant after activation. Our data indicate
that the CLA positive subset produce higher amount of IL-17 than the CLA negative subset.
Among the three groups studied, IL-17 production by CLA positive cells was: psoriasis
(2.6 6 0.3 ng per ml), controls (1.0 6 0.4 ng per ml) and atopic dermatitis (0.3 6 0.2 ng per ml).
The levels of IL-17 produced by the CLA negative subsets were: 0.7 6 0.1; 0.3 6 0.07; and
0.07 6 0.06 (ng per ml) for the three groups, respectively. This data indicate that IL-17 is produced
in high amounts by circulating skin-homing T cells during psoriasis. This is the ®rst data showing
IL-17 production by circulating CLA positive memory T cells.
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Decreased IL-10 Production by Psoriatic Peripheral Blood Mononuclear Cells
Stimulated with Streptococcal Superantigen
S. Aiba, Z. Mollar, S. Nakagawa, S. Sugawara, H. Rikiishi, K. Kumagai, and H.Tagami
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan
The strong association of acute guttate psoriasis and streptococcal throat infection has suggested a
role of streptococcal antigens in the pathogenesis of psoriasis. We have reported that psoriatic
peripheral blood mononuclear cells (PBMCs) showed signi®cantly lower responses to cytoplasmic
membrane-associated protein (CAP) isolated from group A b-hemolytic streptococci, a kind of
streptococcal superantigen. To evaluate the abnormal cytokine production by psoriatic PBMCs to
streptococcal superantigen, CAP, we compared the production of 4 different cytokines, i.e. IL-4,
IL-5, IL-10, and IFN-g, by PBMCs between 13 psoriatic patients and age-matched 16 healthy
controls after the stimulation with CAP or two staphylococcal superantigens, staphylococcal
enterotoxin A (SEA) or E (SEE). When PBMCs were stimulated with CAP, the production of IL-
10 was signi®cantly lower by psoriatic PBMCs than by those from healthy controls, whereas that of
IL-4, IL-5, or IFN-g was not different between the two groups. Such a signi®cant decrease in IL-
10 production by psoriatic PBMCs was not observed when they were stimulated with
staphylococcal superantigens. Flow cytometric analysis of intracytoplasmic IL-10 demonstrated
that the defective IL-10 production by psoriatic PBMCs was recognized in both CD3+ T cells and
CD14+ monocytes. There was a signi®cant positive correlation between IFN-g production by
PBMCs and the proliferation of Vb8+ T cells which was preferentially stimulated by CAP. These
data demonstrating the defective IL-10 production by psoriatic PBMCs stimulated with
streptococcal superantigen can explain the reason why only psoriatic patients evolve the sustained
and Th-1 deviated skin lesions after streptococcal upper respiratory infection.
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Interleukin 4-Induced Immune Deviation as Therapy for Psoriasis
K. Ghoreschi, P. Thomas, S. Breit, T. Biedermann, J. Prinz, C. Sander, G. Plewig, and M.
RoÈcken
Dermatology, Ludwig-Maximilians University, Munich, Germany
The in¯ammation leading to the manifestation of psoriasis is dominated by interferon-g producing
type 1 T cells. Immune deviation of type 1 into interleukin 4 (IL-4) dominated type 2 responses
improves in¯ammatory autoimmune diseases in mice. Since IL-4 is most potent in inducing a type
2 phenotype in T-cells of human origin, we investigated safety and ef®ciency of systemic IL-4
therapy in patients with severe psoriasis (phase Ib study). Five groups, each including 4 patients,
received increasing doses of IL-4 over 6 weeks. The ®rst group received the lowest dose. IL-4 dose
was increased by factor of 2 in each group. The follow up included weekly PASI documentation,
skin biopsy and analysis of immune parameters potentially affected by IL-4. A total of 22 patients
was recruited, 20 terminated the study. Two interrupted and one had side-effects grade II. In 18/
20 patients PASI decreased by 60±80% within six weeks and no rebound occured during the 6
weeks of follow up. Patients treated with higher doses of IL-4 had statistically better improvement
than patients treated with low doses of IL-4. Ef®cient therapy was associated with a decrease of skin
in®ltrating cells and a normalisation of the epidermal structure. Blood cell counts remained
unchanged during IL-4 therapy except of an increase of the eosinophil fraction. Cytokine analysis
of freshly isolated lymphocytes revealed an increase in IL-4+CD4+ T-cells, whereas the fraction of
IL-2+CD4+ T-cells remained unchanged. Monocytes showed a higher CD23 expression during
IL-4 therapy. Importantly serum IgE levels and IFN-g production to unrelated recall antigens were
not in¯uenced. Thus, the data strongly suggest that IL-4 therapy improved psoriasis by immune
deviation affecting exclusively the recently activated T-cells.
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Therapeutic CD11a Ligation Transmodulates Surface Expression of b1 and b2 Integrins
on T-Lymphocytes
J. Krueger, M. Kagen,* R. Nussbaum,* P. Gilleaudeau,* T. Kikuchi,* S. Bodary, and P. Walicke
Genentech, Inc., South San Francisco, California; *Rockefeller University, New York, New York
Anti-CD11a is a nonlymphocyte depleting, humanized monoclonal antibody under investigation
for treatment of moderate to severe plaque psoriasis. CD11a (aL integrin) combines with CD18
(b2 integrin) to form LFA-1, the ligand for ICAM. b2 integrin also forms heterodimers with aM
(CD11b) or ax (CD11c) to constitute the related adhesion molecules, Mac-1 and p150,95.
Lymphocytes also bear two integrins from a separate family which bind to VCAM, a4b1 (CD49d/
CD29, VLA-4) and a4b7. Using FACS analysis, we have measured CD11a, CD11b, CD11c,
CD18, CD49d, CD29, and b7 on circulating T-lymphocytes from psoriatic patients before and
after 14 days of treatment with 2.0 mg/kg/week SC anti-CD11a. At baseline, LFA-1 was expressed
on 99%, VLA-4 on 88%, CD11b on 31% and CD11c on 4% of circulating T-cells. At Day 14 of
treatment, surface expression of CD11a was down-regulated 86% (p = 0.002), as re¯ected by
binding with a noncompetitive antibody. Assay with a competitive antibody showed 95% of
residual surface CD11a was occupied by the therapeutic monoclonal. CD18 surface expression was
reduced by a mean of 86% (p = 0.005). The frequency of CD11b+ cells was reduced by a mean of
65%, but the MFI values for the remaining positive cells was unchanged. Neither the proportion or
MFI staining changed for CD11c + cells. Surface expression of VLA-4 was reduced by a mean of
72% (range 68±77%, p = 0.0001), with consonant reductions in b1 or b7 subunits. Down-
regulation of surface integrins was not observed on lymphocytes after short-term incubation in
vitro. These data suggest a novel in vivo effect of CD11a ligation leading to transmodulation of
related and unrelated integrins. Since endothelial cells in psoriatic plaques up-regulate both ICAM
and VCAM, combined down-regulation of LFA-1 and VLA-4 may effectively inhibit cutaneous
T-cell traf®cking, leading to the reduction in plaque T-lymphocyte number observed in patients
treated with anti-CD11a.
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Alefacept Inhibits IFNg Production by Normal and Psoriatic Peripheral Blood T cells
and Enhances the Action of UVB
H. Sugiyama, S. Kobayashi,* R. Gyulai,* K. Cooper,* S. Stevens,* T. McCormick, A. Vaishnaw,
and D. Shrager
Department of Dermatology, Yamanashi Medical University, Yamanashi, Japan; *Department of Derm.,
University Hosp. Research Institute and Case Western Reserve University, Cleveland, Ohio; ²Biogen, Inc.,
Cambridge, Massachusetts
Psoriasis is mediated, in part, by activated T-cell production of IFNg. Alefacept (human LFA-3/
IgG1 fusion protein, LFA3TIP, currently being developed under trade name AMEVIVE(tm))
shows inhibitory effects on T cells in vitro and in vivo. Phase 3 clinical trials of alefacept are ongoing
in psoriasis. UVB irradiation remains one of the most effective treatments of psoriasis, and we
previously reported that a single in vivo UVB exposure can selectively decrease T-cell IFNg
production. To investigate effects of alefacept on T-cell IFNg production, PBMC from normal
individuals (n = 7) or psoriatic patients (n = 7) were activated and IFNg production was measured
by ¯ow cytometry. For 8 mg per ml alefacept-treated nonpsoriatic PBMC, the number of IFNg+ T
cells decreased in 5/7 cases (20±90% reduction), increased in 1/7 or remained unchanged in 1/7.
In psoriatic PBMC, 8 mg per ml of alefacept caused a decrease in IFNg production in 6/7 patients
tested, with a mean 56 6 0.12% reduction (p < 0.005). PBMC populations could be divided into 2
groups based on IFNg production, high (10%) or low (< 10%) IFNg+CD3+. When considered
separately, both nonpsoriatic and psoriatic high producers were effectively inhibited by 8 mg per ml
alefacept, with a mean reduction of 56% and 65%, respectively. By contrast, low producers showed
little inhibition. AntiFcg RI & III mAb pretreatment abolished the reduction of IFNg by alefacept.
When PBMC populations were pretreated with UVB irradiation (0±20 mJ per cm2), alefacept
enhanced UVB-induced apoptosis and further decreased IFNg by 32.2% (p = 0.009, n = 3). These
results indicate that alefacept inhibits T-cell IFNg production, that an interaction with FcgR
bearing cells is required, and that its combination with UVB may prove effective in reducing the
number and activity of Th1-type cells in the psoriatic lesion.
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A Three-Month Multiple-Dose Toxicity Study of Alefacept in Baboons
C. TenHoor
Biogen, Cambridge, Massachusetts
The toxicity of alefacept (human LFA-3/IgG1 fusion protein, LFA3TIP, currently being
developed under the trade name AMEVIVE(tm)) was evaluated after repeat IV administration to
baboons. 24 baboons were randomized into 4 groups of 3 males and 3 females. Control animals
received saline; treated animals received alefacept doses of 0.1, 2, or 40 mg per kg per week (equal
to, 20 times, 500 times the intended clinical dose [7.5 mg IV], respectively) for 13 weeks. On Day
93, 1 male and 1 female from each group was sacri®ced. The remaining animals were evaluated for
7 months and sacri®ced on Day 316. No mortalities or clinical signs of toxicity were observed
during the dosing or postdose recovery phases. In addition, no evidence of infectious compromise
or neoplastic changes were observed. Alefacept-related changes were limited to dose-dependent
decreases in peripheral and tissue-associated lymphocyte counts. Despite use of doses 500 times the
intended clinical dose, no T-cell subset was fully depleted. The effects on lymphocytes showed
evidence of saturability. Peripheral CD2+ and CD4+ T-cell reductions plateaued at approximately
80% below baseline in the 2- and 40-mg per kg per week groups. No gross abnormalities were
noted in any animal. At the tissue level, alefacept resulted in distinct decreases in cellularity of T
cell-speci®c regions of the spleen and lymph nodes. By Day 316, peripheral lymphocyte counts had
returned to predose baseline levels in the 0.1-mg per kg per week group and continued to recover
toward baseline levels in the 2- and 40-mg per kg per week groups. Tissue changes remained
evident in the spleens of the recovery sacri®ce animals from the 40-mg per kg per week group;
however, the extent of these changes was less evident than in those animals evaluated on Day 93.
In conclusion, despite prolonged lymphocyte reductions, no signs of toxicity or infectious
compromise were observed following weekly administration of alefacept at doses in excess of 500-
fold greater than those administered clinically. Effects on peripheral lymphocytes were saturable.
Doses consistent with the intended clinical dose showed complete lymphocyte recovery.
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Autoantibodies to 155 kDa and Se Antigens in Patients with Clinically Amyopathic
Dermatomyositis
R. Sontheimer, I. Targoff,* E. Trieu,* and D. Racila
Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa; *Internal Medicine, Oklahoma
Medical Research Foundation, Oklahoma City, Oklahoma
Patients (pt) with con®rmed clinically-amyopathic dermatomyositis (C-ADM) have not been
studied systematically for myositis-related auto-antibodies (aab). In this study, an ANA-positive
serum from a pt (Se) with C-ADM immunoprecipitated (IPP) a series of protein bands from HeLa
cell extract of approx. 155, 140, 120, 95, 90, and 50 kd. By IPP, the 155 and 140 kd bands matched
in size those of anti-155 kd, an aab that has also been found in some pt with classical DM.
Absorption studies indicated that this represented anti-155 kd in association with a second aab
labeled anti-Se (the 90-95 kd doublet). Sera of 17 additional C-ADM pt were studied (systematic
testing for myopathy by EMG, biopsy and imaging was not performed on all pt, i.e., the
designation ``clinically-amyopathic''). 3 of the 17 were members of the same family. By IPP, sera
from 12 of 17 (71%) showed a protein of 155 kd consistent in size and appearance with anti-155
kd; 3 of the 5 others showed a protein of roughly similar size but somewhat different in appearance.
5 also showed the typical doublet of Se (29%), while 6 others showed one band possibly consistent
with Se. No associated nucleic acid was consistently seen in the immunprecipitates (IPPs). Western
blot of anti-Se IPPs showed that 5 of 18 (28%) (including Se) reacted with bands in the 95 kd
region. The 3 family members also reacted with at least one band in this region. 10 of 18 (56%)
reacted with one or more additional bands (110 and 120 kd) IPP by Se. 6 of 18 sera (33%) reacted
by blot with the 155 kd band, all of which also reacted with other bands of Se IPPs. Combining
blot and IPP data, 16 of 18 (89%) C-ADM pt showed aab to a 155 kd protein and/or an Se protein.
None of the 18 pt had a myositis-speci®c aab (e.g., Jo-1). Thus, anti-155kd and anti-Se aab are
common in C-ADM, while MSAs are not.
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Analysis of the Effector Cells of Autoimmunity in Transgenic Mice Overexpressing
CD40L in the Epidermis
A. Mehling, T. Luger, T. Schwarz, S. Grabbe, and S. Beissert
Cell biology, Universitaets Hautklinik, Muenster, Germany
CD40/CD40L interactions play a pivotal role in immune-mediated in¯ammatory responses via
activation of antigen presenting cells (APC). To investigate the effects of continuous activation of
the APC of the skin, the Langerhans cells (LC), CD40L expression was targeted to the epidermis of
mice using the keratin-14 promoter. As previously reported, 80% of the CD40L transgenic (Tg)
mice developed dermatitis on the ears, face, tail and/or paws. Surprisingly, they also develop a
systemic autoimmune disease as evidenced by the presence of ANAs, antidsDNA antibodies and
the typical internal organ involvement. Compared to their littermates, Tg mice had a 90% decrease
in LC numbers within the epidermis yet increased numbers within the dermis. DC in the
hyperplastic LN draining from in¯ammed skin of Tg mice exhibited enhanced levels of the
activation markers I-A, CD80 and CD86. Increased numbers of FITC+/CD11c+ in the LN of Tg
mice compared to WT mice following topical application of the hapten FITC were found
indicative of enhanced emmigration of CD40±activated LC. The in®ltrate of the skin consisted of
CD4+ and CD8+ T cells and BM8+ cells. To further substantiate the role of T cells as effector cells
of local autoimmune skin in¯ammation, T cells from the draining LN of Tg mice were transferred
into nontransgenic recipient mice. Only the transfer of T cells from Tg mice evoked the
development of skin lesions similar to those found in the Tg mice. Dermatitis was not dependent
on B cells or immunoglobulins as CD40L Tg backcrossed into the B cell de®cient strain JHT also
developed dermatitis. These ®ndings indicate that in situ activation of LC by CD40L in the skin not
only leads to chronic in¯ammatory dermatitis but also to systemic mixed connective tissue-like
autoimmune disorders. CD40L Tg have the potential of being an excellent model for dissecting the
T cell and immunoglobulin dependent pathways in the pathogenesis of these type diseases.
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Induction of Autoimmune Skin Disease by Passively Transferred T cell?@Receptor
Transgenic T Cells into Keratin 14-Ovalbumin Transgenic Mouse
A. Shibaki, A. Sato, and S. Katz
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
To understand the mechanisms involved in immunological tolerance to skin-associated antigens,
we have developed transgenic (Tg) mice that express a model self-antigen, membrane bound
chicken ovalbumin (OVA), under the control of a keratin 14 (K14) promoter. These K14/OVA
Tg mice express OVA mRNA in the epidermis, do not exhibit any phenotypic abnormalities, and
have similar CD4/CD8 distributions as their littermate controls. Proliferative responses of draining
lymph node (LN) cells were assessed after subcutaneous immunization with OVA + CFA and were
markedly reduced in the Tg mice compared with their littermate controls, suggesting that the Tg
mice were tolerant to OVA. When CD8+ T cells from OVA speci®c T cell receptor (Va2/Vb5)
Tg mice (OT-1) were injected IV into the K14/OVA Tg mice on day 0, OT-1 T cells expanded
and accumulated in LN draining the skin (0.5%, 6.4%, 10.5% of cells in LN on day 2, 4, 7,
respectively). The accumulated T cells that were identi®ed by their Va2/Vb5 transgene exhibited
activation markers (CD25+, CD44Hi, CD62LLo). Furthermore, GVHD-like skin lesions
(accumulation of dermal mononuclear cells and the presence of dyskeratotic cells in the epidermis)
appeared by day 7. There was also signi®cant reduction in thymic size in the Tg mice that received
the OT-1 CD8+ T cells. These studies demonstrate that the K14/OVA Tg mouse can serve as a
good model for the investigation of the pathogenesis, treatment and potential prevention of cell-
mediated autoimmune reactions in skin.
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Topical Application of Interleukin-7 Plasmid DNA Reduces Severity of Skn(Skin)-
Directed Autoimmunity
P. Staton, A. Carpenter, and S. Jackman
Department Microbiology, Immunology & Molecular Genetics and Department Pathology, Marshall
University School of Medicine, Huntington, West Virginia
Previous work has shown that transfer of autoreactive lymphocytes targeted against the mouse
epidermal cell antigens, Skn, can cause skin lesions in recipient animals. This response is contingent
not only on the introduction of autoreactive cells, but also, on the inability of recipient animals to
control the attack. Control of the autoimmune response can be restored by cotransfer of normal
CD4+ T cells and is evident by reduced severity of lesions. Analysis of cytokine gene expression at
the skin site of lesion control revealed a signi®cant increase in interleukin (IL)-7 mRNA. The
current study examined whether exogenous IL-7 delivery by topical application of DNA could
control lesions without the cotransfer of normal CD4+ T cells. Animals were prepared for Skn-
directed autoimmune attack and 5 micrograms of plasmid DNA containing the IL-7 gene was
applied daily to skin sites adjacent to the location of potential lesions. Control animals received
either plasmid DNA without the IL-7 gene or no plasmid. The animals were observed for 7±
12 days and lesions were scored on a scale of 1±5. Delivery of plasmid containing IL-7 signi®cantly
reduced the severity of lesions (lesion score 1.4), as determined by both gross and histologic
examination, when compared to either control group (lesion score 3.3), p < 0.01. Lesion control
was attributed to the presence of plasmid IL-7 gene expression and not to endogenous production
of IL-7, in that, mRNA for plasmid IL-7 identi®ed by a FLAG marker accounted for 99% of the
messages detected at the skin site. These results strongly suggest that topically applied cytokine
DNA can be delivered to target skin sites and may be of value in the treatment of certain skin
disorders.
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Phenobarbital-Induced Eruption: The Drug Preponderantly Stimulates Th2 Cells
Bearing Particular TCRBVs without its Processing
H. Hashizume, Y. Tokura, and M. Takigawa
Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Phenobarbital has a high potential to elicit adverse reactions compared to other drugs. Although
phenobarbital hypersensitivity is thought to be mediated mostly by T cells speci®c to the drug, its
precise mechanism remains unfully elucidated. To characterize T cells reactive with phenobarbital,
we generated drug-speci®c T cell line cells (TCC) from peripheral blood mononuclear cells from
patients with phenobarbital-induced eruption. We found that the majority of TCC were Th2 cells
and some of clones expressed cutaneous lymphocyte-associated antigen. CD4+TCRBV13.1+
phenobarbital-speci®c clones were generated from three individuals with different HLA
haplotypes, and these cells had an ability to proliferate in response to the antigen with
processing-impaired, ®xed antigen-presenting cells (APC). The lack of necessity of processing and
the common usage of particular TCRBV in different individuals suggest that the response is clearly
different from the conventional one with regard to T cell±APC interaction. Our observations are
important to reveal the unsettled mechanism of immune response against such small compounds as
drugs.
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Exocytosis of Cells Stained by Anti-CYP2C9 Antibody in the Mefenamic Acid-Induced
Fixed Drug Eruption
A. Lee, H. Joo, W. Choi, B. Chun, and K. Lee
Dermatology, Eulji Hospital University of Medicine, Seoul, South Korea
Although skin tests with offending drugs have been tried for the diagnosis of drug eruption (DE),
there is no information about the nature of antigen. Metabolic processes of drugs would be
preceded to become antigenic, and cytochrome P450s (CYPs) may participate an antigen
formation through the generated metabolite. The aim of this study was to examine the role of
CYPs in ®xed drug eruption (FDE). 3 cases of FDE caused by mefenamic acid were included in
the study. 2 samples were obtained from a biopsy of lesion, and one was from a biopsy of positive
patch test. The paraf®n-embedded specimens were stained with anti-CYP isozyme antibodies,
1A1, 2C9, 2E1 and 3A4. To identify the cells stained with the antibodies, antikeratin antibody and
antibody for leukocyte common antigen (LCA) were also used. Specimens from negative patch test
and lesions caused by doxyxycline were used for control to compare the results. All sites induced by
mefenamic acid showed exocytosis of in¯ammatory cells stained with LCA. The cells were mostly
stained by anti-CYP2C9 antibody, which was not observed in control specimens. The results
supported that CYPs play a role in occurrence including antigen formation of FDE, and
in¯ammatory cells including lymphocytes would be an important source of the CYPs, although the
reason for recurrence of FDE on the same sites still remains to be clari®ed.
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Peptide ELISA for Detection of Circulating Autoantibodies Against Desmoplakin in
Erythema Multiforme
G. Hinterhuber, Y. Marquardt, R. Horvat,* K. Wolff, and D. Foedinger
Dermatology, University of Vienna, School of Medicine, Vienna, Austria; *Clinical Pathology, University of
Vienna, School of Medicine, Vienna, Austria
Autoantibodies directed against desmoplakin I and II have been identi®ed recently in a subset of
patients with erythema multiforme. Subsequently, a speci®c peptide sequence (YSYSYS) localized
within the very carboxy terminal domain of desmoplakin thought to be responsible for the
assembly of keratin ®laments to the desmosomal plaques was identi®ed as antibody binding
epitope. Sera were tested by immunoblotting, immunoprecipitation and dot blot analysis to varify
the presence of peptide speci®c antidesmoplakin autoantibodies. These methods are laborious and
time consuming. The aim of this study was to establish an enzyme-linked immunosorbent assay
(ELISA) to evaluate serum samples from patients with erythema multiforme for the presence of
peptide speci®c antidesmoplakin autoantibodies. A total of 7 serum samples of two patients with
de®ned peptide speci®c autoantibodies, serum samples of 20 additional patients with erythema
multiforme with and without antidesmoplakin autoantibodies characterized by immunoblotting
and immunoprecipitation and sera of 20 healthy volunteers, were processed for ELISA on
microtiter plates coated with the corresponding synthetic peptide. Correlation of ELISA,
immunoprecipitation and dot blot was 100% and so was the correlation of the results from ELISA
and immunoprecipitation. We thus introduce a peptide ELISA as a practical tool for large scale
screening for peptide speci®c antidesmoplakin autoantibodies.
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An In Vitro Organ Culture Model for Toxic Epidermal Necrolysis
A. Qureshi, E. Letko, K. Bhol, M. Razzaque, C. Foster,* and A. Ahmed
Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts; *Immunology and Uveitis
Service, Massachusetts Eye and Ear In®rmary, Boston, Massachusetts
Purpose: To determine in vitro effect of serum obtained from patients with acute toxic epidermal
necrolysis (TEN) on normal human conjunctiva (NHC), normal human skin (NHS) and normal
human buccal mucosa (NHBM). Methods: Serum samples were collected from patients in the
acute phase of TEN and stored at ±80°C. The NHS, NHC and NHBM were cut into 2-3 mm2
pieces and cultured separately with 10-30% (v/v) of serum from TEN patients at 37°C for 1-12
hrs, 24, 36, 48 and 60 hours. Normal human serum was used as control. Each tissue was then
embedded in a paraf®n block. The blocks were cut and sections were stained with hematoxylin and
eosin, and stained with immunoperoxidase using antibodies to human Fas and Fas Ligand (Fas-
FasL). Results: Acantholysis and vacuolar degeneration were dominant histopathologic features
observed in the epithelium of NHS, NHC, and NHBM cultured in 30% TEN serum after 24 hrs
of incubation. These ®ndings were not observed in the epithelium of NHS, NHC and NHBM
cultured with 30% normal human serum. In addition, by immunoperoxidase staining, compared to
normal serum treated tissues, an increased expression of Fas and FasL was seen in the epithelium of
TEN serum-treated tissues. Conclusions: The TEN serum induced identical morphologic and
immunohistochemical changes in vitro in the epithelium of NHS, NHC, and NHBM. This may
represent an in vitro model for TEN. The Fas/FasL mediated apoptosis may play a role in the
pathogenesis of TEN.
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Factors Secreted by B16 Melanoma Cells Induce Nitric Oxide Production in RAW 264.7
Macrophages ± is Nitric Oxide Contributing to B16 Melanoma Mediated
Immunosuppression and Tumor Facilitation?
S. Bradu, J. Michl, M. Nowakowski, J. Sieminska, and N. Brody
Dermatology, Pathology, SUNY- Brooklyn, Brooklyn, New York, New York
Previous work in our lab has shown that B16 mouse melanoma cells secrete yet unidenti®ed tumor
facilitating factor(s) (TFF). TFF promotes systemic tumor development in both nude and C57BL/6
J mice. TFF also systemically immobilizes macrophages away from sites of in¯ammation, inhibiting
both delayed type hypersensitivity (DTH) and lymphocyte mitogenic responses. Prompted by
recent evidence suggesting that Nitric Oxide (NO) plays a major role in the suppression of
antitumor defenses, DTH responses, and lymphocyte stimulation by antigens, we decided to
examine the effect of TFF on NO production by RAW 264.7 mouse macrophages. In vitro
treatment with TFF induced RAW 264.7 macrophage spreading which was similar to that
observed with mouse macrophages treated in vivo with TFF and plated on glass cover- slips. TFF
also resulted in a marked, dose dependent up-regulation of NO in RAW 264.7 cells, but not in
B16 melanoma cells. The NO up-regulation was not detected at 3 h after TFF treatment, but was
detected at 15 h. Flow cytometry of RAW 264.7 cells grown with or without TFF revealed
inducible Nitric Oxide Synthase (iNOS) up-regulation after treatment for 16 h with TFF. The
RAW 264.7 macrophages treated for 24 h with TFF and washed extensively every 24 h were still
producing NO after 72 h, and returned to basal NO production after 96 h. By using preparative
isoelectric focusing we have determined that the proteins at pI 4.1 and 4.8 coincide with crucial
measurements of TFF activity such as maximal NO production, macrophage spreading, and tumor
facilitation. The fraction at pI 4.1 promoted tumor growth in 6 of 10 mice, and that at pI 4.8 in 5
of 5 mice. In the control mice only 1 of 5 mice grew tumors. These ®ndings raise the possibility
that NO up-regulation induced by TFF may be involved in systemic immunosuppression and
tumor facilitation.
466
a(1,3) Fucosyltransferase VII De®cient Mice Exhibit Impaired Cutaneous Tumor
Immunity
S. Richardson, R. Fuhlbrigge, B. Rich, and T. Kupper
Harvard Skin Disease Research Center, Brigham and Women's Hospital, Boston, Massachusetts
Fucosyltransferase VII is required for the generation of the glycosylation epitope on PSGL-1 that
de®nes CLA, an E-selectin ligand important in the homing of memory T cells to skin. Mice
de®cient in this enzyme have impaired cutaneous hypersensitivity reactions, as well as other
leukocyte defects. To test the ability of these mice to mount effective antitumor immunity, wild
type and FucTVII±/± C57BL/6 (B6) mice were injected intradermally with live J558L BALB/c
plasmacytoma cells. As expected, tumors grew vigorously in syngeneic BALB/c mice, while they
were promptly rejected without any evidence for growth in wild type B6 mice. In FucTVII±/±
mice the tumors grew progressively until day 11, reaching an average size of 1.62 cm. Over the
next three weeks, they began to diminish in size. On day 6 after tumor implantation, the site was
analyzed by histology. WT B6 mice showed a signi®cant local in¯ammatory response consistent
with tumor cell rejection, while both B6 FucTVII±/± and BALB/c mice showed tumor growth
without an observable host in¯ammatory response. To determine whether this defect in cutaneous
tumor immunity was due to a lymphocyte defect, FucTVII de®cient mice were injected
intravenously with WT C57BL/6 lymph node cells at the time of tumor challenge. The transfer of
WT T cells from skin draining lymph nodes led to a dramatic decrease in the time required for
tumor rejection in FucTVII de®cient hosts; in contrast, WT T cells derived from mesenteric nodes
did not confer this activity. To determine whether the defect in tumor immunity was skin speci®c,
J558L cells were injected intraperitoneally. In BALB/c mice, they grew progressively as predicted.
In both WT B6 and FucTVII±/± B6 mice, no intraperitoneal tumor growth was perceptible. This
is the ®rst demonstration that FucTVII de®cient mice have a skin-speci®c impairment of tumor
immunity, and suggests that organ-speci®c homing T cells may play an important role in
immunosurveillance and rejection of tumors by the immune system.
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Melanoma CNS Metastases Display a Different Chemokine Secretion Pattern than Skin
or Lymph Node Metastases
A. Tun Kyi, G. Burg, and N. Nestle
Department of Dermatology, University of Zurich, Zurich, Switzerland
Migration and distribution of melanoma cells during metastasis is poorly understood. Recently,
chemokines, an increasing family of potent chemoattractants, were shown to play an important
role for the distribution and migration of leucocytes during in¯ammation. In the present study we
investigated chemokine and chemokine receptor pro®les in melanoma metastases from different
tissue sites (n = 20; 8 skin (S), 6 lymph node (LN) and 6 CNS (CNS) metastases). Assessment was
performed by PCR based semiquantitative mRNA expression analysis and immunohistochemical
analysis of biopsy samples as well as cell lines. Predominant expression of SDF-1a and MIP-3a was
found in melanoma samples during a PCR based screening process. In skin metastases 6 out of 8
and 4 out of 8 samples expressed MIP-3a and SDF-1a, respectively. In lymph node metastases 4
out of 6 and 5 out of 6 samples expressed MIP-3a and SDF-1a, respectively. In contrast, only 1
out of 6 CNS metastases expressed MIP-3a and 2 out of 6 SDF-1a. Expression pattern of MIP-3a
and SDF-1a was con®rmed by immunohistochemistry. Next we investigated the expression of
MIP-3a and SDF-1a receptors CCR6 and CXCR4. Both receptors were found to be expressed
on melanoma cells in vivo and in vitro. Our data suggest that chemokine expression pattern in CNS
metastases differ from pattern seen in skin and LN metastases. This ®nding might have implications
for tissue homing and redistribution of melanoma cells.
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Serum S100 Level is Predictive of Recurrence-Free Survival in Patients with
Intermediate Risk Melanoma
P. Amin, A. Bar, S. Reynolds, R. Shapiro,* M. Harris,* D. Roses, and J. Bystryn
Dermatology, NYU School of Medicine, New York, New York; *Surgery, NYU School of Medicine, New
York, New York
S100 has been recently explored as a serum marker for malignant melanoma; however, its utility to
predict prognosis remains controversial. In this study we examined whether the presence of S100
in the circulation is predictive of the prognosis of melanoma in patients with different stages of
disease. We measured serum levels of S100 in 126 patients with melanoma (58 with AJCC stage
IIB/IIIA, 48 with stage IIIB, and 20 with stage IV disease) using a double sandwich ELISA. We
found that 31% of patients with stage IIB/IIIA, 42% of those with stage IIIB and 40% with stage IV
melanoma were positive for S100. Recurrence-free survival was signi®cantly shorter in stage IIB,
IIIA, and IIIB patients who were S100 positive compared to S100 negative patients, i.e. by Kaplan
Meier analysis the mean time recurrence-free survival was 11.9 6 0.6 months vs.
20.3 6 0.8 months (p = 0.009). There appeared to be a correlation between the stage of disease
and the prognostic signi®cance of S100 level, as correlation with prognosis was best in patients with
stage IIB, IIIA, and IIIB disease and absent in patients with stage IV disease. These results suggest
that serum S100 levels may be a prognostic marker in patients with resected melanoma at
intermediate risk of recurrence.
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IFN-g Reduces Melanoma Tumor Antigen Expression and Recognition by Cytotoxic T
Cells
I. Le Poole, A. Riker, M. Quevedo, L. Stennett, J. Robinson, and B. Nickoloff
Pathology, Loyola University Chicago, Maywood, Illinois
Boosting the host immune response is currently the treatment of choice for metastatic melanoma.
Most CTL are reactive against melanosomal differentiation antigens, such as MART-1. Achieving
complete remissions by innovative immunotherapeutic strategies utilizing peptides derived from
target antigens is frequently hampered by metastatic lesions that evade immune recognition. In this
study, we sought to de®ne an immune escape pathway by exploring the in¯uence of a T cell
derived cytokine, IFN-g, present within the microenvironment of melanoma tumor cells.
Examination of primary and metastatic melanoma lesions by qRT-PCR revealed up to 188 fold
more abundant IFN-g transcripts when compared to control skin. Using laser capture
microdissection and immunohistology, the majority of IFN-g producing T cells were localized
to tumor stroma, accompanied by a halo of reduced MART-1 expression by the adjacent tumor
cells. IFN-g (100±1000 U per ml) enhanced HLA-DR expression, but markedly suppressed
expression of melanosomal antigens (e.g. MART-1, gp100 and TRP-1) in M14 melanoma cells as
shown by immunohistology and ¯ow cytometry, reducing MART-1 levels by 65%. IFN-g
mediated suppression of MART-1 was regulated at the transcriptional level as determined by
Northern blot analysis, and was dependent on the continued presence of IFN-g. To determine
whether exposure of tumor cells to IFN-g modulates recognition by CTL, HLA-A201 melanoma
cells treated with or without IFN-g were combined with A42 MART-1 reactive T cells.
Cytotoxicity was reduced up to 78% in a 51Cr release assay at effector: target ratios of 10:1 by IFN-
g pretreatment, and could be restored by addition of synthetic MART-1 peptide. Recognition of
normal melanocytes by A42 CTL was not reduced by IFN-g. Thus, while IFN-g is a type-1
cytokine generally regarded as enhancing cellular immune responses, these novel ®ndings indicate
that IFN-g can also reduce target antigen expression and recognition of melanoma cells by CTL.
The apparent sustained recognition of CTL to IFN-g exposed melanocytes in contrast to
melanoma cells may explain how some patients develop extensive vitiligo despite metastatic tumor
sites escaping immune recognition.
470
Identi®cation of Antibodies in the Serum of Patients with Melanoma-Associated
Retinopathy
C. PfoÈhler, C. Thirkill,² A. Palmowski,* A. Haus,* W. Tilgen, and U. Reinhold
Department of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany; *Department of
Ophthalmology, The Saarland University Hospital, Homburg/Saar, Germany; ²Ophthalmology Research,
University of Davis, Davis, California
Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome manifesting in association
with cutaneous melanoma. Signs and symptoms include night blindness, light sensations;
(photopsias), visual loss, and reduced b-waves in the electroretinogram. Retinal degeneration is
believed to result from the production of antibodies reactive with melanoma-associated antigens
which cross-react with epitopes of retinal bipolar cells. We recently analysed 26 melanoma patients
for the presence of subclinical MAR symptoms using scotopic electroretinography, static and
kinetic perimetry, nyctometry and the Farnsworth panel test for color vision. 6 patients showed all
typical signs of MAR, 17 were suspicious of MAR and only 3 had no de®nite signs of MAR. We
conclude, that some patients with cutaneous melanoma may experience a subclinical retinal
involvement suggesting MAR with an incidence more common than previously suspected. In
pursuing the antigenic source of the sensitization process we found that melanomas from the
primary and distant metastases of two of the MAR patients contain cells that express antigen(s) that
react with rabbit antiretina serum. The focus of antibody activity was clearly localized upon the
``rosette'' cell population within the malignancy. These data provide further evidence that the
MAR syndrome may be linked to the expression of antigen(s) able to induce the production of
autoantibodies cross-reactive with retina tissue, and that the ``rosette'' cell population may be the
prime contributor to the induction of this immunologic anomaly. Our ®ndings lead us to
hypothesize that under circumstances yet to be de®ned, loss of tolerance to the ``rosette''-expressed
antigen(s) occurs and if this aberrant reaction is accompanied by leaks in the blood±retina barrier,
the MAR syndrome develops.
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MART-1/MelanA and gp100/PMel17 Immunodominance Revisited: Direct
Enumeration of Frequency of Melanoma Differentiation Antigen (MDA)-Speci®c T-
Cells in Tumor Metastases TIL Cultures
S. Seiter, V. Monsurro, J. Wunderlich,* S. Rosenberg,* and F. Marincola
DTM, NIH, Bethesda, Maryland; *NCI, NIH, Bethesda, Maryland
Melanoma differentiation antigens (MDA) such as MART-1/MelanA and gp100/PMel17 are
considered immune dominant based on the observation that they are often identi®ed as targets of
tumor in®ltrating lymphocytes (TIL) originated from HLA-A*0201 expressing patients with
melanoma. Furthermore, clinical relevance was attributed to this dominance based on the
impression that the adoptive transfer of gp100-recognizing TIL was associated with clinical
responses in a small group of patients. Here, we enumerated MDA-speci®c T-cell precursor
frequency (Tc-pf) in TIL using tetrameric HLA/epitope complexes (tHLA) and functionally
characterized their responsiveness to cognate epitope by cytokine release assay. Tc-pf were
enumerated in 11 fresh tumor preparations and 17 TIL adoptively transferred into HLA-A*0201
bearing patients. Furthermore, the kinetics of TIL expansion in vitro was followed in four lesions by
serial documentation of Tc-pf. MART-1 or gp100-speci®c T cells could be detected in 5 and 2 of
the 11 fresh preparations and in 5 and 2 of the 17 adoptively transferred TIL. With one exception,
Tc-pf in fresh material and TIL ranged between 0.5 and 2.1%. Tc-pf was not signi®cantly higher in
TIL whose administration was associated with clinical response. These data provide evidence that
MDA immune dominance and their clinical in the context of HLA-A*0201 has been probably
overrated.
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Expression of Melanocortin-1 Receptor (MC-1R) in Normal, Malformed, and
Neoplastic Skin Glands and Hair Follicles
S. StaÈnder, M. BoÈhm,* T. Brzoska,* K. Zimmer,² T. Luger,* and D. Metze
Dermatology, Universitiy of MuÈnster, MuÈnster, Germany; *Ludwig Boltzmann Institute for Cell Biology
and Immunobiology of the skin, University of MuÈnster, MuÈnster, Germany; ²Pediatrics, University of
MuÈnster, MuÈnster, Germany
Proopiomelanocortin-derived peptides with neuroimmunomodulating functions have been
identi®ed in many nonpituitary tissues including the skin. To exert their function they bind to
melanocortin (MC) receptors. Recently, expression of melanocortin-1 receptors could be detected
in normal skin particularly in hair follicle epithelia, sebocytes, and sweat gland epithelia. In the
present study, the expression of melanocortin-1 receptor (MC-1R) immunoreactivity in various
cutaneous malformations and neoplasms with adnexal differentiation was examined. A speci®c
antimelanocortin-1 receptor-antibody was applied to a total of 95 skin samples of hamartomas,
cysts, hyperplasias and benign or malignant neoplasms of eccrine, apocrine, sebaceous glands, and
hair follicles. Immunoreactivity was widely preserved in all of the samples as compared to normal
skin and only slight variations with regard to maturation of the neoplasm were found. The adnexal
epithelia showed a preferential intracytoplasmic granular in addition to an intercellular staining
pattern. Immunoelectron microscopical investigations revealed expression of MC-1R both along
the cell surface and within tubular endosomes suggesting internalisation of the receptor. In
summary, MC-1 receptor expression is widely preserved in various adnexal malformations and
neoplasms of the skin. Since alpha-melanocyte stimulating hormone has been shown to increase
sebum production in rodents, our ®ndings suggest a potential role of the MC-1R also in sweat
gland function, follicular proliferation, as well as in tumorgenesis.
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Expression of Melan-A/MART-1 Antigen as a Prognostic Factor in Primary Cutaneous
Melanoma
J. Cerottini, M. Berset, D. Rimoldi,* D. Guggisberg, P. Romero,* F. Burri, and R. Panizzon
Dermatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; *Ludwig
Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland
In the past decade, analysis of the immunogenic properties of human melanomas has allowed the
identi®cation of a wide array of melanoma associated antigens recognized by speci®c cytolytic T
lymphocytes. This study assessed the expression of one of these, the Melan-A/MART-1 antigen,
by immunohistochemistry using mAb A103 in 73 primary cutaneous melanomas and its correlation
with tumor staging and patient survival over 10 years. Melan-A/MART-1 was expressed in 90% of
primary tumors, with loss of expression increasing with Breslow thickness (p = 0.003). Kaplan-
Meier analysis demonstrated a signi®cantly reduced disease-free interval (p = 0.002) and overall
survival rate (p = 0.005) for patients not expressing this antigen. The effect of Melan-A/MART-1
absence on survival was maintained when compared to Breslow thickness in a Cox multivariate
analysis (p = 0.05). The poor prognosis of such patients increased when considering those
presenting with a primary melanoma and a Breslow thickness of > 1 mm (disease-free interval p
< 0.0001; overall survival rate p = 0.0006). Our study suggests that assessment of Melan-A/
MART-1 expression, besides being useful in the diagnosis of primary cutaneous melanoma and the
monitoring of patients in Melan-A/MART-1 vaccination trials, may also provide an additional
factor to re®ne the prognosis of patients with a primary melanoma thicker than 1 mm as measured
by Breslow.
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Cutaneous T Cell Lymphoma is an Antigen-Driven Malignancy Stimulated by Dendritic
Cells
C. Berger, D. Hanlon, D. Kanada, and R. Edelson
Dermatology, Yale University, New Haven, Conneticut
Cutaneous T cell lymphoma (CTCL) cells have been dif®cult to propagate limiting study of the
factors which stimulate their uncontrolled growth. To overcome these problems, we have
developed a long-term culture system in which CTCL lymphocytes and dendritic antigen-
presenting cells (APC) proliferate for at least 3 months. The cultures contain aggregates of CTCL
cells around dendritic cells (DC) reminiscent of Pautrier microabscesses. Proliferation requires
contact of the CTCL cell T cell receptor (TCR) with the cocultured transitional DC.
Leukapheresed CTCL cells were cultured at 30 3 106 per well in media containing GMCSF/IL4
and IL2/IL7. Proliferation was measured with 3[H]-thymidine. Cells were immunophenotyped
for membrane CD83, class II, CD80, CD86 and cytoplasmic CD83 and DC-Lamp. In replicate
cultures, reproducibly established from 5 CTCL patients, both the CTCL cells (15x inc) and the
DC proliferated (4x inc) throughout the 3 month culture period. Either cell type cultured alone
with supportive cytokines died within 3 weeks. CTCL cells were CD4+, CD8±Vb+ and retained
the initial clonal PCRg and b-chain rearrangements. The DC were a mixture of CD14±, class II+,
CD86+, CD80+ immature cells (60%) and CD83+, class II+, CD80+, DC-Lamp+ (40%)
maturing DC. The proliferation of the CTCL cells was inhibited with antibodies (AB) to the TCR
Vb and DC growth was inhibited by CD40 AB. Neutralizing AB to CTCL cell IL10 and the
addition of apoptotic tumor cells resulted in a 37% increase in DC maturation to CD83+/class II+
cells. These studies present the ®rst method for readily establishing long-term cultures of CTCL
cells and maturing DC. This culture system represents an in vitro model for study of the in vivo
pathognomonic hallmark of CTCL,the Pautrier microabcess. Moreover, these studies are the ®rst
demonstration of an antigen-driven T cell malignancy and the reproducible establishment of APC
cultures that can mature into DC in vitro.
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Partial Tumor Regression in Cutaneous T Cell Lymphoma Induced by Anti-Idiotype
Vaccination
J. Muche, T. Sherev, R. Demine, A. Lukowsky, S. Gellrich, H. HolzhuÈtter, W. Sterry, and P.
Walden
Dermatology, ChariteÂ Berlin, Berlin, Germany; *Biochemistry, ChariteÂ Berlin, Berlin, Germany
Peptides derived from the complementarity determining region (CDR)-3 of the tumor-speci®c T
cell receptor (TCR) were found to be recognized by autologous HLA class-I restricted CD8+ T
cells. The present study aimed to identify immunogenic idiotype sequences and to determine their
capacities to induce clinical and immunological responses in CTCL patients. After sequencing the
tumor-speci®c TCRbeta junctional region of four patients with different HLA types, epitopes
were predicted that match both, the proteasome cleavage speci®city and the binding requirements
of the respective HLA molecules using an own algorithm for the former and the SYFPEITHI
database for the latter. CD8+ T cells speci®c for the nonapeptides with the highest predictive
scores were demonstrated in all patients by intracellular IFNgamma staining of peptide activated
cells. In one patient with tumor stage Mycosis fungoides, vaccination with these nonapeptides
together with helper T cells inducing antigens led to partial remission of the tumor nodules. Each
vaccination boostered enhanced frequencies of peptide-speci®c CD8+ T cells in the peripheral
blood. Since tumor-speci®c TCRb DNA but not mRNA was detected in the remaining tumors,
resistance of the neoplastic cells in this case might be mediated by down-regulation or loss of
expression of the tumor-speci®c TCR.
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Functional Characterization of a CD8+CD56+CD45RA+ Malignant T-Cell Line Derived
from a Patient with Unusual CD8+ Sezary Syndrome
H. Yagi, A. Ohshima, Y. Tokura, and M. Takigawa
Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
We established a malignant T-cell line from blisters developing on erythrodermic skin of a patient
with unusual CD8+ Sezary syndrome. The cells showed a CD3low CD2high CD4± CD7± CD8+
CD45RA+ CD45RO± CD56+ CLA+ phenotype. More than 40% of the patient's peripheral blood
lymphocytes (PBL) and 98% or more of cells from blisters had this phenotype. Southern blot
analysis with probes for TCR Cb1 of the patient's PBL and skin specimen exhibited identical
rearranged nongerm line bands. Fresh and long-term-cultured tumor cells proliferated well in
response to IL-2, IL-7 and Con A when cultured for 3 days. Both IL-2 and Con A induced tumor
cell apoptosis and necrosis. On the other hand, IL-7, known as a Sezary cell growth factor,
prevented the cells from apoptosis by retaining a high level of Bcl-2 expression and allowed them
to live over 2 months, while IL-2 induced a marginal enhancement of Bcl-2 expression only for
the ®rst 2 days of culture. By RT-PCR for mRNA expression of cytokines, the cells transcribed
the message for IL-10 and IFN-g but not for IL-2, IL-4 or IL-5 even in the presence of Con A. As
assessed by ELISA of culture supernatants, they produced IL-10, IFN-g, TNF-a and TGF-b1
upon stimulation with Con A. Although the amount of TGF-b1 produced by IL-7-stimulated cells
is higher than that by Con A-cultured cells, IL-7 did not stimulate them to secrete IFN-g or TNF-
a, demonstrating selective production of TGF-b1 by IL-7. The cells did not substantially express
TGF-b receptor type II (TGF-bRII) and, unlike normal T cells, its expression was not enhanced
by Con A stimulation. These results demonstrated that this unusual IL-7-dependent CD8+ Sezary
cells expressed a surface NK cell marker and had a NK1-type cytokine pro®le (IL-10 and IFN-g)
despite their virtual T-cell origin. The production of TGF-b1 and the loss of TGF-bRII
expression suggest that this unique malignant T cell is capable of escaping from tumor
immunosurveillance by virtue of TGF-b1 without self-suppression by this cytokine, leading to
aberrant growth of tumor cells and disease progression.
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Impaired CD40 Ligand Expression and Signaling in SeÂzary Syndrome Results in
Defective Interleukin-12 and TH1 Cytokine Production: Restoration by Recombinant
Soluble CD40 Ligand Stimulation
L. French, R. Shane,* B. Huard, M. Wysocka,* M. Zaki,* and A. Rook
Dermatology, Geneva University Hospital, 1211 Geneva 14, Switzerland; *Dermatology, University of
Pennsylvania, Philadelphia, Pennsylvania
Depressed cellular immunity in SeÂzary syndrome is considered to be partly due to defective TH1
cytokine production, but its mechanism remains to be de®ned. CD40-CD40 ligand (CD40L)
interactions are known to contribute to the development of TH1 responses by inducing the
production of interleukin-12 (IL-12). Here we show by FACS analysis that CD4+ T lymphocytes
of SeÂzary patients (7/7 cases) have a marked defect in CD40L expression upon activation in vitro.
This defect is not restricted to the CD4+/CD7- population, and is more pronounced in patients
with a high circulating tumor burden. In these patients, production of IFN gamma, TNF alpha and
IL-12 by peripheral blood mononuclear cells (PBMC) after in vitro T cell activation was also
strongly reduced, and most markedly in those with a high tumor burden. As a similar defect was
reproduced in healthy control PBMC by CD40L blockade, and no defect in CD40 expression was
detected in SeÂzary patient's APC, defective CD40L expression and signaling was thought to be a
possible cause. Indeed, incubation of PBMC from SeÂzary patients with recombinant soluble
CD40L + IFNg, but not IFNg alone, partially restored TNFa and IL-12 production. These data
suggest that defective CD40L expression contributes to reduced TH1 cytokine production in
SeÂzary syndrome, and that this can be restored in vitro by recombinant CD40L, representing
another potential immunotherapeutic approach to treatment of SeÂzary syndrome.
478
Control of Growth and Malignant Progression of Oncogene SV40-Driven Tumors by
CD4+ T Cells
N. MuÈller-Hermelink, R. Huss,* I. Foerster,² and M. RoÈcken
Dermatology, LMU, Munich, Germany; *Pathology, LMU, Munich, Germany; ² Microbiology, TU,
Munich, Germany
RIP1-Tag2 transgenic mice express the oncogene SV 40 T antigen (Tag) under the control of the
rat insulin promotor in b cells of the pancreas, early during embryogenesis. They develop tumors at
6 weeks of age and become ®rst anergic and T-ag speci®c CD4+ T cells are then deleted. At about
12 weeks, these tumors grow invasively and cause premature death due to a profound
hypoglycemia around week 14. Earlier data show that interferon-g-producing CD4+ Th1 cells
are highly effective in controlling transplanted tumors. Therefore we investigated the effect of Tag-
speci®c Th1 cells on growth and the development of MHC class II-negative endogenous tumors,
driven by a strong promotor. CD4+ T cells were derived from transgenic mice, with a T cell
receptor speci®c for the Tag peptide (362±384) and stimulated in vitro with peptide and anti-IL-4
mAb to generate Tag-speci®c Th1 cells. These Th1 cells were transferred at weekly intervals,
starting at 7 weeks after initiation of hyperplasia and neoangiogenesis. Blood glucose was
documented biweekly and animals were sacri®ced when blood glucose was < 30 mg per dL.
Tumor-growth, tumor-speci®c immune response and angiogenesis were monitored every 3
weeks. Adoptive transfer of Th1 cells prevented the decrease of blood glucose for almost 3 month,
surprisingly without inducing diabetes. Death was delayed from 14 to 25 weeks. The therapy was
associated with the appearance of tumorspeci®c Th1 cells in draining lymph nodes and a strong
in®ltrate of CD4+ and CD8+ T cells in the tumors. In contrast to experiments obtained with
CD8+ T cells, Th1-therapy did not eliminate single adenomas but obviously delayed tumor
growth and dedifferentiation, which is characterized by neoangiogenesis, development of dysplastic
cells and invasive growth. The data suggest a hereto unexpected role for antitumor immune
responses as they demonstrate not only that MHC class II-restricted Th1 cells are capable of
breaking tolerance and controlling growth of MHC class II-negative carcinomas, but act
predominantly by delaying the dedifferentiation-program dictated by the SV40 oncogene.
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Regulation of Transglutaminase 2 by Transforming Growth Factor-b1 in Dermal
Fibroblasts
S. Lee, S. Kim, and P. Steinert
LSB, NIAMS/NIH, Bethesda, Maryland
Transglutaminase 2 (TGase 2) is a calcium-dependent enzyme which mediates covalent cross-
linking between the?-carboxamide group of glutamine and the e-amino group of lysine. The
enzyme is known to cross-link intracellular proteins and extracellular matrix proteins.
Transforming growth factor-b1 (TGF-b1) has been reported to induce TGase 2 in hepatoma
cells, ocular trabecular meshwork and epidermal keratinocytes. This study was performed to
evaluate the role of TGF-b1 on TGase 2 expression and activity in dermal ®broblasts to explore its
possible function in regulation of extracellular matrix formation. Dermal ®broblasts treated with
TGF-b1 (0.2±5.0 ng per ml) were cultured in a 5% CO2 incubator for various times. Western blot
analyses for TGase 2 and ®bronectin and total TGase activity assay were performed with cell
extracts, and RT-PCR for TGase mRNA expression was performed with total RNA extracts.
TGase 2 expression was induced by TGF-b1 as time- and dose-dependent manners. In Western
blot analysis, maximal expression of TGase 2 was observed 18 h after TGF-b1 treatment at a
concentration of 1 ng per ml. Total TGase activities were concordant with the pattern of TGase 2
protein expression. TGase 2 mRNA expression was induced earlier than that of protein expression,
indicating the transcriptional regulation of TGase 2 by TGF-b1. TGF-b1 also induced ®bronectin
expression in dermal ®broblasts by Western blot analysis. The present study shows that TGase 2 is
induced by TGF-b1 in dermal ®broblasts, which in turn cross-links extracellular matrix proteins,
including ®bronectin. Our results suggest that TGF-b1 has an important role in the dermis to
control formation of extracellular matrix expression by mediation of TGase 2.
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Epidermal Growth Factor Up-Regulates Transforming Growth Factor-b Receptor Type
II in Human Dermal Fibroblasts via p38 Mitogen-Activated Protein Kinase Pathway
K. Yamane, H. Ihn, M. Kubo, and K. Tamaki
Department of Dermatology, University of Tokyo, Tokyo, Japan
TGF-b receptors (TbRs) are serine/threonine kinase receptors that bind to TGF-b and propagate
intracellular signaling through Smad proteins. TbRs are known to be repressed in some human
cancers and expressed at high levels in several ®brogenetic diseases. In the present study, we
demonstrated that EGF up-regulated the expression of typeII TGF-b receptor (TbRII) mRNA
and proteins, but not type I TGF-b receptor (TbRI), in human dermal ®broblasts. Actinomycin D,
an RNA synthesis inhibitor, signi®cantly blocked the EGF-mediated up-regulation of TbRII
mRNA expression, whereas cycloheximide, a protein synthesis inhibitor, did not block this up-
regulation. In addition, EGF treatment did not signi®cantly affect the TbRII half-life. EGF-
mediated induction of TbRII expression was inhibited by the treatment of ®broblasts with a
speci®c p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580, wherease mitogen-
activated protein kinase/extracellular signal-regulated kinase inhibitor PD98059 did not block up-
regulation of TbRII. Additionally, EGF induced TbRII promoter activity, which was signi®cantly
blocked by SB203580, not by PD98059. Co-transfection of the TbRII promoter with dominant
negative forms of p38 MAPK signi®cantly abolished the level of EGF induction. These results
indicate that EGF-mediated induction of TbRII expression occurs at the transcriptional levels,
does not require de novo protein synthesis, and involves the p38 MAPK signaling pathway. EGF
induction of TbRII expression may participate in a synergistic interplay between EGF and TGF-b
signaling pathway.
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Expression of p53, p21WAF±1 and Bax Proteins, and Apoptosis in Ischemia-Reperfusion
of Rat Skin
H. Iioka, M. Hatako, A. Tanaka, M. Kuwahara, S. Yurugi, and K. Niitsuma
Plastic Surgery, Nara Medical University, Kashihara, Japan
We investigated p53, p21WAF±1 and Bax proteins, and apoptosis to elucidate the cellular response to
ischemia-reperfusion of skin. Rat left lower limb was amputated retaining bone and femoral
vessels, and vessels were clamped to produce ischemic condition. After 6 h, the clamps were
removed, and the plantar skin was resected at various times up to 72 h after reperfusion. Expression
of three proteins was detected by Western blot analysis. Apoptotic cell was detected using TUNEL
assay. After reperfusion, the levels of p53 and p21WAF±1 proteins were signi®cantly higher in the
ischemia-reperfusion rats as compared with the sham-operated rats. However, the levels of Bax
protein did not show a signi®cant increase at any period studied. Apoptotic cells in both the
epidermis and dermis was not evident as compared with the sham skin, which were similar to that
in nontreated, normal skin. These results demonstrated that p53 and p21WAF±1 proteins were
accumulated after 6 h ischemia of the skin during reperfusion. Moreover, it is suggested that
accumulation of these proteins play an important role in survival of the skin, which may be caused
by inducing growth arrest of the cells, not apoptosis.
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Human Papillomavirus Oncoprotein Expression Alters Cell Cycle Kinase Expression
and Predisposes Animals to Cancer Development
S. Balasubramanian, J. Crish, A. Broome, F. Bone, E. Rorke, J. Sah, and R. Eckert
Physiology and Biophysics, and Dermatology, Case Western Reserve Univeristy School of Medicine,
Cleveland, Ohio
Human papillomaviruse (HPV) is a DNA tumor virus that has been implicated in the genesis of
cancer in various squamous epithelia, including the epidermis. The HPV oncoproteins E6 and E7
are thought to promote cell immortalization and subsequent cancer development by inactivating
the tumor suppressor proteins, p53 and pRB. To study the role of HPV in disease causation in skin
and other surface epithelia, we have developed a transgenic animal model in which the viral E6/E7
oncoprotein-encoding reading frame is targeted to skin using the human involucrin promoter.
These animals display extensive epidermal, oral and cervical hyperplasia, but no tumor formation.
In the present study, we characterize the cell cycle regulatory protein status in the epidermis of
these mice. We show that the hyperproliferation is correlated with increased expression of p53,
p21, p27, cdk2, cdk4, cdk6, cyclin D1 and cyclin E. This phenotype suggests an important role for
E7 in regulating cell cycle kinase function. In addition, treatment of the epidermis with 7,12-
dimethylbenz(a)anthracene (DMBA) results in preferential papilloma formation in E7 mice vs.
controls. Moreover, treatment of the oral cavity with 4-nitroquinoline-1-oxide (4NQO) results in
the formation of large oral tumors in E6/E7 but not control mice. Our results suggest that the
changes in cell cycle protein expression are a compensatory response to the presence of the E6/E7
oncoprotein, and the E6/E7-positive animals are predisposed to cancer formation when challenged
with carcinogens.
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Inducible Expression of TGF-b1 in Papillomas Causes Rapid Metastasis
X. Wang, W. He, B. Weeks,* and K. Olson*
Dermatology, Baylor College of Medicine, Houston, Texas; *Otolaryngology, Baylor College of Medicine,
Houston, Texas
TGF-b is believed to be a tumor suppressor at early stages, however, it has also been postulated to
promote tumor invasion. To determine at which stage and by what mechanisms this functional
switch occurs, we have generated gene-switch-TGF-b1 mice in which TGF-b1 transgene
expression can be induced in skin tumors at speci®c stages. These mice were exposed to a chemical
carcinogenesis protocol, which allows tumorigenesis to develop in progressive stages from benign
papillomas to malignant carcinomas. TGF-b1 induction in early stage papillomas suppressed tumor
formation and growth. However, at later stages, TGF-b1 transgenic papillomas exhibited a
resistance to regression and an increase in malignant conversion. More strikingly, TGF-b1
transgene induction rapidly induced metastasis from tumors with a benign papilloma histotype.
The metastasis-prone papillomas exhibited down-regulation of TGF-b receptors and their signal
transducer, the Smads, and loss of the invasion suppressor E-cadherin/catenin complex. These
molecules were lost only in malignant carcinomas in control mice. Furthermore, metastasis-prone
transgenic papillomas exhibited elevated matrix metalloproteinases, and an increase in angiogensis
which correlated with changes in expression of angiogenesis regulators. Our study provides in vivo
evidence at both the cellular and molecular levels that TGF-b1 overexpression directly induces
tumor metastasis by initiating events necessary for invasion. Down-regulation of TGF-b signaling
components in tumor epithelia selectively abolishes growth inhibition, thus, switching the role of
TGF-b1 from a tumor suppressor to a metastasis promoter. Given that TGF-b1 overexpression is
frequently detected in malignant human tumors, screening expression levels of TGF-b1 and its
signaling components may have an important impact on prognosis and therapeutic approaches.
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Smad3/AP±1 Interactions Control Transcriptional Responses to TGF-b in a Promoter-
Speci®c Manner
F. Verrecchia, L. Vindevoghel,* R. Lechleider,² A. Roberts,² J. Uitto,* and A. Mauviel
Skin Research Institute, INSERM U532, Paris, France; *Dermatology and Cutaneous Biology, Thomas
Jefferson University, Philadelphia, Pennsylvania; ²Cell Regulation and Carcinogenesis, NCI, Bethesda,
Maryland
Smad proteins transduce signals from TGF-b receptors and regulate transcription of target genes
either directly or in combination with other sequence-speci®c transcription factors. AP-1 sites and
their cognate transcription factors also play important roles in the gene regulatory activities of
TGF-b. In this report, we have investigated the functional interactions of the Smad and AP-1
transcription factors. We demonstrate that Smad and AP-1 complexes speci®cally bind to their
cognate cis-elements and do not interact with each other on-DNA, whereas off±DNA interactions
occur between Smad3 and both c-Jun and JunB. Using both arti®cial constructs speci®c for either
the Smad or AP-1 signaling pathways or natural promoters known to be TGF-b-responsive, we
have determined that Jun family members down-regulate Smad3-mediated gene transactivation
whereas AP-1-dependent promoters are synergistically activated by Smad3 and Jun proteins. We
propose a model where the presence of Smad- and/or AP-1-speci®c cis-elements within TGF-b-
responsive genes allows dynamic modulation of gene expression, in contrast to the existing model





Rho Family GTPases, Rac and CDc42, Play an Important Role in Regulation of Human
Keratinocyte Migration on Collagen
Z. Yue, W. Li, C. Nadelman, and D. Woodley
Division of Dermatology, the Norris Cancer Center, the Greater Los Angeles Veteran Administration
Healthcare System, The University of Southern California, Los Angeles, California
Rho family GTPases, including Rho, Rac and Cdc42, belong to the p21-RasGTPase superfamily
and play critical roles in the control of cell mitogenesis and morphogenesis. Activation of Rho,
Rac and Cdc42 causes re-assembly of the actin cytoskeleton, leading to the formation of stress
®bers, lamellipodia and ®lipodia, respectively. The roles of the Rho family GTPases in the control
of ®broblast migration, macrophage chemotaxis and neuronal cell path®nding have been reported.
Whether or not they also mediate the signal transduction in human keratinocytes (HK), leading to
cell migration, has not been studied. We used two independent, well-established cell motility assays
± the in vitro wound scratch assay and the colloidal gold track assay ± to investigate the roles of the
Rho GTPases. In this report, we show that blockade of Rho GTPase activation by Toxin B
completely inhibited HK migration on collagen. We found that continued activation of the Rho
family GTPases was required for the entire (16±20 h) period of the migration assay, because Toxin
B was able to stop the migration at any time point. To study which speci®c Rho GTPase(s) was
involved, we transfected HK with either constitutively active or dominant-negative forms of
RhoA, Rac1 and Cdc42Hs, whose expression was under control of a CMV promoter in pRK5
mammalian expression vector. Overexpression of the constitutively active RhoA, Rac1 and
Cdc42Hs had no signi®cant effect on HK migration on collagen. However, overexpression of the
dominant negative Rac1 and Cdc42hs, but not RhoA, markedly decreased the keratinocyte
migration. One of the downstream effectors for Rac and Cdc42 is the p38-MAPK and our
previous studies have shown that p38-MAPK plays an important role in HK migration on collagen
(Li et al submitted). Taken together, this study suggests that the Rac/Cdc42/p38-MAPK pathway
may mediate collagen signaling in migratory keratinocytes
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Human Serum but Not Plasma Promotes Migration of Human Skin Cells
G. Henry,* W. Li, W. Garner,* and D. Woodley
Division of Dermatology, the Norris Cancer Center and the Greater Los Angeles Veteran Administration
Healthcare System, The University of Southern California, Los Angeles, California; *Department of
Surgery, The University of Southern California, Los Angeles, California
The inward migration of human ®broblasts into the wound bed (®broplasia) and the migration of
human keratinocyte across the wound bed (re-epithelialization) are critical events to heal skin
wounds. The mechanisms of cell motility are not well understood, but are thought to be an
orchestration of both extracellular matrix components and soluble growth factors. During an acute
wound, serum is generated and therefore for the ®rst time skin cells experience serum rather than
plasma. In this study, we asked if serum and plasma were the same or different in terms of
supporting ®broblast and keratinocyte migration. We used two independent, well-established cell
motility assays ± the in vitro wound scratch assay and the colloidal gold track assay. In both assays,
cell motility was strongly supported by human serum (Migration Index/MI 30%) but not by plasma
(MI < 5%). High Performance Liquid Chromatography (HPLC) analysis of human serum
demonstrated that the motility activity was distributed in three major fractions of the total 70
fractions. Each of the three fractions alone, however, only supported cell migration no more than
30% of the maximal motility in complete whole serum. These data strongly suggest that there are
multiple serum factors that contribute to human keratinocyte and ®broblast migration. Further,
these pro-motility soluble factors are absent in plasma suggesting that soluble factors from platlets
similar to PDGF are likely involved. Finally, these factors have dual in vivo wound repair functions
capable of supporting both keratinocyte reepithelialization and the ingress of ®broblasts into the
wound bed to repair the dermal defect.
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PKC Involvement in the Autoregulation of Glucose Transport in Skin Keratinocytes.
Implications to Chronic Diabetes Skin Complication
E. Wertheimer, G. Sizyakov, N. Spravchikov, A. Alt,* T. Kuroki,² and T. Tennenbaum*
Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; *Faculty of Life
Sciences, Bar Ilan University, Ramat Gan, Israel; ²Molecular Oncology Research Center, Showa University,
Tokyo, Japan
Glucose represents a major fuel for most mammalian cells, and a wide range of factors regulate its
utilization. However, abnormally high levels of glucose, as occurs in diabetes, lead to the
development of chronic complications. One of the tissues mainly affected by the diabetes state is
skin. Nonetheless, the pathophysiology by which glucose affects skin function is not known. We
have previously identi®ed effects of glucose on skin keratinocytes. Incubating cells in high glucose
led to decreased proliferation, altered differentiation and down-regulation of glucose transport and
glucose metabolism. In the present work we have extended these studies to investigate the
involvement of the Protein kinase C family of serine-threonine kinases (PKCs) in the
autoregulation of glucose transport in skin keratinocytes. We have found that activation of
PKCs mimicked the high glucose effects on glucose uptake, induced by glucose. Exposure of the
cells to PMA, a known PKC activator, resulted in a decrease in 2dGlc uptake that was similar in
magnitude and time course to that induced by high glucose. Moreover, incubating the PMA
treated cells with 20 mM of glucose could not further down-regulate the glucose transport rate.
Further corroboration of these results was found by incubating proliferating skin keratinocytes in
high glucose and following activation of speci®c PKC isoforms. Incubating the cells in high
glucose was associated with translocation and activation of speci®c PKC isoforms, mainly PKCs d
and z. These results were con®rmed in cells overexpressing these isoforms. In addition, over
expression of PKCd and z resulted in changes in the glucose uptake rate into keratinocytes.
Overall, these results suggest the involvement of PKCs in glucose mediated toxic effects on skin
keratinocytes.
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Development of a Transgenic Model for Conditional Regulation of AP-1 Transcription
Factors in Epidermis
M. Gerdes, M. Levy, L. Michael, J. Moitra, A. Glick, C. Vinson, and S. Yuspa
Division of Basic Sciences, National Cancer Institute, Bethesda, Maryland
Past studies using genetic alterations in members of AP-1 transcription factors have demonstrated a
critical role of these proteins in skin carcinogenesis. To address general contributions of AP-1 to
skin development and speci®c stages of carcinogenesis, a dominant-negative Fos protein (A-Fos)
was generated which abolishes AP-1 activity. A-Fos was placed under regulation of the tetracycline
transactivator promoter (tet-A-Fos). These mice were crossed to mice expressing the tet-
transactivator under keratin 5 promoter regulation (bK5-tTA), such that A-Fos is expressed in the
absence of tetracycline (or the analog doxycycline, Dox) only in keratinocytes. When bK5-tTA
mice were crossed with tet-A-Fos mice in the absence of Dox, a lethal phenotype resulted, in that
no bi-genic mice were born (n = 6 litters). However, when breeders were kept on Dox through
pregnancy, a normal Mendelian distribution of the genotypes was seen, as assessed by PCR.
Expression of the tet-A-fos transgene was con®rned to basal cells as detected by immuno-staining
for HA antigen (engineered in the A-fos transgene). Expression was con®rmed by RT-PCR for A-
fos in RNA from skin. Bi-genic mice, when removed from Dox at birth, develop normally, have
normal skin, and are fertile. When exposed to the hyperplasiogenic and in¯ammatory agent
phorbol 12-myristate 13-acetate (TPA), the A-fos bi-genics exhibited marked increases in
in¯ammatory in®ltration at 24 and 72 h relative to controls. When primary keratinocytes were
isolated from newborns and grown without Dox, cell density decreased by 1 week and cell
morphology changed from cuboidal to a large, ¯at, and senescent phenotype. Bi-genic cells in the
presence of Dox, or single transgenic controls maintained normal cubodial morphology and
growth patterns through 3 weeks in culture. In cultured cells there was no genotypic difference in
expression of keratins 1, 5, and 10 suggesting the phenotype observed is not through a strict change
in the developmental program. When the bi-genic cells were transformed with a Ha-Ras
retrovirus, the cells died after 72 h while control cells evolved a morphology typically seen in
transformed keratinocytes. Results indicate that AP-1 is required for prenatal development and
in¯uences both skin in¯ammation and carcinogenesis. However, they may not be essential for
postnatal epidermal function under conditions of normal homeostasis.
490
Expression of Placenta Growth Factor, Cyclooxygenase, and Thymus and Activation-
Regulated Chemokine in the EpiDerm In Vitro Human Skin Equivalent
P. Hayden, T. Last, M. Klausner, and J. Kubilus
MatTek Corporation, Ashland, Massachusetts
In vitro skin equivalent models are ®nding increased utility as tools in basic skin research, safety
assessment and product development processes. To further utilization for these purposes, we are
currently de®ning a growing list of physiologically signi®cant molecular endpoints to monitor the
effects of experimental treatments on EpiDerm(tm) in vitro human skin tissue. In the present work,
we describe the expression in EpiDerm of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-
2), placenta growth factor (PlGF), and thymus and activation-regulated chemokine (TARC) at the
protein and/or mRNA level. Irradiation of EpiDerm with UVB caused elevated levels of
cyclooxygenase product prostaglandin E2 (PGE2) secretion into the culture medium. Experiments
with selective COX inhibitors indicate a prominent role for COX-2 in UVB-induced PGE2
production. Reverse transcription polymerase chain reaction (RT-PCR) was used to detect both
COX-1 and COX-2 message in EpiDerm. COX-2 message was induced upon exposure to UVB.
Message for the angiogenesis-inducing factor PlGF was also induced by UVB-irradiation. Finally, a
combination of interferon-g and tumor necrosis factor-a induced the expression of the TH2
recruitment CC chemokine TARC. These endpoints expand the utility of in vitro human skin
equivalents for studies involving skin in¯ammation, skin cancer, topical sensitization and related
skin phenomena.
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Novel Glutamate Receptor-Mediated Signaling Found in Bioengineered and Human
Skin
W. Nahm, E. Badiavas, J. Butmarc, L. Zhou, and V. Falanga
Dermatology and Skin Surgery, Roger Williams Medical Center/Boston University School of Medicine,
Providence, Rhode Island
Recent studies have shown the presence of predominantly located-neuronal receptors in cutaneous
tissue. Glutamate receptors, which are the primary mediators of excitatory neurotransmission in the
central nervous system, have been found in animal skin and cultured human keratinocytes, and
their altered expression has been observed in an animal model of wound healing. However, the
expression of glutamate receptors has not been analyzed in human skin and/or models of human
wounding. Our hypothesis is that these receptors may play an important role in human cutaneous
calcium signaling. For these experiments, we used both normal human skin and a bilayered skin
construct (BSC), comprised of human keratinocytes and ®broblasts, which is able to reepithelialize
itself after injury. The expression pattern of a glutamate receptor was examined with
immunohistochemistry using a monoclonal antibody to subunit 1 of the N-methyl-D-aspartate
receptor (NMDAR1). Normal human skin showed a strong NMDAR1 staining pattern in the
stratum malpighii, eccrine structures, sebaceous glands, and selected ®broblasts. The epidermal
staining pattern was granular and peripheral, and the greatest staining intensity was found in basal
cells. Uninjured BSC epidermis showed a similar pattern of NMDAR1 expression to that found in
human epidermis. However, 24 h after injury by meshing, BSC showed markedly increased
NMDAR1 expression in a polar pattern in migrating keratinocytes. These studies provide the ®rst
direct evidence for the presence of glutamate receptor-mediated signaling in human skin in vivo,
and suggest that altered expression or function of NMDARs may play a role in pathological states
where calcium-dependent mechanisms are prominent. Our work also points to glutamate
receptor-mediated signaling as being important in wound healing and the process of
reepithelialization.
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Induction of Multiple Types of Skin Tumors in Mice Overexpressing an Activated Gli2
Mutant
H. Sheng, S. Goich, A. Wang, L. Lowe, H. Sasaki,* and A. Dlugosz
Dermatology, University of Michigan, Ann Arbor, Michigan; *Laboratory of Developmental Biology, Osaka
University, Osaka, Japan
The Sonic hedgehog (Shh) signaling pathway, operating through the Gli family of transcription
factors, plays important roles throughout embryogenesis and in cancer development. Knock-out
and transgenic mouse studies implicate Gli2 as the key transcriptional effector mediating Shh
signaling in skin both under normal conditions and when pathologically activated in basal cell
carcinomas (BCCs). Molecular analysis of Gli2 functional domains reveals a potent repressor in the
amino-terminus: its removal in the Gli2DN2 mutant increases transcriptional activity up to 10-fold
in cultured keratinocytes. Skin-targeted overexpression of this mutant using a K5 promoter in
transgenic mice (K5-Gli2DN2) results in development of a variety of tumor types including
trichoblastomas, cylindromas, basaloid follicular hamartomas, and very rarely, BCCs. This is in
striking contrast to results obtained using mice overexpressing full-length Gli2, which exclusively
produce BCCs. Tumors developed in multiple founders with the highest expression of Gli2DN2
mRNA and protein, while those with lower transgene expression levels were either normal or
exhibited hair follicle dysplasia. Northern blot analysis revealed a positive correlation between
Gli2?N2 mRNA levels and the degree of Shh pathway activation, based on expression of the Shh
target genes Gli1 and Ptch1. Our data point to a crucial role for the amino terminus of Gli2 in
specifying BCC development in transgenic mice.
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IL-1a Overexpression Accelerates Head and Neck SCC in Mice
S. Dayan, G. Gallagher,* and T. Kupper
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; * Oral Pathology, Boston
University, Boston, Massachusetts
The role of chronic in¯ammation in the development of head and neck squamous cell carcinoma
(SCC) remains controversial. To address this question, transgenic mice that overexpress the pro-
in¯ammatory cytokine IL-1a in basal epithelium (called TgIL-1.2) were studied for their
susceptibility to oral cancer. Overexpression of IL-1ain the oral cavity was con®rmed by
immunohistochemistry and ELISA analysis of gingival IL-1a levels. TgIL-1.2 mice and wild type
littermate controls were subjected to the carcinogen 4-Nitroquinoline-1-oxide (4NQO) by thrice
weekly topical applications to the palate. Two dosing periods, 12 and 17 weeks, were evaluated.
Strikingly, 100% of TgIL-1.2 mice (n = 14) developed SCC in at least one site, whereas wild type
mice (n = 18) subjected to the same protocols failed to show any malignant or premalignant
changes. An unexpected ®nding was the occurrence of esophageal SCC in 14% of IL-1a
transgenic mice treated for 12 weeks, and 57% of those treated for 17 weeks. To our knowledge,
this is the ®rst reported genetic mouse model for esophageal SCC. These data conclusively
demonstrate that primary in¯ammatory cytokines produced by epithelium play an important role
in head and neck carcinogenesis. Strategies to inhibit IL-1 signaling pathways and reduce chronic
in¯ammation may be important preventive and therapeutic modalities.
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Induction of Invasive Human Epidermal Neoplasia Resembling Squamous Cell
Carcinoma (SCC) by De®ned Genetic Elements Ras and CDK4
Y. Kubo, M. Dajee, M. Lazarov, S. Tao, and P. Khavari
VA Palo Alto and Department of Dermatology, Stanford University, Stanford, California
Ras acts in combination with other unknown proteins to induce uncontrolled cell division and is
the most commonly mutated proto-oncogene in human cancers. Gene expression pro®ling on
SCCs from 12 patients demonstrated induction of Ras targets in SCCs compared to their clinically
normal skin, suggesting that Ras in concert with other de®ned oncoproteins can directly convert
normal epidermis to invasive neoplasia. To test this, we activated Ras signaling in human epidermis
while simultaneously altering other regulators of cell growth, including p53, CDK4 and hTERT.
Using high ef®ciency retroviral transductions in primary keratinocytes, we expressed active
RasV12 and these regulators either singly or in combination via multicistronic retrovectors and
used these cells to regenerate human skin on SCID mice [n = 4±7 per group]. Ras alone leads to
complete cell cycle arrest within 48 h along with induction of the CDK inhibitor (CKI) p21 while
Ras-p53W248, Ras-hTERT and CDK4 alone fail to induce epidermal neoplasia. In contrast,
within 3 weeks Ras-CDK4 produced large skin tumors in 7/7 mice with histologic features of
SCC, including deep invasion through fat to underlying muscle. Ras-CDK4 tumors, similar to
human SCC, express increased levels of VEGF with neoangiogenesis, elevated MMPs 1/3 and
decreased E-cadherin. Ras-CDK4 cells up-regulate p21 at comparable levels to Ras alone but are
resistant to the mid-G1 CKIs p15 and p16, suggesting that increased resistance to CKIs rather than
a failure to induce them contributes to Ras-CDK4 neoplasia. Cyclin D1 was necessary but not
suf®cient for Ras-CDK4 neoplasia as CDK4-D1 failed to induce tumors [n = 4 mice] while an
antisense D1 retrovector that suppressed D1 tissue protein expression abolished Ras-CDK4
neoplasia [n = 4]. CDK4 synergy with Ras is dependent on intrinsic CDK4 kinase function as the
kinase-dead N158 CDK4 point mutant failed to induce neoplasia when coexpressed with Ras
[n = 4]. These data identify Ras and CDK4 as capable of converting normal human epidermal
tissue into invasive neoplasia and indicate that functional CDK4-D1 is necessary for this process.
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Transfection of CHO Cells with Human EGFR Mutants to Elucidate EGFR Signaling
Pathways in Wound Healing
B. Draper, M. Davidson,* and L. Nanney²
Dermatology, Cell Biology, Vanderbilt University, Nashville, Tennessee; *Dermatology, Vanderbilt
University, Nashville, Tennessee; ²Plastic Surgery, Cell Biology, Vanderbilt University, Nashville,
Tennessee
The epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases is comprised of
four closely related transmembrane proteins that bind multiple ligands of the EGF family. Ligand
binding triggers numerous downstream signaling pathways resulting in a host of biological
responses including proliferation, differentiation, migration and apoptosis. The aim of these initial
studies was to create cell lines containing various EGFR mutants that can be utilized to evaluate the
divergent EGFR signaling pathways following wounding. Chinese hamster ovary-K1 (CHO-K1)
cells possess no detectable EGFR. We transfected CHO-K1 cells with either wild-type hEGFR or
various de®ned hEGFR mutants with altered cytoplasmic domains. Stable transfectants were
generated via multiple rounds of limiting dilution. Transfection ef®ciency was evaluated by
Northern hybridization as well as FACS. Northern analysis revealed either normal or mutant
hEGFR transcript present in all transfected cell lines. Transfected hEGFR mRNA expression levels
were slightly less in CHO-K1 cells compared to that of adult normal human epidermal
keratinocytes. Wild type CHO-K1 cells expressed no EGFR mRNA. FACS analysis showed
detectable levels of either transfected normal or mutant hEGFR on the surface of the CHO-K1
cells. In vitro scratch assays were utilized to compare biological wounding responses of transfected
CHO-K1 cells with that of wild type cells. Following overnight serum and growth factor
depletion, postcon¯uent transfected CHO-K1 cultures were wounded and treated with either basal
media or with basal media plus 10 mM EGF. Depending on the mutant, addition of EGF induced
an increase in either cell proliferation or migration vs. that of untreated transfectants. In addition,
transfected cells had a survival advantage over wild type cells both in the presence and absence EGF
or serum. In conclusion, our initial results suggest that the pleiotropic response of hEGFR to
various ligands is mediated through different domains of the cytoplasmic portion of the molecule.
We are further investigating the speci®c signal transduction pathways induced by the multiple
genetically distinct ligands that activate the hEGFR during the course of normal cutaneous wound
healing.
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MIB-1 Proliferative Activity and Mutant p53 Expression in Cutaneous Squamous
Neoplasms: A Prospective Evaluation of 117 Cases
A. Ormsby, C. Schwimmer, M. Skacel, and K. Hollandsworth
Dermatopathology, The Cleveland Clinic, Cleveland, Ohio,
Background: Accurate assessment of cutaneous squamous neoplasms is essential in the effective
management and treatment of these lesions. Molecular markers of cell proliferation, such as MIB-1,
and mutant p53 expression have been associated with progression to carcinoma and may be helpful
as an adjunct to histomorphology in assessing cutaneous squamous neoplasia. To date, prospective
evaluation using a large patient cohort has not been undertaken. Aim: To prospectively assess the
utility of MIB-1 and mutant p53 immunoreactivity in the evaluation of cutaneous squamous
neoplasms. Methods: 117 patients with squamous cell carcinoma (SCC; n=26), in-situ squamous
cell carcinoma (SCC I-S; n=45) and actinic keratoses (AK; n=46) were evaluated prospectively (6
months). A benign control group was concurrently evaluated (n=9; seborrheic keratoses, verruca
vulgaris and pseudoepitheliomatous hyperplasia) . MIB-1 (AMAC; dilution-1:10) and p53
(DAKO; clone-DO7; dilution-1:10) immunostaining of paraf®n-embedded formalin-®xed tissue
sections was undertaken using a commercially available autoimmunostainer (Ventana ES). Semi-
quantitative assessment of nuclear immunoreactivity within lesional keratinocytes was performed in
all cases (<25%, 25-50%, 51-75%, >75% of cells, respectively) and blindly assessed by 2
dermatopathologists (KH,AHO). Group differences were compared using Fisher's exact test (2-
sided) and sensitivity/speci®city was calculated using Bayesian formulae. Results: Mean age was
69.1 years (range: 33-97 years) and 56% were male. Sites of squamous lesions included the head and
neck (n=54:43%), trunk (n=19; 15%) and extremities (n=53; 42%). MIB-1 and p53 nuclear
immunoreactivity (>50% of lesional keratinocytes) in SCC/SCC I-S (n=71), AK (n=46) and
benign controls (n=9) was seen in 42%, 28%, 0%, and 66%, 41%, 22%, respectively. Either MIB-1
or p53 nuclear immunostaining (>50% of lesional keratinocytes) was seen in 79% (SCC/SCC I-S),
48% (AK) amd 22% (benign controls), respectively. Sensitivity and speci®city of p53 or MIB-1
immunoreactivity for a squamous neoplasm was 67% and 82%, respectively. Conclusion: MIB-1
and p53 immunoreactivity is moderately sensitive and speci®c for cutaneous squamous neoplasms
and supports the use of these markers as an adjunct to histomorphology. Further evaluation of
molecular markers with increased sensitivity and speci®city for cutaneous squamous neoplasms is
warranted.
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A Novel Colorimetric Bead-Binding Assay for Detection of Molecular Interactions
L. Kos, A. Irvine, P. Sun, X. Wang, and A. Paller
Dermatology, Children's Memorial Hospital, Chicago, Illinois
We have developed a new technique that rapidly and reproducibly allows direct visualization of
molecular interactions, including receptor-ligand binding. The technique can be easily applied to
examine binding between proteins and glycoproteins, or proteins and glycolipids, including
gangliosides. In this novel bead-binding assay, a target molecule is bound to colored FluoSphere
beads. These coated beads are then mixed directly with molecules adherent to larger 150 mm
molecules is easily detected by immuno¯uoresence microscopy as colored rosettes. This new
technique has been used to con®rm the direct interaction of the bcholera toxin with ganglioside
GM1 as well as to show the binding of ganglioside GT1b with the a5 subunit of a5b1 and GM3
with the epidermal growth factor receptor. A modi®cation of this technique, in which the coated
beads are bound to protein ®xed on plates, allows a quanti®able colorimetric assay of interaction.
This versatile and rapid technique will have widespread applications for in vitro systems and may
also be useful for in vivo analysis of binding to cell surface receptor molecules.
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Isolation of a HeLa-Derived Cell Line Resistant to E2-Mediated Growth Arrest
L. Manuelidis, E. Goodwin,* and D. DiMaio*
Dermatology, Yale University School of Medicine, New Haven, Conneticut; *Genetics, Yale University
School of Medicine, New Haven, Conneticut
There are more than 70 different types of human papillomaviruses (HPV). Certain high risk HPVs
are associated with carcinomas of the mucosal and cutaneous epithelium. HeLa cells, a human
cervical carcinoma cell line that contains HPV 18 DNA, express HPV E6 and E7 proteins, which
neutralize tumor suppressor function. HeLa cells infected with a recombinant SV40-based virus
expressing the bovine papilloma virus (BPV) E2 protein results in almost complete repression of
HPV E6 and E7 expression, restoration of the p53 and Rb tumor suppressor pathways, and
profound growth inhibition within 48 h of infection. After repeated infections with the
recombinant virus expressing BPV E2, only one in approximately 100 000 HeLa cells proliferated
to form discrete colonies. In order to characterize the nature of these cells that resist growth
inhibition, we expanded individual E2-resistant colonies into cell lines and reintroduced the virus
expressing BPV E2. Although many of these cell lines exhibited only partial repression of HPV E6
and E7 expression, we isolated one cell line (designated res 6B) in which HPV E6 and E7 were
ef®ciently repressed by BPV E2. However, 48 h after E2 expression, the res 6B cell line displayed
10-fold more DNA synthesis than did infected parental HeLa cells. In summary, we isolated a
HeLa-derived cell line in which BPV E2 repressed HPV E6 and E7 expression as well as in normal
HeLa cells. Nevertheless, these cells demonstrated a 10-fold growth advantage as measured by E2-
resistant DNA synthesis. These preliminary results indicate that the res 6B cell line is not dependent
on continued HPV oncogene expression for sustained proliferation, and suggest that these cells
may harbor differences in the downstream p53 and Rb tumor suppressor pathways.
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Telomere-Independent Keratinocyte Senescence Enforced by Coordinate Induction of
p16INK4A and p14ARF; Spontaneous and Experimental Abrogation of this Mechanism
in Culture and In Vivo
J. Rheinwald, J. Wu, H. Tsao,* Z. Guo, M. DeLuca,² and M. Ramsey
Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; *Dermatology, MGH, Boston,
Massachusetts; ²Dermatology, IDI, Rome, Italy
Replicative lifespan in culture of ®broblasts and several other cell types is limited by telomere
attrition, which triggers a p53-mediated, p21cip1-enforced senescence arrest. In contrast, for some
epithelial cell types, including keratinocytes, senescence results from a mechanism that detects an
aspect of cell aging other than telomere loss and which triggers p16INK4a expression. In optimized
culture media, human epidermal, oral, corneal, and conjunctival keratinocytes can undergo more
doublings than stem cells of these tissues are estimated to require during the human lifespan in vivo.
Unlike their typical fate during tissue renewal, however, in culture they cease growth as senescent
cells blocked in G1 with a high p16 content. We have found that abrogating the p16 block by
stably transducing keratinocytes to express a p16-resistant, mutant cdk4 (cdk4R) does not
detectably extend lifespan but results in the cells senescing with either a G1 or G2 DNA content,
consistent with a p53-mediated, p21cip1-enforced arrest. Cells engineered to express both cdk4R
and a dominant negative mutant p53 (p53DD) bypassed senescence, dividing an additional 20±30
times until halted by crisis. Keratinocytes cultured from a p16(+/±) individual senesced after a
normal lifespan, but such cells transduced to express p53DD generated rare p16(±/±) variants that
grew for 30 extra doublings; thus, p16 loss and expression of a p16-resistant cdk4R are equivalent
phenotypically. Keratinocytes having lesions in both p16- and p53-dependent senescence
mechanisms proved to have high levels of the mdm2 inhibitor p14ARF ± evidence that the p53-
dependent component of keratinocyte senescence is activated by p14ARF. Keratinocytes de®cient
in both p16 and p53 control pathways differentiated normally, as did cells we cultured from a
premalignant oral epithelial lesion that had acquired p16 and p53 mutations in vivo. These results
support a model of cancer development in which focal areas of epithelia that undergo chronic,
accelerated renewal fall under selection pressure for variants able to escape both p16- and p14ARF/
p53-dependent lifespan limitation. Such variants are preneoplastic because of their extended
lifespan and ability to divide to crisis with potential of progressing to full malignancy.
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Pemphigus Foliaceus IgG Activates Transmembrane Desmosomal Signaling
D. Rubenstein, M. Lin, P. Berkowitz, L. Arteaga, P. Hu, Z. Liu, L. Diaz, and E. O'Keefe
Dermatology, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina
Pathogenic pemphigus vulgaris (PV) and pemphigus foliaceus (PF) autoantibodies bind the
ectodomain of desmoglein-3 (dsg3) and desmoglein-1 (dsg1), respectively. PV and PF antibodies
trigger epidermal cell-detachment (acantholysis) by unknown molecular mechanisms. Proposed
mechanisms for PV and PF IgG induced acantholysis include (1) proteinase activation (2) steric
hindrance, and (3) activation of transmembrane signaling that down regulates cell-cell adhesion.
The purpose of this study was to test whether puri®ed antidsg1 antibodies can activate
transmembrane signal transduction cascades on normal human cultured keratinocytes in the
presence of [32P] H3PO4. PF antidsg1 antibodies were af®nity-puri®ed using a soluble fraction of
the dsg1 ectodomain produced in the baculovirus system. Control keratinocyte cultures included
cells incubated with no IgG or normal IgG (af®nity-puri®ed on Protein A). Keratinocyte extracts
were examined by two dimensional electrophoresis and autoradiography for the presence of altered
protein phosphorylation. Incubation of normal human keratinocytes with PF IgG resulted in
increased phosphorylation of several proteins resolved by 2D electrophoresis when compared to
control cultures. The PF IgG induced changes in protein phosphorylation are consistent with the
hypothesis that the binding of PF IgG to the dsg1 ectodomain initiates a transmembrane signal
transduction cascade which may contribute to the molecular mechanism of PF IgG acantholysis.
Additionally, this suggests that in addition to mediating cell-cell adhesion, desmosomes function as
ligand dependent transmembrane signaling receptors.
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Expression and Phosphorylation of Mitigen-Activated Protein Kinases in Melanoma
Cells In Vitro and In Vivo. Evidence for a Correlation Between In Vivo Phosporylation
and Tumor Progression
M. BoÈhm, I. Wolff, D. Metze, and T. Luger
Department of Dermatology and Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the
Skin, University of MuÈnster, MuÈnster, Germany
Mitogen-activated protein kinases (MAPK) belong to large family of kinases that are regulated by a
variety of extracellular signals. Although it is known that MAPK2 is activated in normal
melanocytes (NHM) and melanoma cells in response to distinct growth factors and other external
stimuli, little is known about the actual comparative expression and phosphorylation of MAPK1-4
in melanoma cells in vitro and in vivo. Western immunoblotting of whole cell extracts of NHM and
8 human melanoma cell lines derived from different stages of disease progression revealed that
expression of MAPK1, 2 and 3 was similar between most melanoma cell lines and NHM.
Expression of MAPK4 was consistently higher in all of the examined melanoma cell lines than in
NHM. Phosphorylation of MAPK1/2 at Tyr204 in all melanoma cell lines, however, was
markedly elevated in all melanoma cell lines as determined by immunoblotting with a phospho-
speci®c antibody. The latter ®ndings were corroborated by in vitro kinase assays demonstrating an
up to 18-fold higher MAPK1/2 activity in melanoma cells as compared to NHM. In order to
check if phosphorylation of MAPK1/2 at Tyr204 can also be detected in melanomas in situ, a total
number of 73 cutaneous melanomas were evaluated by the immunoperoxidase technique. In
normal human skin, MAPK1/2 phosphorylation was not detectable. In primary melanomas, in
general, immunostaining correlated with tumor invasiveness, while in tumor metastases
immunostaining was heterogeneous. Our data highlight the importance of MAPK in human
melanomas and suggest a role of phosphorylated MAPK1/2 as a molecular correlate of tumor
progression.
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CD44 Proteoglycans from Human Keratinocytes Bind to the Glycosaminoglycan
Binding Domain of Amphiregulin But Not of Heparin Binding EGF
M. Piepkorn, P. Hovingh, T. Peterson, and P. Cook*
Dermatology, University of Washington, Seattle, Washington; *Cascade Biologics, Inc., Portland, Oregon
Evidence from neutralizing antibody inhibition suggests that amphiregulin is the predominant
autocrine mitogen for human keratinocytes, with HB-EGF serving a lesser role. Endogenous
heparan sulfate proteoglycans such as CD44 isoforms may be obligate cofactors in their signaling
through EGFR-class receptors. Exogenous heparinoids, as competitive ligands with endogenous
heparan sulfates, strongly block the proliferative effects of amphiregulin, but not of HB-EGF,
despite the heparin-binding properties of both. That exogenous heparinoids strongly inhibit
keratinocytes thus further substantiates that amphiregulin, and not HB-EGF, is the principal
autocrine factor. We hypothesized that differences in af®nities of the mitogens' binding domains
for speci®c, endogenous heparan sulfates account for the disparate effects of exogenous
heparinoids. Metabolically labeled, heparan sulfate-containing CD44 proteoglycans were isolated
by speci®c immunoprecipitation from cultured cells. Samples were chromatographed on
standardized af®nity columns of either gel-immobilized amphiregulin or HB-EGF peptide, the
25-mer peptide corresponding to each growth factor's putative heparinoid binding domain. CD44
proteoglycans had much stronger af®nity for amphiregulin peptide than for HB-EGF peptide, as
evidenced by little or no binding of any CD44 fraction to the latter. The identities of the eluants
were con®rmed by Western blotting with anti-CD44. These data support the hypothesis that
endogenous CD44 speci®cally regulates the effects of amphiregulin and that HB-EGF may be
regulated by cofactors other than CD44. Collectively, our results further con®rm CD44-regulated
amphiregulin as the principal autocrine factor in keratinocytes.
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Inactivation of O6-Methylguanine-DNA Methyltransferase (MGMT) by Promoter
Hypermethylation is Associated with Loss of MGMT Protein Expression in Skin Cancer
R. Abdel-Fattah, A. Glick, and H. Hennings
LCTTP, North CarolinaI, Bethesda, Maryland
Defective repair of O6-methylguanine adducts is relevant to carcinogenesis since these lesions are
highly mutagenic. Previous studies in human cancer have shown that one mechanism for defective
repair is lack of expression of MGMT enzyme which repairs these lesions. This frequently occurs
through hypermethylation of CpG sites within the MGMT promoter. To assess the role of
MGMT silencing in the multistage mouse skin carcinogenesis model, methylation status of the
MGMT promoter was examined by methylation speci®c PCR (MSP) and bisul®te-modi®ed
sequencing. The results were correlated with the expression status of the gene. Additionally, the
times at which MGMT hypermethylation occurred was detected, and the relationship of MGMT
hypermethylation to mutations in the ras oncogene was also examined. Among 184 skin tumors
examined, 81 (44%) demonstrated MGMT hypermethylation. No signi®cant differences were
observed between MGMT methylation among papillomas and carcinomas. Hypermethylation was
detected in tumors as early as 5 weeks after MNNG initiation and as early as 7 weeks after DMBA
initiation. MGMT methylation was more frequent with DMBA initiation (p = 0.006), and
methylation increased with time (p = 0.009). Promoter hypermethylation was also examined by
bisul®te sequencing. The distribution of methylated sites was heterogeneous. A statistically
signi®cant association was observed between MGMT promoter hypermethylation and the absence
of MGMT protein expression (p < 0.0001; Fisher's exact test). No signi®cant association was
observed between MGMT methylation and either Ki-ras or Ha-ras activation. Thus, MGMT
promoter hypermethylation is an early and frequent event in squamous tumor development, but it
is not linked to ras activation in this carcinogensis model. Silencing of the MGMT gene may
contribute to tumor progression by increasing the frequency of mutagenic events associated with
endogenous alkylation damage of DNA.
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Epidermal Growth Factor Receptor Glycosylation is Required for Ganglioside GM3
Binding and GM3-Mediated Suppresion of Activation
A. Irvine, p. Sun, X. Wang, and A. Paller
Dermatology, Children's Memorial Hospital, Chicago, Illinois
Gangliosides bind to the epidermal growth factor receptor and inhibit its activation, but the
mechanism of this inhibition is unknown. To address the role of receptor carbohydrates in
facilitating interaction with gangliosides, we examined the ability of GM3 to bind the
deglycosylated receptor and inhibit its autophosphorylation. Flow cytometry studies demonstrated
that deglycosylation of the receptor did not affect its transport to the cell membrane. In contrast
with the native (fully glycosylated) receptor, GM3 did not coimmunoprecipitate with the
deglycosylated receptor. Using a novel colorimetric bead binding assay, GM3 was shown to bind
well to the immunoprecipitated native receptor, but not at all to the deglycosylated receptor.
Finally, the addition of GM3 to cells with deglycosylated epidermal growth factor receptors did not
result in signi®cant further inhibition of autophosphorylation of the receptor, despite a 10-fold
decrease in phosphorylation of the native epidermal growth factor receptor by 200 mM GM3.
These studies suggest that ganglioside modulates epidermal growth factor receptor activity through
a direct interaction that requires receptor glycosylation, and contribute to our understanding of the
role of gangliosides in cell membrane function.
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Ganglioside GT1b Induces Apoptosis of Keratinocytes by Modulation of Protein Kinase
B/Akt Phosphorylation through the Integrin Linked Kinase Pathway
A. Paller, P. Sun, and X. Wang
Dermatology, Children's Memorial Hospital, Chicago, Illinois
GT1b comprises 8% of the total membrane ganglioside content of keratinocytes and keratinocyte-
derived SCC12 cells. We have previously shown that GT1b is able to bind directly to the a5
subunit of a5b1 integrin through carbohydrate±carbohydrate interactions, thereby blocking the
binding of a5b1 to ®bronectin (FN) with resultant apoptosis. Integrin linked kinase (ILK) and
protein kinase B (PKB)/Akt are serine/threonine protein kinases that are thought to modulate
keratinocyte cell survival and apoptosis. We hypothesized that GT1b triggers keratinocyte
apoptosis through modulation of ILK activity and its downstream substrates PKB/Akt and
Caspase-9. Western blotting techniques were used to compare the alterations in phosphorylation of
b1 integrin, ILK, PKB/Akt, Bad, and Caspase-9 among SCC12 cells, SCC12 cells pretreated with
speci®c anti-GT1b antibodies, cells supplemented with GT1b, and SCC12 cells depleted of all
gangliosides by gene-modulated overexpression of a ganglioside-speci®c sialidase. Our studies
show that ganglioside depletion increases phosphorylation of Bad, a downstream substrate of PKB/
Akt, and inhibits Caspase-9, thus preventing apoptosis, even when stimulated by serum
deprivation, acetylsalicylic acid, or staurosporine. In contrast, supplemental GT1b suppresses
phosphorylation of Bad, and activates Caspase-9, leading to cell cycle arrest and initiation of
apoptosis. Plating of ganglioside-depleted SCC12 cells on a FN matrix results in stimulation of b1
integrin phosphorylation, ILK phosphorylation, and PKB/Akt activity at both Ser-473 and Thr-
308 sites. The antiapoptotic effect is eliminated when the ganglioside-depleted SCC12 cells are
transiently transfected with PKB/Akt cDNA containing mutations at both the Ser-473 and Thr-
308 phosphorylation sites. The addition of GT1b to SCC12 cells inhibits phosphorylation of b1
integrin and ILK, whereas anti-GT1b antibodies stimulate their phosphorylation; blockade or
addition of other gangliosides does not in¯uence phosphorylation of b1 integrin or ILK. These
studies suggest that GT1b modulation of keratinocyte cell cycle regulation and survival are
mediated through PKB/Akt inhibition via the integrin linked kinase signaling pathway.
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Site-Speci®c Suppression of PKB/Akt Phosphorylation by Keratinocyte Ganglioside:
Relation to Apoptotic Potential
P. Sun, X. Wang, and A. Paller
Dermatology, Children's Memorial Hospital, Chicago, Illinois
Gangliosides have been implicated in the regulation of cell proliferation, differentiation, adhesion
and migration, and apoptosis. The ganglioside content of keratinocyte membranes includes GM3
(62.9%), 9-O-acetylGD3 (16.9%), GD3 (13.7%), and GT1b (6.5%). We have previously shown
that GT1b inhibits the adhesion of keratinocytes on ®bronectin (FN) through binding to and
inhibition of a5b1 activity; GM3 binds to the epidermal growth factor receptor to inhibit cell
proliferation. We studied the effects of these keratinocyte gangliosides on cell apoptosis and on
apoptosis-related signal transduction, including phosphorylation of protein kinase B (PKB)/Akt, a
serine/threonine protein kinase that is thought to modulate cell survival and apoptosis. Depletion
of gangliosides in keratinocyte-derived SCC12 cells by gene-modulated overexpression of a
ganglioside-speci®c sialidase resulted in complete resistance to apoptosis in cells plated on a FN
matrix, even when subjected to serum deprivation, or treatment with acetylsalicylic acid or
staurosporine. In contrast, SCC12 cells supplemented with GT1b became apoptotic when plated
on FN; this effect was not noted when GM3 was substituted for the GT1b. Treatment of SCC12
cells with anti-GT1b antibodies, but not with anti-GM3 antibodies resulted in reduced ability to
apoptose but not complete resistance to apoptosis. In SCC12 cells depleted of gangliosides, protein
kinase B (PKB)/Akt phosphorylation was markedly increased at both serine 473 and threonine
308, resulting in inhibition of Caspase 9 activation. Blockade of GT1b function by anti-GT1b
antibodies increased and treatment with GT1b virtually eliminated phosphorylation of PKB/Akt;
however, modulation of GT1b function affected only phosphorylation of the Ser-473 site.
Blockade of GM3 function by anti-GM3 antibodies and treatment of SCC12 cells with GM3
caused increased and decreased phosphorylation only of the Thr-308 phosphorylation site.
Consistently, inhibitors of EGFR-associated tyrosine kinase and PI3 kinase inhibitor inhibited
phosphorylation only at the Thr-308 site, and not at the PKB/Akt Ser-473 phosphorylation site.
These studies suggest that ganglioside regulation of induced keratinocyte apoptosis is
predominantly modulated at the PKB/Akt Ser-473 phosphorylation site, but that increased
phosphorylation of the Thr-308 site is necessary for complete ganglioside-induced resistance to
apoptosis.
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Gangliosides Modulate Keratinocyte Adhesion, Spreading and Migration by Both
Integrin- and EGFR-Mediated Signaling Pathways
X. Wang, P. Sun, and A. Paller
Dermatology, Children's Memorial Hospital, Chicago, Illinois
Keratinocyte gangliosides modulate both the epidermal growth factor receptor (EGFR)-and a5b1
integrin-mediated signaling pathways. Focal adhesion kinase (FAK) is a widely expressed
cytoplasmic tyrosine kinase that colocalizes with integrins, whereas Ras and MAP kinase (MAPK)
are downstream components common to both EGFR- and integrin-mediated signaling pathways.
We hypothesized that keratinocytes depleted of gangliosides would show increased adhesion,
spreading and migration on a ®bronectin (FN) matrix after exposure to EGF. We proposed that the
mechanism of the effect of ganglioside depletion requires modulation of FAK activity through both
the EGFR- and integrin-mediated signaling pathways. Keratinocyte-derived SCC12 cells were
depleted of ganglioside by gene-mediated overexpression of a ganglioside-speci®c sialidase.
Adhesion, spreading and migration on a FN matrix were increased in response to EGF in sialidase-
transfected cells, but not in parental SCC12 or mock-transfected cells. In parental SCC12 cells
treated with antibodies directed against GM3 or GT1b gangliosides, adhesion, spreading, and
migration were also increased in response to EGF. Concomitantly, FAK and MAP kinase
phosphorylation were greatly increased in these ganglioside-depleted or ganglioside-blocked cells
plated on FN, but not in cells plated on plastic or polylysine-coated plates. Antibodies directed
against ganglioside 9-O-acetylGD3 had no effect on cell function or on FAK or MAPK activation.
Both EGFR-associated tyrosine kinase inhibitor and PI3 kinase inhibitor decreased cell adhesion,
spreading, and migration, and suppressed the FAK and MAPK activation in these ganglioside-
depleted keratinocytes. Ras farnesyltransferase inhibitor also block the MAP kinase activation. We
conclude that gangliosides regulate cell adhesion and migration by modulating FAK phosphoryla-
tion through both EGFR-mediated and integrin-mediated signal pathways in SCC12 cells. In
addition, the FAK signaling pathway affected by gangliosides requires Ras activation for MAP
kinase phosphorylation and modulation of cell behavior on a FN matrix.
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Negative Regulation of the Akt Cell Survival Pathway by the Protein Kinase C Signal
Transduction Pathway
K. Sampat, S. Yuspa, and L. Li
Laboratory of Cellular Carcinogenesis and tumor Promotion, National Cancer Institute, Bethesda, Maryland
Isoforms of protein kinase C (PKC), a family of 11 serine/threonine kinases, are important
mediators of keratinocyte proliferation, differentiation, and apoptosis. While certain downstream
elements of the PKC pathways have been identi®ed, a complete analysis will be required to
identify novel targets for pharmaceuticals that would in¯uence skin biology more speci®cally. One
potential downstream effector of apoptosis is protein kinase B (PKB or Akt), an important
mediator of cell survival. In mouse keratinocytes activation of PKC by 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) reduces Akt phosphorylation on Ser 473 (P-Akt), the active form of
PKB. The reduction of Akt phosphorylation is prevented by treating keratinocytes with the
speci®c PKC inhibitor GF109203X prior to treatment with TPA. Furthermore, pretreatment of
mouse keratinocytes with TPA attenuates Akt phosphorylation induced by insulin-like growth
factor-1, epidermal growth factor or serum. Inhibitors of protein phosphatases, okadiac acid and
calyculin A, increase P-Akt and prevent the reduction of P-Akt caused by TPA treatment. Thus,
activation of PKC signal transduction causes inactivation of Akt, likely by phosphatase activation.
This interaction of PKC and Akt signaling could be associated with apoptosis in keratinocytes
exposed to PKC activators or PKC mediated cell death associated with terminal differentiation.
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Cell Cycle Dysregulation and Apoptosis of Human Epidermoid Carcinoma A431 Cells
by trans-Resveratrol
V. Adhami, F. Afaq, H. Mukhtar, and N. Ahmad
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio
Resveratrol (trans-3, 4¢, 5,-trihydroxystilbene), a potent antioxidant phytoalexin, is known to be
present in grapes, nuts, fruits and red wine. Recent in vitro and in vivo laboratory studies have
suggested that resveratrol possesses cancer chemopreventive properties against many cancers
including chemically induced skin carcinogenesis in mouse model. The mechanism(s) by which
resveratrol imparts skin cancer chemopreventive effects is not clearly de®ned. In this study,
employing human epidermoid carcinoma (A431) cells, we evaluated the involvement and
mechanism of cell cycle dysregulation in antiproliferative properties of resveratrol. Resveratrol (1±
50 mM) treatment of A431 cells resulted in a dose-dependent (i) inhibition of cell growth as shown
by MTT assay (ii) G1-phase arrest of the cell cycle as shown by DNA cell cycle analysis, and (iii)
induction of apoptosis as assessed by enzyme-linked immunosorbent assay. The immunoblot
analysis revealed that resveratrol treatment causes a dose- as well as time-dependent (i) induction of
WAF1/p21 (ii) decrease in the protein expressions of cyclin D1, cyclin D2, and cyclin E, and (iii)
decrease in the protein expression and kinase activities of cyclin dependent kinase (cdk) 2, cdk 4
and cdk 6. These data establish the involvement of cki-cyclin-cdk network during antiproliferative
potential of resveratrol in A431 cells. Because (i) retinoblastoma (pRb) and E2F family
transcription factors are important for the regulation of G1-S transition in the cell cycle, and (ii) the
activity of the pRb is regulated by cyclin-cdk network-mediated phosphorylation, we also
evaluated the effect of resveratrol on pRb-E2F/DP machinery. Immunoblot analysis demonstrated
that resveratrol treatment results in a dose- and time-dependent (i) decrease in the hyper-
phosphorylated form of pRb with a relative increase in hypo-phosphorylated pRb, and (ii) down-
regulation in the protein expression of E2F (1 through 5) family transcription factors, and their
heterodimeric partners DP1 and DP2. Taken together, our study suggests that resveratrol, via
modulating cki-cyclin-cdk network and pRb-E2F/DP machinery, causes an arrest of cell cycle at
G1-phase, which is an irreversible process that ultimately results in an apoptotic death of cancer
cells. Because in recent years, the cell cycle inhibitors are being appreciated as new generation of
anticancer drugs, we suggest that resveratrol may be a potent chemopreventive agent for skin
cancer.
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Loss of Prostaglandin E (PGE) Receptor Subtype EP2 in HaCat Keratinocytes Results in
an Invasive Phenotype and Decreased Expression of the Focal Adhesion Protein Paxillin
R. Konger, G. Scott, Y. Landt,* J. Ladenson,* and A. Pentland
Dermatology, University of Rochester School of Medicine and Dentistry, Rochester, New York; *Laboratory
Medicine, Washington University School of Medicine, St. Louis, Missouri
Increased prostaglandin production and decreased PGE2-coupled cAMP responses are associated
with epithelial malignancies. We transfected a spontaneously immortalized but nontumorigenic
human keratinocyte cell line, HaCat, with sense and antisense constructs for the PGE receptor
subtype EP2. EP2 expression was documented by immunoblot. EP2 receptors are coupled to
activation of adenylyl cyclase. Utilizing a collagen raft made with human diploid ®broblasts (skin
equivalent), 4 of 6 EP2 antisense clones showed a high degree of invasion into the ``dermal''
compartment and marked cellular atypia. These features were not seen in vector controls and sense
transfectants. Invasion with cellular atypia in skin equivalents is typical of squamous cell carcinomas
and virally transformed keratinocytes. Disruption of cellular adhesion to matrix via integrin-focal
adesion complexes is known to be associated with an invasive phenotype. By Western blot, EP2
antisense clones showed decreased expression of paxillin, a critical component of focal adhesion
assemby. HaCat cells synthesize PGE2. Coculture of keratinocytes with ®broblasts is known to
synergistically induce PGE2 formation. EP2 receptors are known to undergo ligand-dependent
down-regulation. We therefore examined the effect of ligand-induced receptor down-regulation
on paxillin expression. Antisense clones were more sensitive to receptor down-regulation using a
selective EP2 receptor agonist. Receptor down-regulation resulted in further loss of paxillin
expression. This data suggests that loss of EP2 receptors represents a mechanism for neoplastic
progression to an advanced invasive phenotype. One potential mechanism for loss of these
receptors is down-regulation by the marked increase in PGE2 produced by malignant tissues.
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Expression of Novel Germ Cell Gene SPAF at Conversion to Squamous Cell Carcinoma
Y. Liu, Z. Wang, and M. Kulesz-Martin
Dermatology, Oregon Health Sciences University, Portland, Oregon
Ectopic expression of primitive stem cell-speci®c genes in adult cells is an attractive conceptual
mechanism for malignant conversion. In search of altered gene expression during multistage
carcinogenesis in a clonal epidermal cell model by RNA differential display, we identi®ed a novel
spermatogonia associated factor (SPAF) that is altered and overexpressed in a poorly differentiated
squamous cell carcinoma compared to normal and initiated progenitor cells. Sequence analysis
reveals that SPAF protein contains two ATPase modules, which classi®es it as a novel member of
the AAA-protein family (ATPase associated with diverse activities). The sequence similarities
between SPAF and other members containing two ATPase modules range from 50%±66%
(identity of 25%±45%) over the whole length of the proteins. Using mouse SPAF cDNA as query,
we retrieved a sequence fragment of candidate human SPAF that was originally cloned from a
human kidney tumor. This is consistent with our ®nding that mouse SPAF is highly expressed in
progenitor cells in testis and abnormally up-regulated in adult epithelial malignancy. The
presumptive human SPAF cDNA was partially cloned by means of RACE PCR from normal
human testis and sequenced. This 1183 bp partial cDNA showed 81% similarity and 78% identity at
the protein level with murine SPAF, which is signi®cantly higher than with other human AAA-
proteins, indicating that the cDNA we cloned most likely represents the human counterpart of
murine SPAF. The availability of mouse SPAF cDNA provided us opportunities to study its
normal functions as well as potential roles in tumorigenesis. In view of a mitochondrial-
localization-like signal, sequence similarities to membrane-associated proteins, ATP binding
properties, and intracellular expression patterns in testis, we speculate that SPAF protein may be
involved in morphological and functional mitochondrial transformations for adaptation to
decreased oxygen tension during spermatogenesis. Ectopic expression of the SPAF gene in
malignant tumors may facilitate the adaptation of cancer cells to the hypoxic conditions common
in solid tumors. Further analysis of SPAF by generation of SPAF knock-out mice and in vivo
tumorigenesis will provide direct evidence regarding its role in germ cell development and
malignant transformation.
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Hair Cycle-Dependent Expression Patterns of STAT-3 in Mouse Skin
A. Engelhard, A. Panteleyev, and A. Christiano
Departments of Dermatology and Genetics & Development, Columbia Universitry, New York, New York
STAT-3 is a member of a family of Signal Transducers and Activators of Transcription that mediate
the biological actions in response to cytokines including interleukins and EGF. Recently, it was
shown that STAT-3 plays a critical role in early mammalian embryonic development and is
essential for hair cycle initiation and skin wound healing possibly by triggering keratinocyte
migration (EMBO J 18:4657, 1999). To further characterize the role of STAT-3 in hair follicle
biology, we have assessed its expression in the back skin of C57BL/6 mice during de®ned stages of
hair follicle morphogenesis and cycling. Immunohistochemistry revealed exclusively cytoplasmic
localization of STAT-3. The early stages of hair follicle morphogenesis were characterized by the
complete absence of STAT-3 in hair follicle epithelia, consistent with normal ®rst hair pelage in
STAT-3 de®cient mice. STAT-3 expression occurred during the IRS formation in its middle
portion and remained constant until the onset of catagen. The catagen-telogen follicles were
STAT-3 negative. Interestingly, during the telogen-anagen transition, a few (usually 1±3) STAT-3
positive cells were localized to the lowermost portion of the hair follicle, in immediate contact
with dermal papilla. In early anagen, STAT-3 positive cells represented only a minor part of the
lowermost downward growing hair follicle. In anagen III, with the initiation of hair matrix
formation, STAT-3 positivity in the lower hair follicle disappeared. Similar to morphogenesis,
during anagen the STAT-3 positive cells formed a thin (1±2 cells) ring within the middle IRS, at
the level where the IRS loses its connection with the hair shaft cuticle. The occurrence of STAT-3
positive cells during anagen initiation in immediate contact with dermal papilla, and restriction of
its expression to selected cells of the rapidly proliferating epithelial bud, suggests a critical role of
STAT-3 in anagen induction. These ®ndings are consistent with a failure of anagen induction in
the skin of STAT-3 de®cient mice (PNAS 97:13824, 2000). The role of STAT-3 expression in the
middle portion of hair follicle epithelial sheath during mature anagen remains to be determined.
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The Epidermal Product of the Shh Target Gene BEG4 Predicts a Conserved Proline-
Rich Protein that Regulates Growth Factor Signaling with the Cytoskeleton
A. Oro, L. Horng, and J. Xu
Dermatology, Stanford University, school of medicine, Stanford, California
Sonic hedgehog (Shh) target gene activation plays a central role in hair follicle morphogenesis and
Basal cell carcinoma (BCCs) formation. Using a microarray screen for genes expressed in BCC, we
have identi®ed a novel gene BCC-enriched gene 4 (BEG4). BEG4 is normally expressed in Shh
responsive cells in the hair follicle and in the epithelium of BCCs, but not in interfollicular
epidermis or squamous cell carcinomas. BEG4 is ectopically induced with ectopic Shh expression
in transgenic animals. BEG4 is expressed in ®broblasts from patched 1 (ptc) ±/± embryos, but no
RNA accumulation is detected in ptc+/± or ptc±/± cells overexpressing wild type ptc, supporting
BEG4's role as a Shh target gene. Previously published transcripts predict a 356 aa protein on
human chromosome 8. However, we have found the major transcript in skin comes from an
alternative promoter that gives rise to an 755 aa protein with a conserved coiled-coil domain. This
longer BEG4 transcript predicts a novel proline-rich protein that coordinates growth factor
signaling with the cytoskeleton.
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Inhibition of TGFb Signaling in Keratinocytes Activates ERK Through a Smad and
MEK Independent Pathway
E. Bhogte, M. Marko, and A. Glick
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland
Recent studies from a number of laboratories have shown shown signi®cant interactions between
the TGFb and mitogen activated protein kinase (MAPK) signaling pathways. To investigate what
role autocrine TGFb signaling has in regulating the MAPK pathway in primary keratinocytes, we
infected cells with an adenovirus expressing a dominant negative TGFb type II receptor
(AdTGFbTR), and measured activation of various MAPK pathways with phosphorylation speci®c
antibodies. Infection of keratinocytes with this adenovirus completely blocks response to
exogenous TGFb1. As early as 6 h after infection with AdTGFbTR, and lasting for at least 24 h,
there was an increase in phosphorylation of ERK1 and ERK2. By 48 h after infection there was a
signi®cant increase in apoptosis in the AdTGFbTR infected keratinocytes. Infection with a control
adenovirus AdGFP or mock infection had no effect on ERK activation, and did not cause
signi®cant induction of apoptosis. There was no alteration in p38 or JNK phosphorylation or
protein levels, indicating speci®city of ERK activation by AdTGFbTR. There was no increase in
phosphorylation of the upstream activators of ERK: MEK1/2 and c-RAF, as well as MEK3/6.
Surprisingly, treatment of AdTGFbTR infected keratinocytes with the MEK1/2 inhibitors
PD90985 or UO126, at concentrations suf®cient to completely block EGF-induced ERK
activation, caused superactivation of ERK. Pretreatment of keratinocytes with TGFb1 caused a
slight inhibition of EGF-induced activation of ERK1/2. To test if ERK activation was dependent
on Smad signaling, we infected keratinocytes with a Smad 7 adenovirus which completely blocks
TGFb1 induced gene expression through inhibition of R-smad phosphorylation by the activated
type I receptor. In these Smad7 infected keratinocytes there was no activation of the ERK, JNK or
p38 signaling pathways. These results suggest that AdTGFbTR blocks a TGFb1 regulated ERK
phosphatase, that is itself inhibited by MEK, and that this signaling pathway is independent of the
Smad pathway.
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The TIG3 Tumor Suppressor Protein is a Potent Negative Regualtor of Keratinocyte
Proliferation
S. Dashti, A. Deucher, R. Chandraratna, and R. Eckert
Physiology and Biophysics, and Dermatology, Case Western Reserve Univeristy School of Medicine,
Cleveland, Ohio
Retinoids (vitamin A and related ligands) cause profound biological changes in keratinocytes. In
vitro, retinoids coordinately regulate expression of a variety of keratinocyte genes, and suppress
keratinocyte proliferation. In vivo, retinoids can cause epidermal thickening, parakeratosis, and
altered differentiation marker expression. The underlying mechanisms that mediate these responses
are not well understood. TIG3 is a novel, recently discovered gene that was isolated from retinoid-
treated psoriatic keratinocytes. TIG3 levels are increased by retinoids and this retinoid-dependent
increase is correlated with reduced cell proliferation. The gene encodes a 164 amino acid tumor
suppressor that is a member of the H-rev protein family of growth regulators. In spite of its potent
biological activity, the mechanism of TIG3 action is not understood. In the present study, we
examine the ability of TIG3 to regulate normal human keratinocyte proliferation. Adenovirus-
mediated expression of TIG3 in keratinocytes produces a TIG3 concentration-dependent
inhibition of cell proliferation. Thus, TIG3 can suppress keratinocyte proliferation alone, in the
absence of other retinoid-associated effects. TIG3 also produced a remarkable morphological
change, causing the keratinocytes to ¯atten and become highly adherent. Immuno¯ourescence
studies shows that TIG3 localizes in a perinuclear region. A mutant form of TIG3, TIG1-134, that
lacks the hydrophobic carboxyl terminus, does not inhibit cell proliferation. This suggests that the
carboxy-terminal hydrophobic domain, which is conserved among members of the H-rev family,
is required for optimal activity. Thus, our results indicate that TIG3 is a potent suppressor of
keratinocyte cell proliferation, and suggest that TIG3 is likely to be an important mediator of
retinoid-dependent growth suppression.
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Endogenous Activation of Protein Kinase C Regulates Proliferation and Differentiation
in HaCaT Keratinocytes
T. BõÂroÂ, H. Papp, G. Czifra, J. LaÂzaÂr, and L. KovaÂcs
Department of Physiology, University of Debrecen, MHSC, Medical School, Debrecen, Hungary
We have previously shown that human HaCaT keratinocytes express numerous protein kinase C
(PKC) isoforms (the ``conventional'' cPKCa, b, and g; the ``novel'' nPKCd, e, h, and q; and the
``atypical'' aPKCz), and that the activation of PKCs by phorbol esters inhibits proliferation and
induces terminal differentiation. In this study we investigated the endogenous role of the PKC
system in the regulation of the above processes using PKC-speci®c inhibitors. Differentiation was
measured by either Western blot analyses of differentiation markers (the granular cell marker
keratin 10 and the spinous cell marker involucrin) or by measuring intracellular calcium
concentration ([Ca2+]i), whereas cellular proliferation was assessed by a bromo-deoxyuridine cell
proliferation ELISA. Inhibition of cPKC and nPKC isoforms by GF109203X did not modify
cellular proliferation. However, GF109203X differentially altered the expression of the
differentiation markers; whereas the expression of the early (granular cell) marker keratin 10 was
not affected, the inhibitor decreased the level of the late-terminal (spinous cell) marker involucrin
in a dose-dependent manner. In addition, selective inhibition of the cPKC isoforms by GoÈ6976
markedly inhibited cellular proliferation in a dose-dependent fashion. Furthermore, GoÈ6976,
similarly to that seen in the case of GF109203X, decreased the expression of involucrin without
signi®cantly modifying the level of keratin 10. Finally, neither inhibitor modi®ed the [Ca2+]i of the
cells. These data indicate that the endogenous activation of PKC isoforms regulates proliferation
and the expression of differentiation markers (but not [Ca2+]i) in HaCaT keratinocytes. In addition,
our data strongly argue for the antagonistic roles of the cPKC and nPKC isozymes in the regulation
of proliferation, and for the speci®c roles of the cPKC isoforms in the regulation of terminal
differentiation of these cells.
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Abrogated Production of Chemokines by HPV16-Harboring Tumor Cells
S. Majewski,* M. Malejczyk,* T. Grzela, F. Breitburd,² J. Jozwiak, G. Orth, S. Jablonska, T.
Schwarz, and J. Malejczyk
Department of Histology, Warsaw Medical University, Warsaw, Poland; *Department of Dermatology,
Warsaw Medical University, Warsaw, Poland; ²Unite des Papillomavirus, Institut Pasteur, Paris, France;
³Department of Dermatology, University of Muenster, Muenster, Germany
Recruitment of leukocytes to the site of HPV infection is necessary for eradication of transformed
cells and lesion regression, which may depend, in part, on local production of chemokines. The
aim of the study was to evaluate production of selected CXC (IL-8 and GROa) and CC (MCP-1
and RANTES) chemokines by nontumorigenic HaCaT keratinocytes and HPV16-harboring Skv,
CaSki, and SiHa tumor cells. Transplantation of these cells into nude mice revealed that HaCaT
cells induced strong local in¯ammatory reaction and were gradually destroyed, whereas HPV16-
harboring tumor cells did not evoke signi®cant in®ltrates and formed rapid growing tumors.
Chemotactic activity of culture supernatants generated by the tested cell lines was evaluated toward
human neutrophils and monocytes using Transwell(r) (Costar) migration system. Chemokine
production was evaluated by speci®c enzyme-linked immunosorbent assays, and chemokine
mRNAs were detected by ribonuclease-protection assay (RPA) using speci®c RNA probes.
HaCaT cells exerted strong chemotactic activity toward both neutrophils and monocytes, and
released relatively high amounts of the respective chemokines. Chemotactic activity of HPV16-
harboring tumor cells toward neutrophils and monocytes was signi®cantly decreased, and
production of the respective chemokines was decreased or absent. Production of chemokines by
HaCaT cells could be signi®cantly up-regulated by recombinant human TNFa (rhTNFa).
However, TNFa only partially stimulated chemokine production by HPV16-harboring cells. The
study showed that cell transformation by oncogenic HPVs is associated with abrogation of
chemokine production that may be an important factor enabling unopposed growth of HPV-
associated lesions.
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Impact of Speci®c Receptor Tyrosine Kinases on Ras in Epithelial Cells
T. Cai and P. Khavari
VA Palo Alto and Department of Dermatology, Stanford University, Stanford, California
Ras proteins function as molecular switches downstream of receptor tyrosine kinases (RTKs) to
transmit signals regulating cell growth and differentiation. A number of RTKs are capable of
activating Ras in various cell types and tissues, however, not all of them function in epidermis. It
has been demonstrated that targeted disruption of the RTKs EGFR, PDGFRa and IGF1R leads to
major defects in epidermal growth and differentiation. To determine the impacts of these RTKs on
epidermal Ras, we stimulated quiescent primary keratinocytes with individual growth factors and
examined Ras activation and MAP kinase activity. Active GTP-bound Ras protein can be pulled
down from total cell extract by a GST fusion to the Ras-binding domain of Raf1 (aa 51±131) and
quantitated as a percentage of total Ras, thus providing a direct biochemical measure of the degree
of Ras activation. EGF activates Ras and MAP kinases at concentrations as low as 2 ng per ml while
PDGF and IGF1 function at 10-fold higher concentrations. Activation of p42/p44 MAPKs does
not completely correlate with the activation of Ras upon stimulation by different growth factors. A
10% increase in active GTP-bound Ras induced by EGF causes a 40% induction of active MAPK,
however, a 35% increase of active Ras by IGF1 only generates a 20% induction in active MAPK,
indicating that these RTK ligands exert differential effects on downstream Ras effectors. Both the
general tyrosine kinase inhibitor genistein and speci®c RTK inhibitors block Ras and downstream
MAPK activation. While all 3 Ras isoforms, H-Ras, K-Ras and N-Ras, are expressed in epidermis,
they respond differently to upstream RTKs. For example, N-Ras is strongly activated by IGF1R
while H-Ras is unaffected. In addition we are undertaking studies with EGFR, PDGFR and
IGF1R knockout mice, which will allow us to study activation of Ras and downstream effectors in
the context of selective absence of speci®c RTKs. These data indicate that Ras can be activated by
3 RTKs of functional importance in epidermis in a tyrosine kinase-dependent fashion, establish
that different RTKs exert differential impacts on speci®c Ras downstream effectors and suggest that
different RTKs may mediate their effects via distinct isoforms of Ras.
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Identi®cation and Characterization of Initiation-Associated Genes in a Clonal Epidermal
Model of Carcionogenesis
E. Horn, Y. Liu, and M. Kulesz-Martin
Dermatology, Oregon Health Sciences University, Portland, Oregon
Our laboratory has developed a strategy to identify and functionally test candidate-initiation genes.
The steps are to (1) detect candidate genes by differential display or microarray comparison of
nontransformed progenitor keratinocytes (291), 7,12-dimethylbenz[a]anthracene (DMBA)-
initiated cells, benign papilloma cells, and squamous cell carcinoma derivatives (2) test transforming
function of candidate genes in vitro by measuring induction of resistance to Ca2+-induced terminal
differentiation and in vivo by skin-grafting and tumorigenesis, and (3) determine relevance and
potential signi®cance of candidate genes by testing frequency of altered expression in
independently derived tumors. As an example, one gain of function at initiation, 2G2, was
detected by differential display representing 5% of cellular mRNA compared to 17 changes at
malignant conversion. Northern blotting con®rmed elevated 2G2 expression in 3 independently
initiated clones. The full-length 2G2 cDNA was cloned from a testis cDNA library and the 5-
prime end was obtained by RACE PCR. At the deduced amino acid level, 2G2 showed 95%
identity to human protein HT2A and includes motifs found in oncogenes and transcription factors:
a ring ®nger domain, cys/his cluster, and coiled-coil region. Initiating ability was tested using
retroviral infection of 291 cells to introduce 2G2, green ¯uorescent protein-GFP, or known
initiator ras. 2G2-expressing colonies resistant to 1.4 mM Ca2+-induced terminal differentiation
were increased 2-fold (17% transformation frequency) compared to GFP (8%) but less than ras
(33%) when treated with 12-o-tetradecanoylphorbol-13-acetate (TPA). Exogenous expression of
the introduced genes was con®rmed by Northern blotting. The role of 2G2 in initiation is subject
to veri®cation by in vivo assays of papilloma formation from 291 cells infected with retrovirus
containing 2G2, GFP, or ras followed by skin-grafting to athymic nu/nm mice and treatment with
TPA. Quantitative real-time-PCR is being used to determine 2G2's prevalence in independently
derived mouse and human squamous cell carcinomas. Microarray analysis will be used to identify
genes responsive to 2G2 to test the hypothesis that 2G2 is a transcription factor for initiation and/
or promotion genes. The current strategy to study initiation genes may provide new leads for the
development of early diagnostic tests, preventive measures, and treatments for human cancer.
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Insulin Induced PKCd Activity Mediates STAT3 Transcriptional Activation in
Keratinocyte Proliferation
M. Gartsbein, A. Alt, G. Nudelman, M. Ohba,* Y. Hanakawa,² K. Hashimoto, T. Kuroki, and T.
Tennenbaum
Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel; *Molecular Oncology Research Center,
Showa University, Tokyo, Japan; ²Department of Dermatology, Ehime University, Medical School, Ehime,
Japan
STAT (Signal Transducers and Activators of Transcription) proteins are a family of transcription
factors recruited by a variety of cytokines and growth factors. Among the seven known STAT
family members STAT3 is unique. Targeted disruption of STAT3 but not other STAT family
members leads to early embryonic lethality. Speci®cally, when STAT3 was conditionally ablated in
skin, skin remodeling was severely disrupted. Upon activation, STAT proteins form homo or
heterodimers, translocate to the nucleus and bind to DNA response elements of target genes to
induce transcription. To elucidate the pathway by which STAT3 activation is regulated in skin we
utilized a model of skin keratinocytes in culture. It was found that in keratinocytes, PKCdbut not
other PKC isoforms expressed in skin (PKCs a, z, h and e) is constitutively associated with
STAT3. Furthermore, insulin regulates phosphorylation and activation of STAT3 via speci®c
activation of PKCd. As early as 5 min following insulin stimulation, PKCd but not PKCs a, h, e
and z is speci®cally activated. PKCd activation is associated with induction of serine and tyrosine
phosphorylation of STAT3 bound to PKCd, which is followed by STAT3 nuclear translocation
and transcriptional activation. Overexpression of adenovirus PKCd, but not of adenoviral
constructs of PKCs a, h, or z induced STAT3 association with PKCd and STAT3 serine
phosphorylation. Furthermore, inhibition of PKCd activity by a pharmacological inhibitor,
rottlerin, or by overexpressing a dominant negative PKCd mutant abrogated insulin induced
STAT3 phosphorylation and nuclear translocation. Finally, overexpression of a dominant negative
PKCd mutant inhibited keratinocyte proliferation induced by overexpression of STAT3. Overall,
these results suggest a role for insulin induced PKCd activity in transcriptional activation by
STAT3 in skin keratinocyte proliferation. Further understanding of the role of insulin in mediating
PKC signaling and transcriptional activation could shed light on the unique role of insulin in
proliferation and differentiation of skin keratinocytes.
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Mitogenic Signaling Pathways Required for Induction of the Novel Immediate Early
Gene IEX-I by Epidermal Growth Factor Receptor (EGFR)
A. Sekulic, K. Squillace, R. Kumar, and M. Pittelkow
Dermatology Research, Mayo Clinic, Rochester, Minnesota
Cells from organs and tissues with higher proliferative rate express higher levels of the novel
Immediate Early Gene, IEX-I. Additionally, overexpression of IEX-I in cultured cells leads to an
increased rate of proliferation. Transcription of IEX-I is rapidly and transiently induced in a variety
of cells upon stimulation with appropriate growth factors. Activation of the Epidermal Growth
Factor Receptor (EGFR) in cultured keratinocytes leads to both induction of IEX-I mRNA
transcription and enhanced proliferation. However the exact nature of the proliferative signals
mediating EGFR induction of IEX-I mRNA is not clearly understood. Both Mitogen Activated
Protein Kinase (MAPK) and Phosphatidylinositol 3-Kinase (PI3K) pathways have been implicated
in regulation of cellular proliferation in multiple cell types. Here we examined whether these
known mitogenic signaling pathways play a role in regulation of IEX-I mRNA induction by
EGFR. We ®nd that pretreatment of keratinocytes (HaCaT) with EKI 785, a speci®c inhibitor of
EGFR, completely abolishes EGF-induced IEX-1 transcription. Inhibition of either MAPK
pathway alone using MEK inhibitor PD98059 or PI3K pathway alone using wortmannin had no
effect on EGFR-mediated IEX-I induction. However, concomitant pharmacologic inhibition of
both MAPK pathway and PI3K lead to a complete abrogation of IEX-I mRNA induction in
response to EGF stimulation. This suggests essential but overlapping roles for these pathways in
EGF-mediated IEX-I induction. Since IEX-1 has also recently been implicated in regulation of
carcinoma growth, selective inhibition of these signaling pathways could be therapeutic targets for
treatment of hyperproliferative as well as malignant epidermal disorders.
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Hydrogen Peroxide is a Key Molecule Modulating Arachidonic Acid-Induced Mitogen
Activated Kinases Activation and Lamellipodia/Filopodia Formation in Keratinocytes
A. Meves, S. Stock, and M. Pittelkow
Dermatology Research, Mayo Clinic, Rochester, Minnesota
Arachidonic acid (AA) is the major precursor of several classes of signaling molecules. Metabolites
of AA, or eicosanoids, including prostaglandins, thromboxane, leukotrienes and hydroxyeicosate-
traenoic acids, have been implicated as mediators or modulators of a number of physiological
functions and pathological conditions in both normal and diseased human skin. We sought to
elucidate AA-induced signaling events in keratinocytes. AA activated Rac1 as determined by
af®nity puri®cation of activated Rac1 through binding to the p21-binding domain of Pak. Rac1
forms part of the NADPH oxidase complex that generates superoxide which is then metabolized to
hydrogen peroxide by superoxide dismutase. Rac1 also mediates the activation of c-Jun N-
terminal kinase (JNK) and induces lamellipodia formation. Signi®cant amounts of superoxide,
nitric oxide and hydrogen peroxide were detected in keratinocytes exposed to AA. We have
identi®ed hydrogen peroxide as a mediator of EGF receptor activation, and levels of hydrogen
peroxide correlated with EGF receptor tyrosine phosphorylation and active extracellular regulated
kinases 1/2 (ERK1/2) in AA treated cells. AA also strongly activated c-Jun N-terminal kinase
(JNK) and induced lamellipodia and ®lopodia formation. Adenoviral overexpression of catalase but
not superoxide dismutase completely inhibited cytoskeletal changes and, further, catalase
overexpression strongly activated JNK. Cells pretreated with PD153035 also showed increased
JNK activity, suggesting an inhibitory effect of hydrogen peroxide-mediated EGF receptor
activation on JNK activity. Neither adenoviral catalase nor superoxide dismutase overexpression
affected AA-mediated cell death. Our results identify hydrogen peroxide as a key molecule
modulating the activation of mitogen activated protein kinases and mediating lamellipodia and
®lopodia formation.
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Peroxynitrite is a Mediator of Arachidonic Acid-Induced Lipid Peroxidation and JNK
Activation
S. Stock, A. Meves, and M. Pittelkow
Dermatology Research, Mayo Clinic, Rochester, Minnesota
Arachidonic Acid (AA), a C20 polyunsaturated fatty acid is the precursor for cells to generate
cyclooxygenase, lipoxygenase and monooxygenase products and therefore plays a central role in
eicosanoid and other lipid synthesis. Metabolites of AA, termed eicosanoids, have been implicated
as mediators or modulators of a number of physiological functions and pathological conditions in
both normal and diseased human skin. Reactive oxygen species are important regulatory molecules
mediating many of the effects triggered by AA. We found that keratinocytes exposed to AA
produced both superoxide and nitric oxide in a time dependent manner which strongly correlated
with the activation of c-Jun N-terminal kinase (JNK), a stress-induced kinase reported to be
activated by end products of lipid peroxidation (LPO). Indeed, AA also induced strong LPO in
keratinocytes. Neither nitric oxide nor superoxide alone are strong inducers of LPO. However,
peroxynitrite, a potent oxidizing and nitrating species formed in a diffusion-limited reaction
between nitric oxide and superoxide, is a well known mediator of LPO. By using antibodies
against nitrosylated tyrosine residues and ¯ow cytometry, confocal and Western blotting analysis,
we demonstrated that signi®cant amounts of peroxynitrite were generated in keratinocytes exposed
to AA. Adenoviral overexpression of superoxide dismutase, by inhibiting LPO, also inhibited JNK
activation, whereas catalase overexpression lead to strong activation of JNK, presumably through
inhibtion of hydrogen-peroxide-mediated EGF receptor activation. Overexpression of superoxide
dismutase or catalase were also examined to determine the role of oxidative stress in mediating AA-
induced cell death. We identify peroxynitrite as a mediator of AA-induced JNK activation and
LPO.
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A Role for Smad3 in the Senescence Response of Mouse Keratinocytes to Oncogenic
Ras
K. Vijayachandra, and A. Glick
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland
Alterations in transforming growth factor b (TGF b) signaling and response in mouse keratinocytes
have been linked to accelerated premalignant progression in vivo and resistance to ras induced
senescence in vitro. To explore further the possible role of TGFb signaling as a modi®er of skin
carcinogenesis, we have compared the tumor and senescence response to activated v-rasHa of
keratinocytes from several inbred mouse strains and the relationship of this response to TGFb
signaling. Following infection with a replication defective retrovirus expressing v-rasHa, primary
Balb/c and C57/BL6 keratinocytes underwent hyperproliferation but then growth arrested and
senesced, while FVB/N keratinocytes had a signi®cantly delayed senescence response. When
grafted onto nude mice, v-rasHa transduced Balb/c and C57/BL6 keratinocytes formed primarily
benign papillomas while FVB/N keratinocytes rapidly progressed to squamous cell carcinoma. All
the three strains had similar growth inhibitory responses to high concentration of exogenous
TGFb1, but following transduction with v-rasHa Balb/c keratinocytes secreted approximately 2
fold higher levels of total and active TGFb1 compared to FVB/N. Ras induced senescence of
Balb/c and C57/BL6 but not FVB/N keratinocytes was associated with an increase in expression
of the cyclin dependent kinase inhibitor p15ink4b, a TGFb responsive gene, suggesting altered
TGFb signaling in FVB/N keratinocytes. Addition of exogenous TGFb1 and adenovirus mediated
overexpression of Smad3 but not Smad2 accelerated senescence in v-rasHa transduced FVB/N
keratinocytes. In addition Smad3±/± keratinocytes had a delayed senescence response associated
with poor induction of p15ink4b. These results indicate that Smad3 plays an important role in
senescence response of mouse keratinocytes to oncogenic ras, and that susceptibility to
carcinogenesis in different inbred mouse strains is associated with altered TGFb signaling.
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Aberrant Association of Wild Type p53 and Mdm-2 at Epidermal Malignant Conversion
M. Kulesz-Martin, C. Knights, and Y. Liu
Dermatology, Oregon Health Sciences University, Portland, Oregon
A clonal epidermal cell model of carcinogenesis with nontransformed (291), chemically induced
initiated (291.03C), and squamous cell carcinoma (291.03R) derivatives was used to investigate
p53 inactivation in multistage carcinogenesis. We previously reported elevated p53 mRNA
expression and reduced immunoprecipitable p53 protein in 291.03R without p53 gene mutations.
We therefore examined wild type p53 protein defects by immunoblotting of p53-inducible
proteins and DNA binding assays of endogenous p53 proteins. The p53 protein was activated in
291 and 291.03C by g-irradiation: mdm-2 and p21 proteins were induced and p53 and mdm±2
protein interactions were markedly reduced, consistent with stabilization of p53 protein and an
intact p53 pathway. In contrast, p53 protein was not induced in 291.03R cells after g-irradiation
and was defective in sequence-speci®c DNA binding and transactivation of its downstream genes.
Although not induced by g-irradiation due to the p53 defect, mdm-2 protein was constitutively
expressed in 291.03R at ~14 fold higher levels than in 291 cells. Mdm-2 abundance alone was not
responsible for the lower levels of p53 protein, since p53 protein in 291.03R cells was readily
detectable in complex with mdm-2 protein by coimmunoprecipitation. The defect appeared to be
in p53 protein activation, since mdm-2 protein from the carcinoma lysate failed to bind activated
p53 protein of 291.03C cells. Surprisingly, mdm-2 formed a trimeric complex with p53 and its
consensus DNA sequence, suggesting that the p53 protein effector pathway could be defective in
part due to mdm-2 protein inhibiting recruitment of p53 N-terminal binding factors required for
transcriptional activation. Mdm-2 protein abundance was not due to losses of its regulator protein
p19ARF, which was expressed and able to associate with mdm-2 protein. Rather, southern analysis
revealed mdm-2 gene ampli®cation. These results suggest that defects in wild type p53 protein
post-translational modi®cation allowed association of mdm-2 with p53 protein, even when bound
to DNA, resulting in enhanced degradation of p53 protein and inhibition of transactivation. Ser15
phosphorylation was inducible in 291.03R, suggesting Thr18 and Ser20 as candidate sites for
defects in the upstream pathways of p53 activation. We speculate that the defects in wild type p53





Pro®ling Genomic Expression in Disorders of Epidermal Proliferation Identi®es Egr-1
as a Potent Regulator of Epidermal Growth
S. Wee, Q. Lin, S. Tao, H. Fan, and P. Khavari
VA Palo Alto and Department of Dermatology, Stanford University, Stanford, California
Epidermal hyperproliferation characterizes a number of skin disorders, including squamous cell
carcinoma (SCC), basal cell carcinoma (BCC) and psoriasis. Based on the hypothesis that
understanding the underlying gene expression programs responsible for the common and distinct
features of these disorders, we performed gene expression pro®ling on a series of lesional and site
matched normal control skin specimens from the same patients (n = 4 for each disorder) and
veri®ed these ®ndings with protein expression analysis on a series of 125 patients via
immunohistochemical analysis. Initial microarray hybridizations with 12 000 genes were extended
to triplicate studies on 1200 genes. Cluster analysis readily differentiated each disorder by pattern
grouping, indicating that these disorders display disease-speci®c patterns of gene expression. The
disorders demonstrated the following order of gene expression homogeneity; psoriasis BCC SCC.
This is consistent with psoriasis being a reactive disorder of normal tissue, with BCC arising via
de®ned pathways and SCC arising via multiple mechanisms. These disorders displayed
commonalties and differences in expression of discrete genes, as also veri®ed by protein expression
levels in at least 25 patients for each disorder. PDGF-A was increased in all 3 disorders compared to
site matched normal controls, suggesting that the PDGF axis may be a common mediator of
epidermal hyperproliferation. Egr-1, a zinc ®nger transcription regulator, was induced strongly in
psoriasis but completely absent in both BCC and SCC, raising the possibility that Egr-1 may help
differentiate benign and malignant proliferation. Consistent with this, Egr-1 dramatically inhibited
growth of proliferating normal human keratinocytes as well as HPV18 E6/E7 transformed cells and
SCC-25 cells. In contrast, a DNA binding domain Egr-1 deletion mutant exerted no growth
effects, implicating DNA binding by Egr-1 in epidermal growth suppression. Targeted epidermal
expression of Egr-1 in transgenic mice has been achieved, with growth effects currently being
analyzed. These data indicate that common disorders of epidermal hyperproliferation can be
distinguished on the basis of global gene expression patterns, implicate the PDGF axis as a common
mediator and suggest that differential expression of Egr-1 may contribute to differences in biologic
behavior of these conditions.
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Integrin a6b4 Ligation Controls Keratinocyte Morphology and Chemotaxis Through
Opposing Stimulation of the Small GTPases, Rac and Rho
A. Russell, E. Fincher, V. Vela, R. Smith, and M. Marinkovich
Program of Epithelial Biology, Stanford University School of Medicine, Stanford, California
A number of functions of a6b4 integrin appear to be independent of its attachment to laminin 5.
We studied the signi®cance of this to keratinocyte function through point mutation of the b4
subunit in an identi®ed extracellular attachment domain and its comparison to functional b4 when
transduced by retrovirus into b4 de®cient epidemolysis bullosa keratinocytes (EBK's). Monolayer
scratch and Boyden chamber migration assays indicated that functional a6b4 and laminin 5 are
required for induction of chemotaxis through EGF (2 ng per ml). We examined cytoskeletal
changes in cells after treatment with EGF. Blank vector (BV) transduced EBK and attachment
de®cient a6b4 (AD) EBK's produced only transient (30 min) lamellopodia while wild type a6b4
(WT) transduced EBK's could sustain lamellopodia formation for at least 4 h. Lamellopodia
formation is normally driven through the small GTPase Rac, and retroviral expression of dominant
negative (DN) Rac completely inhibited a6b4 dependant chemotaxis. Unexpectedly, AD EBK's
exhibited numerous markers suggesting chronic stimulation of the small GTPase Rho, these
included growth factor independent epithelial to mesenchymal transition with prolonged
incubation (24 h), cell scattering and increased stress ®bers and focal adhesions containing a3b1
integrin. Transduction of AD EBK's with DN Rho completely reversed the mesenchymal
phenotype. Furthermore, DN Rac transduced WT EBK's exhibited profound mesenchymal
transformation while BV transduced DN Rac EB cells remained epithelial. Since Rac activation
impairs Rho in epithelial cells we conclude that a6b4 integrin controls an opposing balance of
attachment dependant Rac activation and attachment independent Rho activation. Control of this
balance is essential for EGF induced chemotaxis, while an imbalance in these opposing forces may
explain many of the alternative functions of a6b4 in transformed cells.
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Loss of Expression of p16INK4a and p14ARF Genes Via Deletion and Promoter
Hypermethylation in Human Non Melanoma Skin Cancers
A. Paci®co, A. Ouhtit, L. Goldberg,* S. Bolshakov, K. Peris,² S. Chimenti, and H.
Ananthaswamy
Immunology, Maryland Anderson Cancer center, Houston, Texas; *DermSurgery Associates, Houston,
Texas; ²Dermatology, University of l'Aquila, L'Aquila, Italy; ³Dermatology, University of Tor Vergata,
Rome, Italy
The INK-ARF locus localized on human chromosome 9p21 encodes two alternatives reading
frame proteins (p16INK4a and p14ARF) known to function as tumor suppressors via the
retinoblastoma or the p53 pathway. Inactivation of p16INK4a can lead to dysregulation of these
two pathways. Although mutations in the p53 gene are well documented in human nonmelanoma
skin cancers (NMSC), the role of p16INK4a and p14ARF in the development of human NMSC is
not well studied. We therefore analyzed 40 NMSC (21 primary human squamous cell carcinomas,
17 basal cell carcinomas and 2 actinic keratoses) for alterations in p16INK4a and p14ARF genes by
PCR. The results indicated that about 85% of the tumors had deletions in exon 2 of the p16INK4a
gene. In addition, methylation-speci®c PCR experiments revealed that about 45% of the tumors
had hypermethylation in the p16INK4a and p14ARF promoter regions. Immunohistochemical
analysis revealed loss of expression of p16 and p14 proteins in 97% of NMSC. As expected, about
80% of human NMSC analyzed contained UV signature mutations in the p53 gene and almost all
of them were strongly positive for p53 immunostaining. Based on these data, we conclude that in
addition to mutations in the p53 gene, loss of expression of p16INK4a and p14ARF genes via
deletion and promoter hypermethylation also plays an important role in the pathogenesis of human
NMSC.
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Keratinocyte Growth Inhibition by High Doses of Epidermal Growth Factor is Mediated
Through Autoinduction of Transforming Growth Factor b: A Negative Feedback
Mechanism of Keratinocyte Growth
K. Yamasaki, N. Toriu, Y. Hanakawa, Y. Shirakata, S. Tokumaru, Y. Yahata, M. Tohyama, K.
Sayama, and K. Hashimoto
Dermatology, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
The epidermal growth factor receptor (EGFR) ligand-EGFR signal is a major signaling pathway
that regulates keratinocyte growth in an autocrine manner. However, it is well known that high
doses of EGFR ligands inhibit keratinocyte growth. Recently, STAT1-dependent p21Waf1/Cip1
induction was reported as a mechanism of EGF-dependent cell growth arrest in an A431 squamous
carcinoma cell line. However, transfection of dominant negative STAT1 adenovirus vector did not
block EGF-induced growth inhibition in normal keratinocytes. Since transforming growth factor b
(TGFb) is a potent inhibitor of keratinocyte proliferation, we hypothesized that TGFb contributed
to EGF-mediated keratinocyte growth inhibition. First, we used p3TP-lux, which contains three
tandem TGFb-smad signaling responsive elements, to examine whether TGFb acts in an autocrine
manner in normal human keratinocytes. 100 ng per ml EGF up-regulated p3TP-lux luciferase
activity 8-fold compared to no stimulation. This EGF-dependent induction of p3TP-lux luciferase
activity was disrupted by transfection of the dominant negative form of type 1 TGFb receptor
(ALK5) adenovirus vector, which indicated that EGF-induced TGFb acts in an autocrine manner
in keratinocytes. Consequently, 10±100 ng per ml EGF induced TGFb1 mRNA in a dose- and
time-dependent manner, and about 40 pg per ml per 106 cell of TGFb1 was detected in culture
medium incubated with 100 ng per ml EGF using an ELISA method, but 0.1±1 ng per ml EGF did
not induce TGFb1 production. Moreover, transfection of the dominant negative form of ALK5
adenovirus vector completely blocked the growth inhibition induced by 100 ng per ml EGF in
normal keratinocytes, which indicated that EGF-induced TGFb mainly inhibits keratinocyte
proliferation. These data demonstrate that an autocrine TGFb-ALK5 pathway is a negative
feedback mechanism for EGFR-dependent normal keratinocyte growth.
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Collagen-Activated Keratinocyte Collagenase-1 Expression Requires ERK 1/2 MAP
Kinase Signaling
B. Pilcher, K. Spradling, A. McDaniel, and W. Parks*
Cell Biology and Dermatology, UT South-western Medical Center, Dallas, Texas; *Pediatrics and Cell
Biology, Washington University, St. Louis, Missouri
Following injury, keratinocytes switch from a gene expression program that promotes
differentiation to one that supports migration. A hallmark of the activated keratinocyte is the
precise and invariant expression of collagenase-1 (MMP-1) at the leading edge migration in
wounds with a disrupted basement membrane. Previously, we have shown that contact with type I
collagen mediates keratinocyte MMP-1 expression via a2b1 integrin signaling. Recent evidence
from others has shown that cell type-speci®c signaling cascades regulate induction of collagenase-3
(p38 MAPK) and gelatinase B (jun kinase) in ®broblasts and endothelial cells, respectively. We
assessed if the intracellular signaling mechanism(s) mediating collagen induction of keratinocyte
MMP-1 is controlled by similar pathways. Within 10 min following collagen contact, extracellular
signal-regulated kinase 1,2 (ERK 1/2) and p38 MAPK were markedly phosphorylated, whereas
JNK phosphorylation remained at basal levels. Blocking the ERK 1/2 pathway with MEK 1/2
inhibitors PD98059 or UO126 dramatically inhibited collagen-stimulated MMP-1 protein and
mRNA and transcription from a 2.2-kb MMP-1 promoter-luciferase construct. In contrast,
treatment with the p38 inhibitor SB203580 or the JNK inhibitor curcumin had no effect on
MMP-1 production. Because MMP-1 activity is required for keratinocyte migration across type I
collagen, we assessed the effects of these signaling inhibitors on cell motility. Migration of
keratinocytes across collagen was inhibited by treatment with PD98059 and UO126, but relatively
unaffected by SB203580 or curcumin. These results demonstrate that ERK 1/2 MAPK signaling is
required for collagen-mediated induction of keratinocyte MMP-1 and provide further evidence
that cell type-speci®c signaling cascades regulate MMP expression by a variety of stimuli.
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Reciprocal Changes in the Expressions of Nicotinic Acetylcholine Receptors, and the
Cell Cycle and Differentiation Genes can Mediate Pathobiologic Effects of Tobacco
Products on Keratinocytes
J. Arredondo, V. Nguyen, A. Chernyavsky, M. Sha®i, K. Pinkerton, and S. Grando
Department of Dermatology and Institute of Toxicology and Environmental Health, University of California,
Davis, California
Smoking and smokeless tobacco cause morbidity originating from the epithelium lining skin and
upper digestive tract. Keratinocytes (KC) express nicotinic acetylcholine receptors (nAChRs) that
bind nicotine (Nic). We studied the mechanism of receptor-mediated toxicity of tobacco products
on KC. Preincubation of normal human oral KC with Nic altered ligand binding kinetics of their
nAChRs, suggesting structural changes of nAChRs. This hypothesis was con®rmed by ®nding
transcriptional and translational changes in the exposed KC. From 1.5 to 2.9 fold increase of
mRNA and protein levels of a3, a5, a7, b2, and b4 nAChR subunits could be detected by
semiquantitative RT-PCR and immunoblotting. Exposure of KC to Nic also changed their
mRNA and protein levels of Ki-67, PCNA, p21, cyclin-D1, p53, ®laggrin, loricrin and
cytokeratin 10. These alterations could be abolished in the presence of the nicotinic antagonist
mecamylamine, indicating that Nic-induced changes of the expression of both the nAChR and the
cell cycle/differenatiation genes resulted from a pharmacologic stimulation of nAChRs. To
establish relevance of these ®ndings to the pathobiologic effects of tobacco products in vivo, we
studied the above parameters in the oral tissue of rats and mice after their exposures for 3 weeks to
the environmental cigarette smoke or drinking water containing equivalent concentrations of Nic.
The changes of nAChRs and cell cycle/differentiation were similar to those found in vitro, and
semiquantitative immuno¯uorescence of tissue specimens validated these ®ndings. Thus, some
pathobiologic effects of tobacco products in the skin and oral tissues may stem from Nic-induced
alterations of structure/function of nAChRs that alter the physiologic regulation of the cell cycle
by the cytotransmitter acetylcholine.
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Rapid and Sustained Induction of Smad7 in the Epidermis and Hair Follicles of
Transgenic Mice Conditionally Expressing Active TGFb1
X. Liu, V. Alexander, M. Marko, and A. Glick
Loaboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda,
Maryland
We have previously established a conditional transgenic expression system for active TGFb1 using
the tetracycline regulated transactivators tTA and rTA targeted to the epidermis with the bovine
keratin 5 promoter, and the constitutively active mutant of TGFb1 linked to the tetO binding site
for the tTA and rTA. Overexpression of TGFb1 in the epidermis of adult mice causes a reversible
alopecia associated with hyperplasia and increased apoptosis. To identify primary targets of TGFb1
which could contribute to this phenotype, we have examined expression of Smad7, an inhibitory
Smad which can block TGFb mediated signal transduction and is itself induced by TGFb in vitro.
In the alopecic skin of bigenic mice overexpressing TGFb1, Smad7 protein was highly expressed
compared to the single transgenic and uninduced bigenic mice. Indirect immuno¯uorecsence
showed that Smad7 expression was cytoplasmic and predominantly localized to the suprabasal layer
of the epidermis and inner root sheath of hair follicles. In K5/rTA double transgenic mice, the
induction of Smad7 mRNA and protein occurred rapidly and closely paralleled induction of
TGFb1 mRNA following addition of doxycycline. A similar pattern of induction occurred in K5/
tTA mice removed from doxycycline. In primary Balb/c keratinocytes infected with a Smad7
adenovirus, both the TGFb1 mediated induction of gene expression from the 3TP-lux reporter
plasmid and TGFb1-induced growth inhibition were blocked. To further examine the effects of
Smad7 on TGFb1-mediated gene expression, cDNA microarray expression pro®les were
compared between TGFb1 treated control and Smad7 adenovirus infected primary keratinocytes.
Interestingly, Smad7 blocked most TGFb1 induced genes including extracellular matrix proteins,
and by itself Smad7 also altered gene expression in primary keratinocytes. These results show that
Smad7 is a primary target of TGFb signaling in vivo and suggest its prolonged expression may
signi®cantly alter the response of keratinocytes to TGFb1, and contribute to the development of
alopecia.
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MAP Kinase Cascade Regualtion of Human Papillomavirus Transcription in
Keratinocytes ± a Differential Role for Erk1 and Erk2
M. Sturniolo and R. Eckert
Physiology and Biophysics, and Dermatology, Case Western Reserve Univeristy School of Medicine,
Cleveland, Ohio
Human papillomavirus (HPV) is an important disease-causing entity in the epidermis, cervix, and
oral cavity. The HPV upstream regulatory region (URR) promoter drives transcription of the viral
oncoproteins, E6 and E7, in a differentiation-dependent manner; however, little is known
regarding the signal transduction cascades that regulate URR activity. To identify these signals, we
use a reporter construct encoding the human papillomavirus type 16 (HPV16) upstream regulatory
region (URR) that drives transcription in normal keratinocytes. TAM67, a dominant-negative
mutant of c-jun that inactivates activator protein 1 (AP1) transcription factors, reduces URR
activity. Likewise, GADD153, a dominant-negative CCAAT/enhancer binding protein (C/EBP)
isoform, reduces expression. These results suggest that the AP1 and C/EBP transcription factor
binding sites present in the URR are important for expression. We next evaluated the role of
various signal transduction kinases. Constitutively active Ras markedly increases promoter activity,
while dominant-negative Ras inhibits expression. Dominant-negative MEKK1 also markedly
reduces URR activity. This Ras- and MEKK1-associated regulation appears to target the ERK
family of mitogen activated protein kinases (MAPK). Studies using dominant-negative ERK
isoforms, suggest that ERK1 is a strong suppressor and ERK2 a strong activator of URR activity.
Additional studies show that the URR DNA element that mediates this regulation is localized in a
small region proximal to the transcription start site that contains AP1 and C/EBP factor binding
sites. These results suggest that a Ras, MEKK1, MEK1, ERK1/2 mitogen-activated protein kinase
cascade that targets AP1 and C/EBP transcription factors regulates HPV promoter activity in
keratinocytes via a unique mechanism that involves differential activation of ERK1 and ERK2.
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Epithelial Interactions with Basement Membrane Control Early Neoplastic Progression
in Tissue Models of Premalignant Disease
F. Andriani, M. Vaccariello, Y. Wang, N. Fusenig,* and J. Garlick
Oral Biology & Pathology, SUNew York at Stony Brook, Stony Brook, New York; *German Cancer
Research Center, Heidelberg, Germany
Perturbations of epithelial±stromal interactions are features of advanced malignancy but their role
in the initiation and progression of premalignant disease is unclear. We have used novel in vitro and
in vivo human tissue models for premalignancy of strati®ed epithelium to dissect the contribution of
basement membrane components to early neoplastic progression in this tissue. This was
accomplished by following the fate and behavior of intraepithelial tumor cells which were
genetically marked with the gene for b-galactosidase and mixed with normal human keratinocytes
(NHK) at a 4:1 ratio (NHK:tumor cells), to generate skin-like, organotypic cultures which were
assembled in the presence or absence of basement membrane. We found that low-grade (HaCaT-
II-4), intraepithelial tumor cells were retained in a basal position in vitro and underwent
intraepithelial expansion after transplantation to nude mice to generate a dysplastic epithelium
when grown in the presence of basement membrane. In contrast, these tumor cells were sorted to
the suprabasal compartment and did not persist after grafting when grown without basement
membrane. To determine if a particular basement membrane component was associated with
neoplastic progression, 4:1 mixtures were seeded on polycarbonate membranes coated with
puri®ed basement membrane components (Type IV collagen, ®bronectin, Type I collagen or
®bronectin-type I collagen) which were placed on a contracted collagen gel containing dermal
®broblasts. Only Type IV collagen was found to be permissive for the intraepithelial expansion of
II-4 cells, suggesting that this component directed the adhesion and persistence of II-4 cells. In
contrast, when a high-grade tumor cell line (SCC13) was mixed with normal cells, it was found
that these cells did not require contact with basement membrane components to undergo
expansion and invasion. Our ®ndings demonstrate that intraepithelial tumor cells at an early stage
of transformation are sensitive to microenvironmental control by basement membrane. This may
contribute to the regulation of early cancer progression in human strati®ed squamous epithelium.
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Metalloproteinase Inhibition Blocks Invasion of Squamous Cell Carcinoma Cells
T. de Angelis, A. NoeÂ, M. Chatterjee, and J. Mulholland
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Increased metalloproteinase activity correlates with increased invasiveness of most tumor cells.
Matrilysin, MMP7, is the only metalloproteinase expressed by epithelial cells, and in skin, MMP7
expression is elevated in aggressive forms of squamous cell carcinoma (SCC). TIMP-3, a
metalloproteinase inhibitor, shows the same expression pattern in skin and SCC as MMP-7.
Therefore, the effects of metalloproteinase activity on invasiveness of SCC cells was examined.
Four cell lines were tested in a matrigel invasion assay. FaDu and A431 cells were highly invasive,
but SiHa and HaCat did not invade matrigel. BB-94 (Batimastat), a synthetic metalloproteinase
inhibitor, blocked matrigel invasion in both FaDu and A431 cells, but stimulated invasiveness in
HaCat cells. Expression of mRNA for MMP7 and TIMP-3 was examined by semiquantitative
RT-PCR. The ratio of MMP7/TIMP-3 was highest in the most invasive cells, FaDu, and lowest
in the noninvasive HaCat cells, indicating that TIMP-3 regulates MMP7 activity. Immunoblotting
for pro-MMP7 and active MMP7 demonstrated that in the noninvasive HaCat cells, inactive pro-
MMP7 predominated, whereas in the highly invasive FaDu cells, active MMP7 was predominant.
These results suggest that MMP7 plays an important role in SCC invasiveness and that inhibitors of
metalloproteinases may prove therapeutic in the treatment of squamous cell carcinoma.
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Fas/FasL Pathway Involved in Arsenic Induced p53-Dependent Apoptosis in Cultured
Keratinocytes
W. Liao, K. Chang, L. Chang,² and H. Yu*
Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan; *Dermatology, Kaohsiung Medical
University, Kaohsiung, Taiwan; ²Environmental Health and Occupational Medicine, National Health
Research Institute, Kaohsiung, Taiwan
Epidermiological studies demonstrated that long-term exposure to arsenic induces arsenical skin
cancers, including Bowen's disease. Histologically, it shows proliferating and apoptotic
characteristics at Bowen's disease lesion. To investigate how arsenic induces cellular apoptotic
death, we exposed cultured human foreskin keratinocytes to different concentrations of sodium
arsenite for 48 h, the expression of apoptotic proteins and receptors were detected by Western
blotting and ¯ow cytometry. Arsenic enhanced keratinocytes proliferation at low concentrations,
however, apoptosis was induced at high arsenic concentrations (¡UÁ 5 mM). Arsenic enhanced p53
expression and arrested keratinocytes cell cycle at G0/G1 phase. The level of apoptotic protein Bax
was increased in a Bcl-2 down regulated manner when keratinocytes were exposed to arsenic.
Arsenic could also affect expression of transcriptional factors. Arsenic enhanced not only the
quantity of c-Jun/c-Fos proteins in keratinocyte, the phosphorylation of c-Jun was also enhanced,
which indicated the activation of AP-1 signals. However, the cellular level of NF-kB was down
regulated while the expression of IkB-a increased. The results of arsenic induced AP-1 activation
and NF-kB decrease indicate a tendency of apoptotic death at the signal transduction level. The
expression of several apoptosis related receptors were then detected, we found cell membrane Fas
and Fas ligand (FasL) increased through arsenic treatment. Our results suggest that Fas/FasL
pathway is involved in arsenic induced p53-dependent apoptosis in cultured keratinocytes.
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Involvement of Retinoblastoma (Rb) and E2F Transcription Factors During
Epigallocatechin-3-Gallate-Mediated Cell Cycle Dysregulation and Apoptosis of
Human Epidermoid Carcinoma A431 Cells
N. Ahmad, S. Gupta, P. Cheng, and H. Mukhtar
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio
Epidemiological, in vitro cell culture and in vivo animal studies have shown that green tea or its
constituent polyphenols, particularly its major polyphenol epigallocatechin-3-gallate (EGCG) may
protect against cutaneous in¯ammatory responses and cancer skin cancer. Consistent with this
notion, many cosmetic- and skin care- products supplemented with green tea are available at
present. Studies from this laboratory have shown that EGCG causes a G0/G1-phase cell cycle
arrest and apoptosis of human epidermoid carcinoma (A431) cells. We also showed the
involvement of nuclear factor kB (NF-kB) pathway and cyclin kinase inhibitor (cki)-cyclin-cyclin
dependent kinase (cdk) machinery during cell cycle deregulatory/apoptotic response of EGCG. A
complete understanding of the mechanism of antiproliferative effects of green tea polyphenols is
important. The proteins of the retinoblastoma family pRb, p107 and p130, collectively referred to
as ``pocket proteins'', in association with E2F family transcription factors, have been shown to
regulate the G1-S transition in the cell cycle. The activity of the Rb proteins is regulated by cyclin-
cdk network-mediated phosphorylation. Here, we provide evidence for the involvement of pRb-
E2F/DP machinery as an important contributor of EGCG-mediated cell cycle dysregulation and
apoptosis. Immunoblot analysis demonstrated that EGCG treatment of A431 cells resulted in a
dose- as well as time- dependent decrease in the hyper-phosphorylated form of pRb with a relative
increase in hypo-phosphorylated pRb. Immunoblot analysis also revealed that EGCG-caused
decrease in phosphorylation of pRb occurs at serine-780. EGCG treatment of A431 cells was also
found to result in dose- and time- dependent inhibition of other Rb family proteins viz. p107 and
p130. These responses were accompanied with down-modulation in the protein expression of all
®ve E2F (1 through 5) family transcription factors, and their heterodimeric partners DP1 and DP2.
These results suggest that EGCG causes a down regulation of ``pocket proteins'' that, in turn,
compromises with the availability of free E2F. We suggest that these events result in a stoppage of
the cell cycle progression at G1-S transition thereby leading to a G0/G1 phase arrest and a
subsequent apoptotic cell death.
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The Role of Caspases in Execution of Apoptosis in Human Epidermoid Carcinoma
A431 Cells by Green Tea Polyphenol (±) Epigallocatechin-3-Gallate
S. Gupta, K. Hastak, N. Ahmad, and H. Mukhtar
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio
Our studies have established that green tea possesses anti-in¯ammatory and anticarcinogenic effects
in the skin and that epigallocatechin-3-gallate (EGCG); the major polyphenol present therein is
responsible for most of its biological activity. Earlier we have shown the involvement of apoptosis
in the antiproliferative effects of EGCG. Because EGCG was shown to exhibit preferential
apoptosis in cancer cells as compared to normal cells, a complete understanding of sequence of
events by which EGCG mediates apoptosis is important. Since caspase activation is regarded as a
triggering event in execution of apoptosis, we assessed the activation of caspases during EGCG-
mediated apoptosis of human epidermoid carcinoma A431 cells. Treatment of cells with EGCG
resulted in dose- and time- dependent apoptosis as shown by the formation of DNA ladder, PARP
cleavage and by TUNEL assay. Further, EGCG treatment (20 mg per ml) of cells resulted in a
signi®cant activation of caspases as shown by an increase in DEVDase activity, assessed by
measuring the release of 7-amino-4-tri¯uoromethyl coumarin (AFC) from N-acetyl-Asp-Glu-Val-
Asp (DVED)-AFC substrate. Immunoblot analysis demonstrated a dose- as well as time-dependent
up-regulation in the protein expression of caspase-3, ±8 and ±9 following EGCG treatment.
Pretreatment of cells with the general caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(OMe)-
¯uoromethylketone (Z-VAD-FMK) prevented EGCG-mediated apoptosis as assessed by (a)
TUNEL positive cells, (b) PARP cleavage, and (c) ¯uorescence microscopy. Similar apoptosis
inhibitory effects although of the lower magnitude, were observed with speci®c caspase-3
inhibitor, Z-DVED-FMK. Treatment of A431 cells with Z-VAD-FMK also resulted in inhibition
of the protein expression of caspase ±3, ±8 and ±9. Since bax/bcl2 has been shown to be involved
in caspase activation and apoptosis, we next assessed the effect of EGCG on the levels of bax and
bcl2 proteins. As shown by immunoblot analysis, EGCG treatment was found to result in a dose-
and time-dependent increase in the levels of bax without affecting bcl2, thereby shifting the ratio in
favor of apoptosis. Taken together, based on our data we suggest that EGCG modulates bax/bcl2
ratio followed by caspase activation, which in turn triggers apoptotic death of cancer cells.
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Paclitaxel-Induced Apoptosis is Dependent on Activation of Caspase-8 and 3 with a
Preceding Activation of Survival Modulator Akt in Cultured Human Keratinocytes
Y. Wan, K. Hokeness,* Q. Zhang, H. Wanebo,* and S. Mehta²
Biology, Providence College, Providence, Rhode Island; *Surgery, Roger Williams Medical Center,
Providence, Rhode Island; ²Health and Clinical Sciences, University of Massachusetts, Lowell, Massachusetts
Paclitaxel is a natural antimicrotubule agent shown to possess antitumor activity. It is currently used
as a chemotherapeutic agent in the treatment of ovarian and breast carcinomas. We investigated the
molecular effects of paclitaxel on cultured human keratinocyte cells (HaCaT), assessing the
induction of both the apoptotic pathway and the cell survival signals. Results from MTT dye assay
indicated that paclitaxel reduced keratinocyte growth in a 3-day bioassay with an effective ED50of
6±600 ng per ml. A large variation in ED50can be attributed to the asynchronous population of
cells. Western Blot analysis showed that paclitaxel treatment did not signi®cantly affect
phosphorylation of bcl-2 in cultured keratinocytes. Results did indicate that within 6 h of
paclitaxel exposure there was an increase in both Caspase 8 and 3 activities, indicating the
activation of apoptotic pathways. Paclitaxel treatment also induced phosphorylation of Akt (Ser473
and Ser308) in a time dependent manner. AKT phosphorylation was detectable at 30 min post
paclitaxel treatment (600 ng per ml), peaked at about 1 h and remained elevated up to 2 h. These
results indicate that paclitaxel activates PI3-kinase/AKT cell survival pathway while inducing
apoptotic machinery in cultured human keratinocytes. Collectively, our data indicate that (a)
paclitaxel-induced apoptosis is independent of the bcl-2 phosphorylation, (b) the blockade of PI 3-
kinase/AKT pathway may help potentiate the apoptotic effects of paclitaxel and (c) the apoptotic
signaling pathways are initiated with the activation of caspase-8 and 3 activities.
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p53 Stabilizing Compound, CP31398, Induces Apoptosis by Activating Caspases
G. Li, Y. Luu, K. Cheung, and J. Bush
Department of Medicine, University of British Columbia, Vancouver, BC, Canada
p53 is considered the guardian of the genome. Wild-type (wt) p53 has a number of biological
functions including cell cycle arrest, DNA repair and apoptosis. In a recent study by Foster and
colleagues, the pharmacological compound CP31398 was found to stabilize wt p53, enabling it to
activate transcription and slow tumor growth in mice. CP31398 is also able to revert mutant p53
back to wild-type conformation. We hypothesize that CP31398 induces apoptosis by stabilizing
p53. We have found that CP31398 induces cell death in the p53 wt melanoma cell lines MMRU
and MMAN, while the mutant p53 melanoma cell lines MEWO and SK110, were more resistant.
To further investigate the mechanisms of CP31398-induced cell death, we used two colon
carcinoma cell lines, HCT116+/+ which contains wt p53 and HCT116±/± which lacks the p53
gene. We demonstrated that CP31398 kills cancerous cells by triggering apoptosis in a dose- and
p53-dependent manner. Furthermore, we found that CP31398 induces cleavage of caspase-9 and ±
8, suggesting that it activates the mitochondrial- or death receptor-mediated apoptotic pathways,
respectively. In addition, p21waf1 is up-regulated after CP31398 treatment, implying that it may
be involved in cell cycle growth arrest. Taken together, our results indicate that CP31398 induced
cell death is p53-dependent. Elucidating the mechanism by which CP31398 induces cell death may
allow it to be used as anticancer treatment for different forms of cancer.
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The Epidermal Platelet Activating Factor Receptor Protects Squamous Cell Carcinoma
Cells Against Chemotherapy-Induced Apoptosis
T. Li, M. Southall, Q. Yi, and J. Travers
Dermatology, Indiana University School of Medicine, Indinapolis, Indiana
The mechanism of action of many chemotherapeutic agents involves the induction of apoptosis on
malignant target cells. Recent studies suggest that cytokines produced by carcinomas such as
interleukin-1 can protect against apoptosis induced by various agents. Though the lipid mediator
platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is synthesized by
keratinocytes and carcinoma cell lines in response to diverse stimuli, and these cell types express
PAF receptors (PAF-R), it is not known whether the PAF system can affect chemotherapeutic
agent-induced toxicity. Using a novel model system created by retroviral-mediated transduction of
the PAF receptor-negative human epidermal cell line KB with the human PAF-R, we tested
whether the PAF-R could modulate toxicity induced by etoposide and mitomycin C. Treatment
of control or PAF-R-expressing KB cells with etoposide and mitomycin C resulted in a dose-
dependent increase in caspase 3, indicating that these agents induced apoptosis in these cell types.
Preincubation of KB cells with the PAF-R agonist CPAF resulted in decreased apoptosis in
response to etoposide and mitomycin C only in PAF-R-expressing cells. Treatment of KB cells
with two separate PAF-R antagonists inhibited the protective effect of CPAF, indicating CPAF
exerted its protective effects via activation of the epidermal PAF-R. These studies demonstrate that
the PAF system can protect PAF-R-positive carcinoma cells against chemotherapeutic agents.
Inasmuch as PAF would be expected to be generated during an in¯ammatory response, these
®ndings might provide a clinically relevant mechanism by which carcinoma cells may be protected
against chemotherapeutic agents.
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Curcumin Decreases Spontaneous Proliferation and Induces Apoptosis in Squamous
Cell Carcinoma Cell Lines In Vitro
F. Azmi, Q. Yi, J. Travers, and J. Petersen
Dermatology, Indiana University School of Medicine, Indianapolis, Indiana
Curcumin (diferuloylmathane), is the major chemical constituent of turmeric, a spice commonly
used in many Asian cultures. Curcumin has potent antioxidant effects, and has been reported to
signi®cantly inhibit experimentally induced tumorigenesis on mouse skin. The exact mechanism of
its antioxidant and chemopreventive activity is not known. However, curcumin inhibits
arachidonic acid-induced in¯ammation in mouse skin and triggers apoptosis in several tumor
cell lines. We tested the effects of curcumin on the spontaneous proliferation and viability of
HaCaT and A-431, two human keratinocyte-derived carcinoma cell lines. Treatment with
curcumin inhibited the spontaneous proliferation of both carcinoma cell lines using a tetrazolium-
based (MTT) cell proliferation assay in a dose-dependent manner. Curcumin treatment decreased
cell viability and triggered caspase 3 enzymatic activity, suggesting that this natural product induces
apoptosis in squamous cell carcinoma cell lines. These studies provide preliminary data suggesting
that curcumin could have therapeutic potential in the treatment of human cutaneous squamous cell
carcinomas.
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Increased Resistance to Apoptosis in FGFR3 Mutant Keratinocytes is Not Mediated by
STAT3 Phosphorylation
G. Bellus, D. Kelly, and D. Norris
Dermatology, University of Colorado School of Medicine, Denver, Colorado
Mutations that result in constitutive activation of ®broblast growth factor receptor 3 (FGFR3)
cause several different skeletal dysplasia and craniosynostosis syndromes, some of which are
associated with acanthosis nigricans. Several investigators have shown that these FGFR3 mutations
lead to phoshorylation of STAT1, growth arrest and increased susceptibility to apoptosis in
chondrocytes. In addition to skeletal dysplasias, activating FGFR3 mutations have been reported in
several different malignancies including multiple myeloma, bladder and cervical cancers. In
multiple myeloma, FGFR3 mutations result in phosphorylation of STAT3, increased exression of
Bcl-XL and increased cell survival. We have reported previously that keratinocytes from patients
with acanthosis nigricans due to FGFR3 K650M and A391E mutations exhibit increasesd
expression of Bcl-2 and resistance to apoptotic triggers. In order to investigate whether increased
survival in keratinocytes with FGFR3 mutations is mediated by STAT3 we evaluated pSTAT3
levels by immunoblots in control and FGFR3 mutant keratinocytes (K650M) under actively
growing conditions and after several different apoptotic triggers. Control and mutant keratinocytes
expressed very little pSTAT3 under all conditions tested. We conclude that increased resistance to
apoptosis in FGFR3 mutant keratinocytes is not mediated by activation of STAT3 and must
involve other signaling pathways. These results further demostrate that cellular outcomes due to
FGFR3 signaling is highly tissue speci®c.
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Signaling for Growth or Apoptosis Through the 75 kDa Neurotrophin Receptor
M. Yaar, S. Zhai, I. Hadshiew, B. Arble, and B. Gilchrest
Derm, Boston University, Boston, Massachusetts
p75, nerve growth factor (NGF) coreceptor, is a member of the tumor necrosis factor (TNF)
receptor superfamily and is expressed by melanocytes (Mc). We have shown that NGF a
keratinocyte cytokine, activates p75 on Mc to induce proliferation at 5 nM but death at 60 nM.
TNF-a receptors are present as trimeric complexes and as monomers, but signal apoptosis only
when ligand binds receptor trimer. To determine p75 organization and its bearing on signaling, Mc
were treated with a cross linker. By Western blotting p75 exists as a preformed trimer and as a
monomer. To explore NGF-mediated p75 signaling, Mc and p75 expressing 3T3 cells were
provided 5 or 60 nM NGF. Within minutes, as shown by Fluo-3-Am NGF increased intracellular
Ca2+. However, 5 nM NGF increased Ca2+ in the cytosol but 60 nM elevated Ca2+ also in
nuclei, consistent with Ca2+ requirement for apoptotic endonuclease activity. Pretreatment with a
cyclic peptide CATDIKGKEC (cycP) that blocks NGF binding to p75 abrogated this response.
Moreover, only 60 nM NGF induced apoptosis associated activation of c-Jun amino terminal
kinase (JNK) as measured by phosphorylation of its substrate, and this response was abolished by
cycP. Further, Bax mRNA and protein were strongly induced within 24 h of 60 nM NGF and
anti-BAD as well as anti-BID antibodies, showed substantial induction of these proteins that act
upstream of Bax, consistent with caspase 8 activation. Sustained c-myc protein induction
accompanied this response. Finally, both TUNEL analysis and cytoplasmic DNA-histone levels
proved that these signaling lead to apoptosis that was abrogated by cycP. In contrast, 5 nM NGF
led to brief induction of c-myc and cyclin D that was abrogated by cycP. We show that different
NGF concentrations induce opposing events in Mc and speculate that high NGF doses activate p75
trimers leading to apoptosis, whereas low NGF levels activate p75 monomers to induce
proliferation. NGF's differential effects may explain irregular Mc distribution in sun damaged skin.
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The Epidermal Platelet Activating Factor Receptor Protects Keratinocytes from TNF-a
and TRAIL-Induced Apoptosis Through a Nuclear factor kB-Dependent Process
M. Southall, H. Nakshatri, J. Isenberg, D. Spandau, and J. Travers
Dermatology, Indiana University School of Medicine, Indianapolis, Indiana
A number of chemical mediators can induce keratinocytes and keratinocyte-derived carcinomas to
undergo apoptosis, or programmed cell death. Recent evidence suggests exposure to cytokines,
such as IL-1B, results in an antiapoptotic effect, protecting keratinocytes from pro-apoptotic
stimuli. The platelet activating factor receptor (PAF-R), present on keratinocytes, is a G protein-
coupled receptor activated by the pro-in¯ammatory lipid mediator platelet activating factor (PAF).
Since PAF is produced by keratinocytes in response to diverse stimuli, and the keratinocyte PAF-R
is involved in numerous cell functions, we utilized a model system created by retroviral-mediated
transduction of the PAF-R into the PAF-R-negative human epidermal cell line (KB) to assess the
effect of PAF on tumor necrosis factor-a (TNF-a) and tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL)-induced apoptosis. Exposure to TNF-a or TRAIL induced apoptosis in
PAFR-negative (KBM) and PAFR-positive (KBP) cells in a dose and time dependent-manner.
Pretreatment with the PAF-R agonist, CPAF, protected KBP, but not KBM cells from TNF-a
and TRAIL-induced apoptosis, whereas exposure to IL-1B protected both KBP and KBM cells
from these aptogens. Pre-incubation with PAF-R antagonists blocked the antiapoptotic activity of
CPAF, but not IL-1B, in KBP cells. We next sought to identify the cellular mechanisms mediating
the antiapoptotic activity of PAF. Exposure to CPAF or IL-1B induced a rapid (within 15 mins)
degradation of IKB, the inhibitor of nuclear factor-kB (NF-kB), resulting in a maximal increase in
NF-kB within 1 h. Retroviral-mediated transduction of KBP cells with a super-repressor IKB,
blocked the CPAF-induced increase in NF-kB and abolished the antiapoptotic effects of CPAF.
These studies indicate that activation of the PAF-R protects KB cells against TNF-a and TRAIL-
induced apoptosis through a NF-kB dependent pathway. Furthermore, this study is the ®rst to
demonstrate that activation of a G protein-coupled receptor can attenuate apoptosis induced by
members of the TNF-a receptor super-family. Since PAF is produced by epidermal cells in
response to numerous stressors, we hypothesize that this mediator exerts a protective effect against
pro-apoptotic stimuli generated by immune cells
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Inhibitory Effects of Selected Chinese Herbs on UV- or TNF-a-Induced Activation of
p38 MAP Kinase in Cultured Human Keratinocytes
Q. Zhang, J. Xu,* C. Li,* A. Townsend, and Y. Wan
Biology, Providence College, Providence, Rhode Island; *Pharmacology, Fujian Medical University, Fuzhou,
China
Thus far accumulated evidence have established that UV-induced skin damage is largely due to two
major cellular/molecular events including (1) overexpression of MMPs that destroy skin
connective tissues through MAP kinase pathway and AP-1 activation and/or (2) overexpression
and release of cytokines through NF-kB pathway. Reagents from synthesized chemical library and
natural resources have been extensively searched to prevent UV- or cytokine-induced activation of
MAP kinase and NF-kB pathway. Using cultured human keratinocytes we tested a group of
selected Chinese herbs that have been known in long history of traditional Chinese medicine to be
effective in anti-in¯ammation or in beautifying human skin, to investigate the uncovered
molecular mechanisms. Among those we found that extracts from TQDHY (Gynura bicolorDC),
YXC (Houttuynia cordataThunb), and ZHDD (Viola yedloensisMak) dramatically inhibited TNF-a-
induced phosphorylation of p38, to less extent inhibited UV-induced p38 phosphorylation, but
had no effect on TNF-a- or UV-induced JNK phosphorylation. These data suggest that those
herb extracts may not necessarily act merely as antioxidants. Both water- and DMSO-soluble
fractions from TQDHY inhibited TNF-a-induced p38 phosphorylation in a time and dose
dependent manner. Surprisingly, all herb extracts tested had no effects on TNF-a-induced IkB
degradation, suggesting that those herbs do not interfere with NF-kB pathway. We contend from
our data that those selected Chinese herbs target p38 MAP kinase pathway and could be applied to
prevent UV-induced skin photoaging and skin in¯ammation.
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Cyclosporin A Induces Secretion of Cyclophilin B Via the Constitutive Pathway in
Human Keratinocytes
P. Fearon and N. Reynolds
Department of Dermatology, University of Newcastle, Newcastle upon Tyne, United Kingdom
Cyclosporin A (CsA) is effective treatment for in¯ammatory skin diseases. Its mechanism of action
in T-cells is well characterized, although the effects of CsA in nonimmune tissue and skin are less
well understood. Cyclophilin B (CypB) is one member of the ubiquitous family of proteins known
as cyclophilins which are de®ned by their ability to bind CsA and to catalyze the isomerisation of
peptidyl-prolyl bonds. CypB is a 21-kDa endoplasmic reticulum resident protein, which in T-cells
contributes to mediating CsA effects and is secreted in response to CsA. However, the
physiological role of CypB remains to be fully de®ned. The aim of this study was to investigate
whether CypB is expressed in skin, if CsA modulates the intracellular location of CypB, and if CsA
promotes secretion of CypB in keratinocytes. Immuno¯uorescence staining showed expression of
CypB by suprabasal keratinocytes and Western blotting con®rmed that CypB is expressed by
keratinocytes. Cultured human keratinocytes were treated with CsA (1 mM) for 15 min, 2 h or 18 h
and then either (1) ®xed and double labeled with an anti-CypB antibody and BODIPY-ceramide,
a probe for the golgi apparatus (n = 3), or (2) culture medium was collected, concentrated and
analysed using Western blotting (n = 3). In untreated cells, punctate cytoplasmic staining and strong
nuclear staining of CypB was observed. After treatment with CsA, cytoplasmic CypB redistributed
to the golgi apparatus and also was found to localise at the plasma membrane. Western analysis
showed that CypB accumulated in the medium in response to CsA in a time dependent manner,
which could be completely inhibited by pretreatment with brefeldin A, a potent inhibitor of
constitutive secretion. These data shows that keratinocytes constitutively secrete CypB in response
to treatment with CsA. This suggests that CypB displays similar functions in keratinocytes as those
observed in T cells, and therefore may play a role in mediating the action of CsA in in¯ammatory
skin disease.
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Adherens Junction Mediated Signaling in Human Keratinocytes: Support for the
Hypothesis
P. Hu, E. O'Keefe, P. Berkowitz, and D. Rubenstein
Dermatology, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina
b-catenin and plakoglobin function in adherens junction mediated cell-cell adhesion and in Wnt
mediated signal transduction. We have previously shown that tyrosine phosphorylation of b-
catenin and plakoglobin reversibly regulates their association with E-cadherin and a-catenin in
human keratinocyte adherens junctions. In Wnt mediated signal transduction, binding of
extracellular Wnt to Frizzled family receptors results in formation of transcriptional regulatory
complexes between b-catenin and TCF/LEF family members. We hypothesize that the cadherin
family of cell-cell adhesion proteins transduce signals from the extracellular to the intracellular
compartment and that b-catenin and plakoglobin are integral components of cadherin signaling
cascades. By translocation from cell-cell junctions to the nucleus, b-catenin and plakoglobin could
directly link the ``sensing'' of altered cell-cell adhesion at the cell surface to transcription in the
nucleus. To investigate this hypothesis, normal human keratinocytes in tissue culture were treated
with the tyrosine phosphatase inhibitor peroxovanadate and the distribution of plakoglobin
examined by (i) immuno¯uorescent confocal microscopy and (ii) subcellular fractionation and
Western blot analysis. The ability of plakoglobin to bind to TCF/LEF family members was
investigated by coimmunoprecipitation and gel shift assays. After treatment with peroxovanadate,
keratinocytes displayed (i) increased nuclear localization of plakoglobin, (ii) tyrosine phosphoryla-
tion of nuclear plakoglobin, and (iii) increased complex formation between TCF/LEF family
members and plakoglobin in nuclear fractions. Our results indicate that plakoglobin, released from
adherens junctions by tyrosine phosphorylation, translocates to the nucleus and binds to LEF/TCF
family member transcription factors, suggesting a direct link between the adherens junction and
subsequent transcriptional regulatory events.
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Dermal Fibroblasts Convert Benzene to Non-Phenolic Compounds that are less Toxic
than the Phenolic Metabolites of Benzene
N. Philips, D. Burchill, D. O'Donoghue, and S. Gonzalez*
Natural Sciences, Mathematics and Computer Science, Georgian Court College, Lakewood, New Jersey;
*Dermatology, Massachusetts General Hospital, Boston, Massachusetts
Benzene is a natural component of petroleum and a major pharmaceutical commodity. Benzene is
known to cause systemic disorders via its metabolism in the liver to phenolic compounds. Skin is a
signi®cant route of entry of benzene into the body and has remarkable metabolic activity. The
metabolism of benzene in the skin has not been reported. Nor are there reports on the effects of
benzene metabolites, phenolic or nonphenolic, on skin. We examined (1) the metabolism of
benzene in human dermal ®broblasts and (2) the effects of the formed metabolites and the known
phenolic metabolites on ®broblast toxicity, apoptosis, lipid peroxidation and interstitial collagenase.
The major benzene metabolites, as analyzed by gas chromatography and mass spectrometry, were
toluene, its oxidized products (benzaldehyde and benzoic acid), and aniline. With the exception of
aniline, these nonphenolic metabolites did not compromise cell viability at concentrations ranging
from 1 mM to 160 mM, but induced lipid peroxidation and collagenase. Cell toxicity of the
phenolic metabolites, hydroquinone, t-butyl hydroquinone (phenol derivative) and phenol,
corresponded to approximate LC50 values, in micro molars, of 30, 50 and 1500, respectively. At
concentrations that allowed for greater than 80% cell viability these phenolic compounds induced
apotosis. With the exception of phenol, all the phenolic metabolites induced lipid peroxidation,
whereas only phenol induced collagenase. We infer that the skin converts benzene to nonphenolic
metabolites that are less toxic and induce oxidative stress response to a lesser degree than the
phenolic metabolites of benzene. However, these nonphenolic metabolites can facilitate skin aging
by stimulating collagenase expression.
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Overexpression of the 16 kDa N-Terminal Pro-Domain of IL-1a in Basal Layer
Keratinocytes Accelerates the Progression Stage of Cutaneous Chemical Carcinogenesis
J. Murphy, B. Rich, and T. Kupper
Harvard Skin Disease Research Center, Brigham and Women's Hospital, Boston, Massachusetts
Interleukin 1 alpha (IL-1a) is synthesized as an active 31 kDa precursor molecule that accumulates
in cells. Keratinocytes have been shown to store signi®cant levels of bioactive pro-IL-1a.
Activation of cells by stimulatory molecules, such as inonomycin or LPS, or disruption of the
epidermal barrier, results in the extracellular release of the mature 17 kDa C-terminal IL-1a
protein. We have previously reported that mice overexpressing this 17 kDa IL-1a protein under
the control of the keratin 14 promoter are completely resistant to papilloma and carcinoma
induction using the two-stage chemical carcinogenesis model. Cleavage of the 31 kDa precursor
also generates a 16-kDa N-terminal pro-piece which remains in the cell. The 16 kDa peptide has a
nuclear localization sequence, and transfection of cells with cDNA encoding this molecule induces
malignant transformation (Stevenson et al, PNAS 94:508±513, 1997). To test the transforming
potential of the pro-IL-1a protein in cutaneous carcinogenesis, a K14/pro-IL-1a strain of
transgenic mice was created and their response to the two-stage chemical carcinogenesis protocol
of DMBA and PMA was tested. The kinetics of papilloma formation were enhanced in the pro-IL-
1a overexpressing transgenics relative to the wildtype littermate controls, although the maximum
number of papillomas per mouse was similar (WT: 13.6 6 4.2 (n = 11) and Tg: 11.8 6 7.2 (n = 10).
However, the average latency time to carcinoma formation was decreased by 6±8 weeks in the
K14/pro-IL-1a Tg mice and the conversion frequency at week 30 postinitiation was 2.5 fold
greater than the littermate controls. These results support a role for pro-IL-1a in enhancing
tumorigenesis, in particular the well-characterized progression phase of the two-stage model.
Further investigation into the biological activity of the 16 kDa pro-IL-1a protein will be required
to determine its precise role in cutaneous oncogenesis in vivo.
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Macrophage Fusion Up-Regulates N-Acetyl-Glucosaminyltransferase V, b1±6
Branching, and Metastasis in Cloudman S91 Mouse Melanoma Cells
J. Pawelek, A. Chakraborty, N. Taniguchi,* M. Ichihashi,² Y. Ikeda,* E. Miyoshi,* Y. Funasaka,
and N. Kolesnikova
Dermatology, Yale Sch Medical, New Haven, Conneticut; *Biochemistry, Osaka University Medical Sch,
Osaka, Japan; ² Dermatology, Kobe University Sch Medical, Kobe, Japan
Macrophage 3 melanoma fusion hybrids were described with enhanced metastatic potential in vivo
compared to parental Cloudman S91 cells. These hybrids also showed markedly altered N-
glycosylation patterns, and it was proposed that this could be at least one underlying mechanism for
enhanced metastasis. N-acetyl-glucosaminyltransferase V (GNT-V) is the enzyme responsible for
b1±6 branching of N-glycans with the addition of poly N-acetyllactosamines, and is strongly
associated with motility and metastasis in a variety of human cancers, including melanoma. Here
we show that GNT-V is up-regulated with regard to both mRNA levels and enzymatic activity
speci®cally in metastatic hybrids as well as parental macrophages, compared to weakly metastatic
hybrids and parental melanoma cells. The metastatic hybrids also showed increased binding of the
lectin L-PHA which speci®cally binds the b1,6-branched moiety. In addition, exposure in vitro of a
cell panel to L-PHA inhibited cAMP-induced motility, speci®c to metastatic hybrids, suggesting a
role for GNT-V in the motility of these cells. Further, there was increased expression of LAMP-1
and b1 integrin, two proteins known to be substrates for GNT-V and also to be associated with
metastasis. In summary, macrophage fusion with melanoma cells often causes increased metastatic
potential which is associated with enhanced expression of GNT-V and b1,6-branching of N-
glycans. These results support the notion that elevated GNT-V in metastases could re¯ect prior
fusion of tumor cells with tumor-in®ltrating phagocytes, initiating progression to the metastatic
phenotype.
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Control of Survivin Expression in Human Melanomas
Y. Shellman, B. Grimison, R. Sclafani, and D. Norris
Dermatology, University of Colorado Health Science Center, Denver, Colorado
Survivin is an important antiapoptotic protein in cancer research since expression of survivin is
correlated with unfavorable prognosis in patients with neuroblastroma, gastric carcinoma,
colorectal carcinoma and bladder cancer. Survivin has been found in metastatic and invasive
malignant melanomas, however, there are no data on whether survivin expression are associated
with melanoma progression, such as the critical switch from radial growth phase (RGP) to vertical
growth phase (VGP) or VGP to metastatic stage. In this project we investigated the control of
survivin expression during melanoma progression and the mechanism involved. We used
Immunoblot to measure survivin expression in melanoma cell lines from RGP melanomas, VGP
melanomas and metastatic melanoma. There was higher survivin expression in metastatic
melanoma cell lines (average of 8 fold), and in VGP melanoma (average of 3 fold), than in RGP
melanoma cell lines. Since deletion of p16 expression has been proposed as a critical event in
familial melanomas, and even in early sporadic melanoma, we devised a system for transient
transfection of p16±/± melanoma cell lines with a p16 construct to determine whether p16
expression controlled survivin expression. Over-expression of p16 in both RGP and metastatic
melanoma lines cells almost completely abolished survivin expression. However, arresting cells at
G1/G0 with serum withdrawal and high con¯uence growth conditions also down-regulated
survivin expression, suggesting that control of survivin expression might be more complex and be
associated with high proliferation in the cells. We are currently determining whether signaling
elements which control other antiapoptotic defenses in melanoma, such as activated Ras or PI3K,
affect survivin expression in melanomas. These experiments help understand the expression of
survivin in melanomas, and might provide a basis for ®nding a diagnosis tool for melanoma
progression.
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The Chromogen Diaminobenzene Reacts with an Unidenti®ed Substance in Murine
Melanoma Cells
T. Johnson, R. Kumar, and N. Amin
Dermatology, Univerisity of Illinois, Chicago, Illinois
The phytoalexin Resveratrol (RES) has been shown to have an inhibitory effect on the growth of
murine and human melanoma cell lines. Flow cytometric studies using the Annexin-FITC method
have shown that RES-treated murine melanoma cells undergo characteristic apoptotic membrane
alterations. We used the TUNEL method, immunohistochemical (IHC) assays for active caspase 3
and PARP and DNA fragmentation gel electrophoresis to detect additional apoptotic changes in
RES-treated B16-F10 murine melanoma cells. To detect DNA fragmentation, cells were grown in
tissue culture and treated with varying concentrations of RES dissolved in 100% EtOH. DNA was
isolated by ethanol precipitation with phenol extraction and examined by agarose gel
electrophoresis. The DNA banding pattern of RES-treated melanoma consistently displayed a
banding pattern suggestive of apoptosis. For the TUNEL assay and IHC assays cells were grown in
tissue culture and implanted by subcutaneous injection into the ¯ank of C57BL mice. The primary
tumors that grew in these animals were in®ltrated with graded concentrations of RES dissolved in
100% ETOH, grossly dissected and paraf®n embedded onto microscope slides. All of the IHC assay
techniques utilize a primary antibody, a secondary antibody conjugated to HRP and a developing
solution containing the substrate diaminobenzene. Method controls showed that samples treated
with only the secondary antibody and DAB developing solution produced a pattern consistent with
a positive result. Upon reinvestigation, it was found that the same result could be obtained by
treating the samples with the DAB developing solution alone. We feel that these results suggest that
murine melanoma contains a substance with endogenous peroxidase activity that reacts with DAB.
Furthermore, we have shown that this property cannot be quenched by standard H202
pretreatment and therefore chromogenic assays utilizing the diaminobenzene substrate are
inadequate for the study of B16-F10 murine melanoma. Future investigations will screen
developing solutions for a suitable chromogen so that the TUNEL method, antiactive caspase 3
and PARP immunoassays may be used in our model system. Data on chromatin condensation in
RES-treated murine melanoma using the Hoechst dye technique are currently underway in our
laboratory.
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The Novel Tumor Suppressor p33ING1 is Overexpressed but Rarely Mutated in Human
Melanoma Cell Lines
E. Campos, J. Cheung, and G. Li
Medicine, The University of British Columbia, Vancouver, BC, Canada
Cutaneous malignant melanoma is a severe life-threatening cancer. Epidemiological evidence
indicates that ultraviolet radiation exposure is directly linked to the evident increase of both
incidence and mortality rates of melanoma observed in the past years. However, the genetic
changes caused by ultraviolet radiation that lead to melanoma formation remain unclear. Although
the tumor suppressor gene p53 has been shown to be mutated in over 90% of nonmelanoma skin
cancers, its mutation is only observed in 15±25% of melanoma biopsies suggesting that p53
mutation may not be an early step in melanoma development. Recently, a potential tumor
suppressor gene p33ING1 was cloned and shown to inhibit cell growth in the presence of p53.
ING1 is able to suppress cell proliferation and up-regulate a p53 downstream target gene, p21waf1,
leading us to believe that ING1 may be an important tumor suppressor in melanoma formation. To
investigate if p33ING1 plays a role in melanoma formation, we examined the p33ING1 protein
levels in 14 melanoma cell lines and found that ING1 is overexpressed in 13 of 14 cell lines
compared to normal melanocytes. Single-strand conformation polymorphism analysis showed band
shifting in two melanoma cell lines. DNA sequencing was performed to verify if p33ING1 was
mutated in human malignant melanoma. We detected eight point mutations in exon 2 of the
ING1 gene in the SK24 cell line; none were distinctive ultraviolet C to T transitions. Taken
together, our data suggests that mutation of p33ING1 is rare in melanoma cell lines.
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Melanocytes do Not Exhibit Directional Migration in a DC Electric Field
R. Isseroff, J. Grahn, D. Reilly, and R. Nuccitelli*
Dermatology, University of California, Davis, Davis, California; *Cell, Molecular and Developmental
Biology, University of California, Davis, Davis, California
Upon wounding, the endogenous transepithelial battery drives a current out of the wound,
generating an electric ®eld of approximately 100 mV per mm at the wound perimeter. Our prior
work has demonstrated that when skin-derived keratinocytes are exposed to DC electric ®elds of
this physiologic magnitude, they exhibit galvanotaxis, or directional migration, and we have
suggested that this directional migration contributes to wound healing. Since melanocytes must
also migrate into the healing wound to repigment it, we examined melanocyte motility during
exposure to a DC electric ®eld. Melanocytes were isolated from neonatal foreskins and cultivated
in Melanocyte Growth Medium (MGM, Cascade). Cells were plated onto collagen i-coated
coverslips, and placed in an electric ®eld of 100 mV for 2 h in MGM with 2 mM CaCl2.
Melanocytes, either exposed to the DC ®eld or nonexposed controls, exhibited similar motilities of
12 mm per h, signi®cantly (3±5 fold) lower than the motility rates of keratinocytes under identical
conditions. In addition, melanocytes exhibited no directional migration in the DC ®eld; their
migratory paths were random. This is in sharp contrast to contrast to keratinocytes which migrate
toward the cathode in an electric ®eld. Dendritic neurons have been reported to lengthen and
realign their dendrites in a DC electric ®eld, prompting us to examine the orientation of
melanocyte dendrites during electric ®eld exposure. Neither the number of primary dendrites per
cell (2±6), nor the orientation of the dendrites with respect to the ®eld vector (random), nor the
average length of the dendrites (38 mm) was signi®cantly different in melanocytes exposed to the
DC electric ®eld as compared to nonexposed controls. We conclude that in marked contrast to
keratinocytes, human skin-derived melanocytes do not respond to DC electric ®elds of physiologic
magnitude with either directional migration or reorientation of dendrites. This may contribute to
the delay in repigmentation that often accompanies wound reepithelialization.
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SCF and a-MSH Co-Operatively Drive the Proliferation and Survival of Melanoma 661,
a Process Converted to Cell Death by Histamine H1 Receptor Antagonism
J. Grichnik, F. Lin, and J. Burch
Medicine/Dermatolgy, Duke University Medical Center, Durham, North Carolina
Stem cell factor (SCF) and a-MSH have variable growth effects on metastatic melanoma lines and
most often, if an effect is noted, they are growth inhibitory. We have identi®ed a unique
melanoma line, 661, that like normal melanocytes, proliferates in response to SCF and a-MSH.
The 661 cells are KIT+, HMB-45+ and TRP-1+/± and form tumors in human skin grafts.
Melanoma 661 growth in vitro is maximized in the presence of serum but the dose±response effect
of SCF and a-MSH is most dramatic under serum-free conditions. SCF (50 ?g per ml) induces a
130% increase in cell number after 6 days compared with untreated controls. Similarly a-MSH
(10 mM) induces an 80% increase. In cultures with SCF and a-MSH an increase of 200% is noted.
Interestingly, the positive growth response to these cytokines can be switched to a negative
response if the histamine H1 receptor is blocked with Ketotifen which inhibits 661 growth in a
dose responsive manner. In presence of Ketotifen (20 mM) cultures with SCF and a-MSH exhibit a
80% decrease in cell number in 3 days compared with controls (Ketotifen only).
Diphenylhydramine (H1 antagonist) can be substituted but not Cimetidine (H2 antagonist).
These results suggest that SCF and a-MSH have the capacity to function either as a proliferative/
survival factor or a cell death factor dependent on cellular conditions and that this process may in
part be modulated through the histamine H1 receptor.
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Atorvastatin Inhibits the Invasive Behavior of Melanoma Cells
M. Kolodney, I. Chen, and M. Ochoa
Department of Medicine, Division of Dermatology, UCLA School of Medicine, Los Angeles, California
Malignant melanoma is the deadliest skin cancer primarily because of its tendency to metastasize to
distant sites. The high metastatic potential of melanoma is thought to result, in part, from enhanced
cell motility. Recent evidence suggests that the increased motility of metastatic cells results from
activation of proteins belonging to the rho family of small GTPases. HMG CoA Reductase
inhibitors prevent the post-translational lipidation of rho proteins, a step essential in their control of
cell motility. We tested the hypothesis that disruption of rho activation by the HMG CoA
reductase inhibitor, atororvastatin, would block the invasive behavior of melanoma cells. An
invasion chamber assay was used to measure the effect of atorvastatin on the motility of A375
melanoma cells. Under the conditions of our assay, A375 cells invaded a model basement
membrane while normal melanocytes were unable to do so. Atorvastatin, at a concentration of
4 mM, completely blocked invasion of A375 cells. Moreover, atorvastatin induced a dendritic
morphology in A375 cells thereby causing these melanoma cells to resemble non-invasive
melanocytes. Atorvastatin, at 40 mM, caused nearly complete killing of the melanoma cells but did
not cause death of normal human melanocytes. Tunnel assays showed that the majority of the
melanoma cells were dying through apoptosis. Geranylgeranylpyrophosphate blocked both the
anti-invasive and apoptotic sequelae of atorvastatin suggesting that these effects resulted from
decreased post-translational geranylation. Our results indicate that HMG CoA reductase inhibitors
may be effective agents for preventing metastasis and relatively higher doses of these agents might
prove to be useful chemotheraputic agents for treatment of melanoma.
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Regulation of Phospholipase D by Protein Kinase C in Human G361 Melanoma Cells
M. Oka, H. Nagai, M. Matsumura, M. Kukunaga, and A. Kageyama
Dermatology, Kobe University School of Medicine, Kobe, Japan
Regulation of phospholipase D (PLD) by protein kinase C (PKC) isozymes was studied in human
G361 melanoma cells. Hydroxyapatite column chromatography and Western blot analysis revealed
that G361 cells express PKCb, d, e, z but not a. Cells were incubated with [14C]lyso
phosphatidylcholine (PC) in the presence of ethanol to label endogenous PC and assayed for
release of [14C]phosphatidylethanol after treatment with 100 ng per ml of 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) for 30 min. In the cells transfected with PKCa, basal level of PLD
activity and TPA-induced PLD activation were increased. In the cells transfected with the kinase
negative mutant of PKCa, basal level of PLD activity and TPA-induced PLD activation were
increased. These results indicate that PLD is regulated by PKCa and kinase activity of PKCa is not
necessary for the activation of PLD in G361 melanoma cells. Furthermore, in the cells transfected
with PKCe, TPA-induced PLD activation were inhibited, indicating that PLD is differentially
regulated by PKCa and PKCe in G361 melanoma cells.
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The Effect of Vascular Endothelial Growth Factor on Primary Human Melanocytes
E. Kim, H. Park, N. Puri, M. Yaar, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts
Vascular endothelial growth factor (VEGF) regulates endothelial cell proliferation during
embryogenesis and tumor formation. It is constitutively produced by keratinocytes but has no
known epidermal target cell. We previously reported that normal human melanocytes (Mc) express
one VEGF receptor, neuropilin-1. To determine if Mc express other VEGF receptors, Mc were
maintained in serum free, hormone and growth factor supplemented medium without phorbol
ester or choleragen. By Western blotting, Mc constitutively expressed the tyrosine kinase VEGF
receptor 2 (VEGFR-2), in contrast to earlier reports that examined Mc maintained in the presence
of phorbol ester. When Mc underwent more than 8 population doublings (~8 weeks) in phorbol
ester (50 ng per ml), VEGFR-2 protein expression was lost, emphasizing the importance of
studying cultured cells under as physiologic conditions as possible. As this receptor is known to
mediate VEGF-induced endothelial cell proliferation and migration, we performed Boyden
chamber experiments with Mc and found that VEGF was chemoattractant to Mc and strongly
induced their migration. Because UV irradiation is a major modulator of keratinocyte±melanocyte
interactions, we examined its effect on Mc VEGFR-2 levels. Within 48 h, UV irradiated Mc had
twice the amount of VEGFR-2 compared to sham irradiated cells. Conversely, VEGF (20 ng
per ml) decreased the VEGFR-2 level to half of the baseline within 72 h. Tumor necrosis factor-a
(TNF-a), which is reported to modulate VEGFR-2 levels in endothelial cells, is also produced by
UV irradiated keratinocytes. We observed that TNF-a (40 ng per ml) down-regulated VEGFR-2
in Mc to one-fourth the baseline level within 72 h. The data demonstrate that Mc express
VEGFR-2 and migrate in response to VEGF, and that Mc VEGFR-2 expression level is
modulated by UV irradiation, VEGF, and TNF-a and thus, Mc may be a target for VEGF of
keratinocyte origin in skin.
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CC Chemokine Receptor 7 (CCR7)-Transduced B16 Melanoma Cells Show Enhanced
Early Metastases to Regional Lymph Nodes
E. Gonzalez, H. Wiley, and S. Hwang
Dermatology Branch, North CarolinaI, Bethesda, Maryland
CCR7 plays a critical role in the migration of activated dendritic cells from the skin to afferent
lymphatics and regional lymph nodes (LN). Both lymphatics and T cell areas of LN constitutively
express CCL21, a ligand for CCR7. Since melanoma can metastasize to regional LN via lymphatic
channels, we asked whether expression of CCR7 was suf®cient to increase the low, spontaneous
rate of regional LN metastases by murine B16 melanoma. CCR7 was stably integrated into B16/F1
cells by retroviral gene transduction. By quantitative RT-PCR, CCR7-transduced B16 (CCR7-
B16) expressed 1000 fold more mRNA for CCR7 than vector-transduced B16 (Vec-B16).
CCR7-B16, but not Vec-B16, showed a Ca2+ ¯ux in response to CCL21. After injection of either
CCR7- or Vec-B16 cells into the footpads of syngeneic C57/BL6 mice, draining popliteal LN
were recovered at 1 and 3 weeks for RT-PCR and gross inspection, respectively. At 1 week when
tumors in the footpad were not grossly visible, pooled draining LN from CCR7-B16 injected mice
showed at least 200 fold more mRNA for tyrosinase-related protein-1 than did LN from Vec-B16
injected mice in 2 separate experiments. At 3 weeks, 6 of 14 draining LN from CCR7-B16-
injected mice (vs. 1/14 LN from Vec-B160-injected mice) showed evidence of metastases.
CCR7-B16 LN metastases were larger and sometimes formed multiple colonies within the same
LN. Footpad tumor sizes were not different (n = 14, p > 0.5), and CCL21 did not enhance the
growth rate of CCR7-B16 cells in culture. CCR7-B16 LN metastases retained a Ca2+ ¯ux
response to CCL21 even after 7 passages in vitro. Interestingly, 1 of 4 melanoma cell lines initially
derived from human LN metastases expressed 10-fold more mRNA for CCR7 than did normal
cultured melanocytes. Thus, the expression of a single chemokine receptor gene can increase the
early metastases to LN, raising the possibility that cancer cells may co-opt normal mechanisms of
LN homing as a means of metastatic dissemination.
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Differential Growth Regulation in Human Melanoma Cell Lines by Tissue Inhibitors of
Metalloproteinases-1 and ±2
T. Hoashi, T. Kadono, K. Kikuchi, T. Etoh,* and K. Tamaki
Dermatology, University of Tokyo, Tokyo, Japan; *Dermatology, Tokyo Teishin Hospital, Tokyo, Japan
In addition to inhibiting the proteolytic activity of the matrix metalloproteinases, tissue inhibitors
of metalloproteinases (TIMPs) promote the growth of cells in the absence of other exogenous
growth factors. In this study, we investigated TIMP-1 and TIMP-2 gene expression and protein
production using different malignant melanoma cell lines (MCLs), and examined the role of
TIMP-1 and TIMP-2 in the growth regulation of MCLs. Primary MCLs (PM-WK and KHm-4),
recurrent primary MCLs (r.p.m.-EP and r.p.m.-MC), lymphnode metastatic MCLs (MM-AN,
MM-BP, and MM-RU), and a visceral metastatic MCL (MM-LH) were used. Reverse
transcriptase-coupled polymerase chain reaction (RT-PCR) and immunoblotting revealed that all
MCLs expressed and produced TIMP-1 and TIMP-2 except for cell line PM-WK, which neither
expressed nor produced TIMP-1. TIMP-1 and TIMP-2 levels were measured by enzyme-linked
immunosorbent assay (ELISA) in supernatants of cells cultured in the absence or presence of
transforming growth factor (TGF)-¦AÁ 1, interleukin (IL)-6, and oncostatin M (OSM). In MM-LH
and MM-BP, metastatic MCLs which were thought to be cytokine resistant, TGF-¦AÁ 1 and IL-6,
respectively, up-regulated production of both TIMP-1 and TIMP-2. Moreover, we found that the
TIMP-1 production level in MCLs was correlated with the cell migration rate of the MCLs. Cell
proliferation was determined by thymidine incorporation after incubation with various
concentrations of either TIMP-1 or TIMP-2. The growth of the primary MCLs was stimulated
by TIMP-1 and inhibited by TIMP-2. In constast, the growth of the visceral metastatic MCL was
stimulated by TIMP-2. We conclude that an altered responsiveness to TIMP-1 and TIMP-2 may
be associated with disease progression and acquisition of malignant properties in human
melanomas.
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Can Persistent Elevated Wild-Type p53 Expression Explain the Paradox of Low Non-
Melanoma Skin Cancer in Vitiligo?
K. Schallreuter, S. Picksley, D. Tobin, E. Peters, S. Behrens-Williams, and A. Panske
Clincal and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford,
Bradford, United Kingdom
Previously several case studies reported that patients with vitiligo have a low incidence of actinic
damage and nonmelanoma skin cancer (NMSC). This result warranted further systematic
investigation in a larger patient population, since these patients lack frequently protective pigment
in chronically sun-exposed areas (i.e. neck, head and hands) together with a history of extensive
sun sensitivity in association with numerous episodes of sun burns. Considering the onset of the
disease in early childhood and adolescence, it would be expected that the cumulative UVR-dose
should initiate an increase in sun-related damage (i.e. photodamage, NMSC). Therefore we
examined 136 caucasian patients with vitiligo (M/F = 43/93; mean age 42.4 years, skin phototypes
II n = 8; III n = 128 Fitzpatrick classi®cation, mean disease duration 17.4 years, positive family
history in 66/136). 19 patients received extensive PUVA during their lifetime but none showed
lentigines or actinic damage. 16 patients were outdoor workers. Surprisingly, 35% of the entire
group (48/136) did not experience sun sensitivity despite a recreational out door life. A thorough
examination for photoaging (wrinkles, atrophy, mottled pigmentation, telangectasia, pseudo-scars
and laxity) did not show any sign for increased photoaging. Furthermore, there was no case with
actinic keratosis (AK) and NMSC. Since p53 is elevated in AK, BCC and SCC as well as in patients
treated with PUVA, it was tempting to study p53 expression together with MDM2 and
thioredoxin reductase as two representatives of the p53 regulatory system. Surprisingly, we
detected a persistent wild-type p53 up-regulation together with down regulation of MDM2 and
thioredoxin reductase. There was no increased apoptosis. Our results suggest a direct protective
role for wild-type p53 in vitiligo and could explain the low incidence of actinic damage and
NMSC in this disease.
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Induction of Invasive Human Melanocytic Neoplasia by De®ned Genetic Elements
P. Khavari, S. Sheu, P. Robbins, Y. Kubo, M. Dajee, and J. Goodnough
VA Palo Alto and Department of Dermatology, Stanford University, Stanford, California
Among the three major types of skin cancers, malignant melanoma is the most likely to result in
metastasis and death, underscoring the importance of de®ning factors that induce this cancer.
Although forms of melanocytic neoplasia have been developed in transgenic murine tissue models
using viral oncogenes, neoplasia is much more easily induced in mouse tissue than human, making
generation of a human tissue melanocytic neoplasia from endogenous oncogenes an important
goal. To address this, we transduced a mixed population of normal human melanocytes and
keratinocytes with a panel of oncogene retrovectors and used them to regenerate human skin on
SCID mice. Oncogenes studied alone and in combination via multiplex gene transfer included
dominant-negative p53, dominant-negative IkB, CDK4, telomerase (hTERT), cyclin D1 and Ras
(n = 4 human tissue grafts on SCID mice per vector and vector combination). Of all the
combinations of these genes examined, only Ras and hTERT together produced regenerated
human skin with clinical and histologic resemblance to malignant melanoma. Unlike the other
tested combinations and lacZ controls which entirely lacked any clinical or histologic melanocyte
abnormalities, Ras-hTERT skin (n = 4) was characterized in all cases clinically by a black plaque
occupying the entire human skin graft. Histologically, Ras-hTERT skin tissue displayed massive
junctional melanocytic hyperplasia with cellular atypia, abundant mitoses, upward pagetoid spread
into suprabasal epidermal layers and dermal invasion of melanocytes through the basement
membrane down into the deep dermis to the subcutaneous fat. The keratinocytic component of
the epidermis in Ras-hTERT tissue was either entirely normal or only mildly hyperplastic. There
was no evidence of metastatic spread in the grafted mice at 8 weeks. These data suggest that
interactions between Ras V12 and hTert alone may be suf®cient to directly induce features of
malignant human melanoma in vivo and therefore, may provide both insights into pathogenesis and
potential molecular targets for therapy. These ®ndings also establish a general approach to generate
human cutaneous neoplasms from de®ned genetic elements.
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Constitutive Phosphorylation/Inactivation of Retinoblastoma Protein (pRb) by MAPK
in Melanoma Cells
M. von Willebrand, E. Cheng, A. Levitzki,* and R. Halaban
Dermatology, Yale University, New Haven, Conneticut; *Hebrew University, Jerusalem, Israel
Uncontrolled growth of melanoma cells is mediated in large part by the unrestricted activity of E2F
family of transcription factors, responsible for the induction of cell cycle progression genes.
Increased E2F transcriptional activity is due to persistent inactivation by phosphorylation of
retinoblastoma (pRb) family of proteins (pRb, p107 and p130), eliminating their suppressive
association with E2F. Although unregulated cyclin-dependent kinase activity has been implicated
in melanomas, the signal transduction pathway and the possible involvement of other kinases have
not yet been elucidated. Therefore, we employed AG1024, a speci®c inhibitor of receptor tyrosine
kinase, to investigate the mechanism of pRb inactivation. AG1024 inhibited melanoma cell
growth in vitro at high ef®ciency (IC50 less than 50 nM) within 24 h of application. Furthermore,
the inhibitor restored tumor suppressive function to pRb within 30 min of exposure, observed by
the accumulation of dephosphorylated forms of pRb, p107 and p130, and the formation of growth
suppressive DNA binding complexes between E2F and pRb. Surprisingly, the activity of cyclin-
dependent kinases (CDKs) was not affected at this early time point. Instead, AG1024 inhibited
MAPK activity with similar kinetics as pRb/p107/p130 dephosphorylation. All together, the
results suggest that MAPK, a known mediator of cell surface receptor activation, directly
neutralizes pRb tumor suppressive function in human melanoma cells probably due to the
continuous activity of a receptor tyrosine kinase.
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Role of LEF-1 in Melanoma with Increased Metastatic Potential
T. Murakami, T. Etoh,* H. Byers,² S. Toda, M. Ohtsuki, and H. Nakagawa
Dermatology, Jichi Medical School, Kawachi-gun, Japan; *Dermatology, Tokyo Teishin Hospital, Tokyo,
Japan; ²Dermatology, Boston University School of Medicine, Boston, Massachusetts
A constitutive complex of b-catenin and LEF-l has been detected in melanoma cell lines expressing
either mutant b-catenin or mutant APC (Rubinfeld et al, Science 275:1790±1792, 1997). However,
it has been recently reported that b-catenin mutations are rare in primary malignant melanoma, but
its nuclear and/or cytoplasmic localization, a potential indicator of Wnt/b-catenin pathway
activation, is frequently observed in melanoma (Rimm et al, Am J Pathol 154:325±329, 1999). In
human malignant melanoma, the appearance of the tumorigenic phase represents a capacity for
metastasis and is the signi®cant phenotypic steps in disease progression. Invasive malignant
melanoma is proposed to involve at least three steps: (1) capacity to bind the basement membrane;
(2) ability to digest the basement membrane; and (3) capacity for cell migration. The current focus
of the study is on the latter step, and cell motility is thought to play a crucial role in metastatic
behavior. In this work, we sought to determine which LEF/TCF transcription factor of the family
was preferentially involved in human melanoma from different stages of tumor progression. We
show that LEF-1 mRNA expression is predominant in highly migrating cells from metastatic
melanomas. These highly migrating cells showed nuclear accumulation of beta-catenin and active
transcription from a reporter plasmid of LEF/TCF binding site. These results may provide a new
insight into the role of Wnt/b-catenin signaling pathway in tumor progression of malignant
melanoma.
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Flotillin-2 Expresssion Confers Metastatic Behavior to Malignant Melanoma Cells
P. Hazarika, M. McCarthy, M. Bar-Eli, and M. Duvic
Department of Dermatology and Cell Biology, Maryland Anderson cancer Center, Houston, Texas
Flotillin-2 (Flot-2) is a 42-kDa, highly conserved, caveolae-associated protein we cloned with a
monoclonal antibody ECS-1 raised to human keratinocytes. Flotillins have recently been
implicated in the pathogenesis of Alzheimer's disease and neuronal regeneration. Over-expression
of Flot-2 induced ®lopodia in cos cells giving them a dendritic, neuron like appearance. Thus, we
asked whether expression of Flot-2 differed among cancer cell lines derived from epidermis and
neuronal origin. Higher Flot-2 protein was associated with highly metastatic melanoma cell lines
compared to nonmetastatic lines. In glioblastoma cell lines higher Flot-2 expression was observed
in tumorigenic compared to nontumorigenic lines. To further study Flot-2 in the pathogenesis of
metastatic malignant melanoma, we transfected a low tumorigenic, nonmetastatic melanoma cell
line (SB2) with green ¯uorescent protein Flot-2 (pEGFPC2Flot-2) or GFP vector constructs.
Stable transfectants were injected into groups of 5 BALB/c nude mice. Two different EGFP Flot-2
transfected SB2 cell lines, but not vector controls, injected subcutaneously, formed tumors as early
as 20 days. Flot-2 transfected SB2 cells injected into the lateral vein of nude mice formed lung
metastases (range 2±200) in all of the mice in contrast to 3 mice with nontumorigenic control cells
(range 0±1) (F = 109.61, p < 0.01, analysis of variance). Flot-2 has an important role in the
tumorigenicity and metastatic behavior of malignant melanoma and may offer new therapeutic
avenues for treatment of this deadly malignancy.
568
The Alkaloid Noscapine is a Low Toxicity Agent with Signi®cant Antitumor Effects in
Melanoma
R. Lang, J. Landen, S. McMahon, A. Adams, R. Campbell, P. Bonaccorsi, D. Archer, J. Ansel, H.
Joshi, and C. Armstrong
Emory University School of Medicine, Atlanta, Georgia
Noscapine is an alkaloid derived from opium that has been widely used as a cough suppressant in
humans. Our previous studies demonstrated that noscapine binds stoichiometrically to cellular
tubulin and thus inhibits normal microtubule assembly. As a result noscapine has a considerable
cytotoxic activity against a variety of different types of tumors. We have recently demonstrated that
noscapine inhibits melanoma growth in vivo. In this study we examined the mechanism by which
noscapine is able to inhibit the growth of murine melanoma cells. In addition, we evaluated the
toxicity of noscapine in vitro and in vivo in a murine model to determine its potential use as a
chemotherapeutic agent in melanoma therapy. Our results demonstrated that noscapine exhibited
potent cytotoxicity effects against murine B16LS9 melanoma cells in a time (0±96 h) and dose-
dependent fashion (0±1000 mM) in cell-viability assays. Flow cytometric studies also demonstrated
cell cycle perturbations with growth arrest of murine B16LS9 melanoma cells in G2/M phase after
noscapine exposure, while normal melanocytes were unaffected. In vivo, noscapine treatment of
melanoma-bearing C57/BL6 mice did not have any signi®cant hematologic toxicity compared to
untreated mice. Additionally other rapidly dividing tissues like gut epithelium, did not exhibit
signi®cant toxicity after noscapine treatment. Therefore our results indicate that noscapine has a
potent antitumor activity against melanoma cells and demonstrates little toxicity in normal tissue.
These studies support the use of noscapine as a potential low toxicity therapy in malignant
melanoma.
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Antisense Histone Deacetylase 1 Expression Increases Apoptosis Mediated by Sodium
Butyrate in Human Melanoma Cells
E. Medrano* and D. Bandyopadhyay
Dermatology, Baylor College of Medicine, Houston, Texas; *Molecular and Cellular Biology, Baylor College
of Medicine, Houston, Texas
Histone deacetylases are active components of transcriptional corepressor complexes. Inhibition of
the histone deacetylase HDAC1 by sodium butyrate (NaBu) or trichostatin A (TSA) results in
apoptosis in a variety of normal and tumor cells. Here we demonstrate that inhibition of HDAC1
by millimolar concentrations (1±10 mM) of NaBu results in apoptosis of human metastatic
melanoma cells. Apoptosis was preceded by histone H3 and H4 hyperacetylation, p53 acetylation
and up-regulation of Bax and down-regulation of Bcl-2 proteins. To determine the speci®c role of
HDAC1 in apoptosis, we generated stable human melanoma cell lines that express sense or
antisense HDAC1 vectors. Treatment of HDAC overexpressing cells with NaBu resulted in
reduced Bax protein levels and apoptosis compared to cells expressing an empty vector.
Conversely, reduced HDAC1 levels (mediated by antisense repression) increased apoptosis
mediated by NaBu. Our results are in agreement with recent ®ndings showing that interaction of
HDACs with p53 results in its deacetylation, thereby reducing its transcriptional activity.
Modulation of HDAC levels could have potential applications for future intervention therapies in
the treatment of malignant melanoma.
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Molecular Staging of Melanoma Patients and Analysis of Melanoma Pathogenesis
J. Siddiqui, J. Goldstein,* A. Gilliam,* K. Cooper,* and G. Wood
Dermatolgy, University of Wisconsin and Middleton VAMC, Madison, Wisconsin; *Dermatology and
Plastic Surgery, Case Western Reserve University and Stokes VAMC, Cleveland, Ohio
Routine histopathological examination of sentinel lymph node (SLN) biopsies provides important
staging and prognostic information for patients with clinical stage I-II cutaneous melanoma.
Because of its relative insensitivity, however, alternatives to routine histopathology have been
sought for evaluation of SLNs. We have adapted a highly sensitive molecular RT-PCR assay to
amplify melanoma-related transcripts from fresh-frozen SLNs from 65 patients with clinical stage I-
II disease referred to our Multidisciplinary Melanoma Program. Because of variable expression by
tumor cells, a panel of 5 transcripts is being studied concurrently: Tyrosinase, GP-100, MAGE-3,
MART-1 and MUC18. Positive and negative controls were run in each experiment including B-
actin for RNA integrity. All positive RT-PCR results were con®rmed by repeat analysis. Seven
biopsies were both pathologically and RT-PCR positive. Of the 58 pathologically negative
biopsies, 49 were RT-PCR negative whereas 9 were RT-PCR positive. The number of
reproducibly positive RT-PCR markers ranged from 2 to 5 for pathologically positive cases and 1±
4 for pathologically negative cases. Hence the use of a multimarker RT-PCR is more sensitive
than routine pathological examination or single marker RT-PCR. Melanoma pathogenesis is
being studied at the transcript level using differential tyrosine kinase display and microarray
differential gene expression. Our Northern blot and real-time PCR analyses con®rm that DDR2
tyrosine kinase is up-regulated and associated with up-regulation of matrix metalloproteinase-1
expression (an enzyme that speci®cally cleaves native ®brillar collagen) in HT1080 PMA activated
cell line (positive control) and in 2 of 3 melanoma lines relative to normal melanocytes. These
®ndings may have relevance to mechanisms of melanoma invasion and metastasis.
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Multiple Moles: High Frequency of Allelic Deletions at 9p21
I. Bogdan, G. Burg, and R. Boni
Dernatology, University Hospital of Zurich, Zurich, Switzerland
The most important risk factor for the development of malignant melanoma is the total number of
benign and atypical melanocytic nevi. Individuals with more than 60 clinically normal nevi
harbour a 16 times higher risk for developing melanoma and melanoma risk has been shown to
increase steadily with increasing number of benign melanocytic nevi. These ®ndings are based on
epidemiologic case control studies. To date however, there are no molecular data supporting these
®ndings. Chromosome 9p21 is a site of frequent chromosomal deletion during melanoma
development and allelic deletions within this chromosomal region most often include the tumor
suppressor gene p16. We aimed to search for genetic alterations in melanocytic nevi of patients
with different numbers of multiple moles and examine possible differences of these genetic
alterations in melanoma patients vs. non melanoma patients. According to the nevus number we
divided our patients into three groups: patients with less than 20 nevi, 20±60 nevi and more than
60 nevi. Using the microdissection technique, we analysed 7 archived histologically diverse nevi of
5 patients with only a few nevi (< 20), 32 archived nevi of 17 patients with 20±60 nevi and 27
lesions of 14 patients with more than 60 nevi. Using the polymorphic DNA markers D9S171,
IFNA and D9S270 we searched for loss of heterozygosity (LOH) at 9p21 within the melanocytic
lesions. In patients with < 20 nevi, LOH was detected in 2/7 (29%) of informative cases with at
least one marker, in patients with 20±60 nevi in 8/26 (31%) informative cases (6 not informative)
and in patients with more than 60 in 12/24 (50%) of cases (three not informative). These data show
an increase of LOH with increasing nevus number. Melanoma patients showed LOH in 13/19
(68%) of their lesions (5 not informative) compared to 9/38 (24%) in non melanoma patients (4 not
informative) p = 0002. Nevi with melanocytic dysplasia showed LOH in 57% of lesions compared
to 35% in benign nevi. Our results show considerable LOH in benign and atypical melanocytic
nevi of patients with multiple moles and therefore support the epidemiologic ®ndings of increased
melanoma risk by molecular studies. In this subset of patients melanoma patients furthermore show
signi®cantly more LOH within their melanocytic lesions than non melanoma patients. Our data
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Loss of Heterozygosity in 6q22±23 in Melanomas and Intradermal Nevi
A. Moore, A. Maitra, T. Moore, P. Lapinski, G. Netto, T. McCarty, and A. Gazdar
Dermatology, The University of Texas South-western Medical Center, Dallas, Texas
Introduction: Chromosome 6 is frequently rearranged in melanomas, with deletions of 6q being
observed in 35% to 50% of late-stage melanomas. In particular, rearrangements of the oncogene
MYB (located on 6q22) have been observed and postulated to promote late metastasis. Purpose:
The objective was to identify new or better genomic markers for predicting risk of nodal metastasis
in cutaneous melanoma. Methods: The frequency of 6q22-23 deletion in 19 sporadic melanomas
with (11) or without (8) sentinel lymph node involvement and 5 intradermal nevi was examined.
Laser capture microdissection (LCM) was used to identify loss of heterozygosity (LOH), using
markers D6S1038 and D6S310, in melanocytic cells extracted from the primary lesions. Controls
included keratinocytes and lymphocytes from respective patients. Results: In the 24 LCM-
enriched tissue samples, 19 out of 24 (79%) were informative for one or more markers. Of these
19, LOH at 6q22-23 was noted in 12 (63%), with no signi®cant difference noted in melanomas
with (6/8) or without (3/6) sentinel lymph node involvement or in intradermal nevi (3/5).
Conclusions: Using LCM for cell enrichment, our data indicate that 6q22-23 losses may not be
related to metastatic spread as previously stated. In contrast, allelic loss at this locus appears to occur
very early in the spectrum of melanocytic neoplasia, and is present even in intradermal nevi.
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Distribution of Transforming Growth Factor-1b in Benign and Malignant Melanocytic
Neoplasms
C. Golomb, E. Badiavas, J. Butmarc, C. Wikel, and V. Falanga
Dermatology and Pathology, Roger Williams Medical Center, Boston University School of Medicine,
Providence, Rhode Island
Introduction: Transforming growth factor b (TGF-b) is potent inhibitor of cellular proliferation in
a variety of normal cells. Mutations in the TGF-b pathway have been described and correlate with
progression to malignant phenotypes in a number of cancers. The purpose of this study is to
evaluate the expression of TGF-b1 in malignant melanocytic neoplasms and benign nevi. We
hypothesize that malignant melanocytic neoplasms become resistant to growth inhibition by TGF-
b1 with a subsequent increase in TGF-b production, which promotes angiogenesis, cell motility
and loss of immune surveillance. Materials and Methods: Archival cases were reviewed and
representative sections of benign nevi and melanoma were selected. Each specimen was
deparaf®nized in xylene, followed by serial ethanol dilutions and rehydration. The tissue was
incubated with a rabbit ant-TGF-b1 antibody and a secondary anti-rabbit antibody and red
chromogen were used for visualization. Positive control was a non-Hodgkins lymphoma and
intrinsic smooth muscle. Results: Eleven malignant melanomas, one metastatic lymph node and 14
benign melanocytic neoplasms (compound nevi, intradermal nevi and blue nevi) were studied.
Melanomas stained strongly positive for TGF-b1 while benign proliferations were negative or
exhibited only weak staining. Conclusion: These results suggest that TGF-b1 may contribute to
the mode of progression of malignant melanoma. Production and secretion of TGF-b1 by
melanoma cells may have a vital role on suppressing the activation and proliferation of immune
modulatory cells.
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Targeted Overexpression of Activated Notch1 Leads to Hair Follicle Abnormalities and
``Mohawk Alopecia'' in Transgenic Mice
H. Uyttendaele, J. Kitajewski,* A. Panteleyev, and A. Christiano
Department of Dermatology, Columbia University, New York, New York; *Department of Pathology,
Columbia University, New York, New York
Notch genes encode a family of highly conserved transmembrane receptor proteins that play a
pivotal role in cell fate decisions during vertebrate development. Several Notch genes and their
corresponding ligands are expressed in the developing mammalian hair follicle. The aim of our
study was to investigate the role of Notch1 in mouse hair follicle development by using a
transgenic mouse model. The involucrin promoter was used to drive expression of a gain of
function mutation of the Notch1 gene to the inner root sheath (IRS) of the hair follicle. To
facilitate analysis of transgene expression, b-galactosidase was expressed simultaneously from the
involucrin promoter using an IRES. Transgenic mice displayed both hair and skin abnormalities
that can be identi®ed soon after birth. The skin initially appears more wrinkly and scaly and their
coats appear more disheveled with wavy hairs. Animals also develop a progressively spreading
alopecia that reproducibly spares the midline hair follicles, which we refer to as ``mohawk
alopecia''. Histological examination reveals hyperkeratosis and acanthosis of the epidermis, hair
follicles that are abnormally aligned in different orientations, and abnormal differentiation of both
the IRS and hair shaft medulla. Analysis of hair follicles from different hair cycle stages reveals
defects in hair cycling, with lack of the typical catagen transformations and persistent tricholemmal
keratinization.
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Deregulated Activation of the Hedgehog Signaling Pathway Gives Rise to Basaloid
Follicular Hamartomas in Adult Mice
M. Grachtchouk, V. Grachtchouk, G. Frantz,* F. DeSauvage,* and A. Dlugosz
Dermatology, University of Michigan, Ann Arbor, Michigan; *Molecular Oncology, Genentech, South San
Francisco, California
Constitutive activation of Sonic hedgehog (Shh) signaling is a hallmark of basal cell carcinomas
(BCCs) and can be caused by loss-of-function PTCH mutations or gain-of-function SMO
mutations, both identi®ed in human BCCs. It is not yet known whether either of these genetic
alterations alone, when present in keratinocytes, is suf®cient for the formation and maintenance of
full-blown BCCs in adults. To begin exploring this issue, we targeted a constitutively active
mutant SMO allele (M2SMO) to mouse skin using a truncated K5 promoter, which is active in a
subset of K5-positive cells and can thus bypass lethal phenotypes seen with the full-length K5
promoter. Multiplem dK5-M2SMO transgenic founders exhibited progressive alopecia but,
surprisingly, skin tumors were not observed even after one year. Microscopic analysis of skin from
adult transgenic mice revealed numerous immature follicle-like structures, anastomosing strands
and cords of epithelial cells, and occasional cysts. This histology and additional immunostaining
results revealed striking similarities to human basaloid follicular hamartomas, which may be
congenital (unlike BCCs) and are frequently associated with alopecia. Northern blot analysis
revealed up-regulation of several Shh target genes in transgenic skin, con®rming that M2SMO
caused constitutive Shh signaling as expected. BCCs were also not seen in an adult transgenic
generated using the full-length K5 promoter to drive M2SMO expression, while a K5-Gli2
transgene produced numerous BCCs in multiple founders and offspring. Proximal activation of
Shh signaling in keratinocytes using the human M2SMO mutant, when initiated during mouse
embryogenesis, is thus incompatible with BCC development. Moreover, our ®ndings strongly
implicate deregulation of the Shh pathway in the genesis of human basaloid follicular hamartomas.
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Anti-Tumor and Tumor-Promoting Capacities of ab and gd T Cells in Cutaneous
Squamous Cell Carcinoma Development are Dependent on Model of Carcinogenesis
M. Girardi, E. Glusac, R. Filler, R. Tigelaar, and A. Hayday*
Dermatology, Yale University Sch. of Medical, New Haven, Conneticut; *Immunology, Guy's/St. Thomas
Medical, London, United Kingdom
Squamous cell carcinoma (SCC) of the skin respresents one of the most common malignancies, and
chemical carcinogen exposure in the industrual workplace is a major etiologic stimulus. To study
the relative roles of ab and gd T cells in SCC development, we utilized T cell receptor b and d
knockout (KO) mice on strain backgrounds FVB and C57BL/6, and several modes of SCC
induction. Following a single intradermal injection with methylcholanthrene (MCA), FVB bKO
and dKO mice were much more susceptible to SCC development than FVB wild-type (w.t.)
controls (rel. risk 3.13 for bKO, 3.03 for dKO; p < 0.02 for both), indicating that both major
subset of T cells exert antitumor responses. Similarly, intradermal injection of PDV, a
dimethlybenzathracene (DMBA)-transformed keratinocyte tumor line, induced more carcinomas
in both bKO (96.7% sites; 2.3 6 0.2 week latency) and dKO mice (40.0% sites; 7.0 6 0.4 week
latency) than syngeneic C57BL/6 controls (12.5% sites; 7.3 6 1.2 week latency). However,
strikingly different results were observed utilizing two-stage, DMBA/TPA, chemical carcinogen-
esis protocols. Under ``high-dose'' DMBA/TPA exposure, there was a marked resistance to tumor
(tum) development and carcinoma (ca) progression in FVB bKO (12.7 6 1.7 tum/mouse and
0.3 6 0.1 ca/mouse) relative to FVB w.t. controls (20.9 6 2.0 tum and 2.5 6 0.4 ca/mouse; p
< 0.0005 for both tum and ca) ± indicating that ab T cells paradoxically acted in a tumor-
promoting capacity. Under ``low-dose'' DMBA/TPA exposure, more tumors developed in both
FVB dKO (13.4 6 1.3 tum/mouse) and FVB bKOdKO (15.6 6 1.7 tum/mouse) than FVB w.t.
mice (3.1 6 0.9 tum/mouse; p < 0.0005 for both); however, more carcinomas were observed in
FVB dKO (3.5 6 0.5 ca/mouse), but not in FVB bKOdKO (1.3 6 0.3 ca/mouse), than in FVB
w.t. mice (1.3 6 0.3 ca/mouse; p < 0.002 for dKO vs. w.t.). Taken together, these studies
demonstrate for the ®rst time: (1) an in vivo antitumor function for gd T cells in three different
models of cutaneous carcinogenesis, and (2) the capacity of ab T cells to promote tumor
development and drive progression to carcinoma in two-stage, but not one-stage, carcinogenesis
protocols.
VOL. 117, NO. 2 AUGUST 2001 ABSTRACTS 485
577
Immunohistochemical Detection for Nuclear b-Catenin in Sporadic Basal Cell
Carcimona
F. Yamazaki, Y. Aragane, A. Kawada, and T. Tezuka
Dermatology, Kinki University School of Medicine, Osakasayama-shi, Japan
Despite the increasing incidence of basal cell carcinoma (BCC), its pathogenesis has remained
largely unknown. Recently, it was reported that genes involved in tissue morphogenesis, like sonic
hedgehog or patched, were found to be mutated in BCC, suggesting the involvement of those
molecules in the pathogenesis of this tumor. Furthermore, there is evidence that the Wnt-mediated
signaling pathway may be one of the downstream targets of sonic hedgehog-mediated signaling,
which has led us to focus on molecular events on the Wnt pathway in BCC. Among signal
transducers involved in the Wnt pathway, it is clear that b-catenin plays a pivotal role in promotion
of morphogenesis and cell growth. In respect to this, it has been reported that, in particular
circumstances, as in colorectal cancers, b-catenin migrates to nuclei, where it exerts the ability to
activate transcription of various genes. Based on this knowledge, we investigated cellular
localization of b-catenin in BCC. Therefore, biopsy specimens derived from BCC (n = 20), from
in¯ammatory skin diseases (n = 10) or from squamous cell carcinoma (n = 5) were immunostained
with an antibody directed against b-catenin. Consequently, it was found that 14 of 20 BCC
samples tested showed positive nuclear localization of b-catenin, while none of other samples gave
rise to positive nuclear staining, indicating nuclear localization of b-catenin as a characteristic
feature of BCC, and thereby suggesting its tumorigenic role in this tumor. Hence, this gives us
further insight into the molecular pathogenesis of BCC.
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PI3-Kinase/Akt-Mcl1 Siganl Pathway is Involved in IL-6 Regulated Anti-Apoptosis
Activity to UVB in BCC Cells
S. Jee, H. Chiu, W. Tsai, and M. Kuo
Dermatology, National Taiwan University Hospital, Taipei, Taiwan
Interleukin-6 (IL-6) has been shown to be associated with several human tumors. We have
established IL-6- over-expressing basal cell carcinoma clone (BCC/IL-6) which is tumorigenic in
nude mice. Recent studies demonstrated IL-6 induced Bcl-2 family protein to exhibit
antiapoptosis activity to TGF-b through phosphatidyl-inositol 3-kinase (PI3-kinase)/Akt pathway
in hepatoma cells. The purpose of the present study therefore was to investigate the PI3-kinase/
Akt signaling pathway of IL-6 on the regulation of UVB induced apoptosis in BCC cells. By
Western blotting, amount of pAkt and Mcl-1 is found elevated in BCC/IL-6 cells. After treating
the BCC cells with IL-6 for 1 h, the amount of pAkt increased 63% comparing with the control
BCC cells. After treating the BCC/IL-6 cells with PI 3-kinase inhibitors Wortermannin (100 nM)
and LY294002 (25 mM) for 4 h, the amount of pAkt and Mcl-1 decreased to 42.18% and 15.75%,
respectively, and, the ¯ow cytometry detected a 40% increment in amount of UVB-induced
apoptosis cells. Transient transfection of dominant negative Akt (dnAkt) into BCC/IL-6 cells
decrease Mcl-1±17.3% 48 h later. Taking together, these data demonstrated that the PI 3-kinase/
Akt-Mcl-1 signaling pathway is involved in IL-6 regulation of UVB induced apoptosis in BCC
cells.
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Expression of a Sonic Hedgehog Signal Transducer, HIP (Hedgehog-Interacting
Protein), by Human Basal Cell Carcinoma
M. Tojo, K. Iwatsuki, and F. Kaneko
Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan
Sonic hedgehog (SHH) plays a role in the control of cell differentiation and proliferation in
vertebral development and epithelial±mesenchymal interactions. In basal cell nevus syndrome
patients, mutations of a gene, patched (PTC), which encodes a receptor for SHH, were found and
are thought to be one of the major causes of the disease. Recently, a novel membrane protein,
hedgehog-interacting protein (HIP) was found to bind SHH directly and attenuate SHH signaling
like PTC, while its expression was induced by SHH signals (Nature, 1999). The HIP gene mRNA
expression is detected in murine embryonic skin, but it has not been shown in normal human skin
or skin tumors. We examined the expression patterns of HIP, SHH, and PTC gene mRNA by
human BCCs, in comparison with those by normal human skin and various skin tumors. We
found that the mRNA expression of both HIP and PTC genes was enhanced in all samples of
BCCs, whereas none of other skin tumors tested exhibited an increased level of such mRNA as
compared with that of normal skin. The transcription of SHH gene, however, was in a baseline
level in most BCCs. These results indicate that both HIP and PTC gene expressions are speci®cally
involved in the development of BCCs, and that the production of HIP is linked with the
expression of PTC but not SHH gene.
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Patched-Smoothened Signaling in Basal Cel Carcinoma
M. Lerner and T. Thompson
Dermatology, Utsw Medical Center, Dallas, Texas
Basal cell carcinoma induction is tightly linked to Sonic hedgehog pathway dysfunction. Pathway
signaling starts at the cell membrane with a complex composed of two proteins: Patched and
Smoothened. Patched normally keeps Smoothened inactive. Pathway activation commences when
soluble Sonic hedgehog binds to Patched. Sonic hedgehog binding does not result in a physical
dissociation of Patched-Smoothened, but it stops Patched from inhibiting Smoothened.
Smoothened then up-regulates expression of the transcription factor Gli1. Our preliminary
studies using a melanophore based G-protein coupled receptor assay show that Gai is activated by
Smoothened: hence Smoothened is a G-protein coupled receptor. Smoothened's Gai activating
property and its Gli1 regulating property correlate in three ways: (a) Patched inhibits both activities
(b) Sonic hedgehog releases both inhibitions and (c) in the presence of Patched, a mutant
Smoothened retains both activities. To provide a more complete understanding of the process by
which Smoothened couples to Gai, we are using site directed mutagenesis to investigate speci®c
regions within three of Smoothened's four intracellular domains.
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Gene Expression Portraits of Human Basal Cell Carcinoma using cDNA Microarrays
B. Howell, N. Solish, B. Wang, I. Freed, S. Shahid, W. Kalair, H. Watanabe, and D. Sauder
Division of Dermatology, Sunnybrook & Women's College Health Sciences Centre, University of Toronto,
Toronto, Ontario, Canada
Variation in gene expression accounts for much of the biological diversity of human cells and
tumors. We propose that the phenotypic diversity of skin tumors results from a corresponding
diversity in gene expression patterns, and we have captured these genotypic pro®les using cDNA
microarray technology. In this study, gene expression portraits of human basal cell carcinoma
(BCC) were created using cDNA microarrays spotted with 1700 fully characterized human genes
relevant to in¯ammation, immunity and cancer. BCC tumor specimens from 50 Mohs'
Micrographic Surgery patients were compared to their normal skin, and hierarchical gene cluster
analysis of the microarray data has revealed novel regulation of numerous families of genes. Certain
gene expression patterns are common to all BCCs, while others are speci®c for BCC histological
subtypes (e.g. sclerosing vs. nodular). For example, signaling and angiogenesis activating molecules
are up-regulated by greater than two-fold in all BCCs (including ras-related protein RAB-27 A,
WEE1-like protein kinase, erbB-3 receptor tyrosine kinase, caspase-8 and endothelin-1).
In¯ammatory mediators and cell cycle regulatory molecules are down-regulated by greater than
two-fold in all BCCs (including interferon regulatory factor 4, prostaglandin-E2 receptor, Lyk
tyrosine kinase and G2/mitotic-speci®c cyclin G1). The following changes appeared speci®c for
sclerosing BCCs: a greater than two-fold up-regulation of proto-oncogene c-crk and melanoma-
associated antigen-1 (MAGE-1), and a greater than two-fold down-regulation of integrin a-6 and
GM-CSF. In addition, a greater than two-fold down-regulation of IL-6 and interferon-induced
proteins appeared speci®c for nodular BCCs. Collectively, our BCC microarray data signi®cantly
contributes to our understanding of UV-induced carcinogenesis and cutaneous tumor biology.
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Ultraviolet Radiation Sensitizes Melanoma Cells to TRAIL-Induced Apoptosis
E. Zeise, M. Weichenthal,* and T. Schwarz
Department of Dermatology, University MuÈnster, MuÈnster, Germany; *Department of Dermatology, St.
Georg Hospital, Hamburg, Germany
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) is a death inducing ligand which
was initially described to selectively kill tumor but not normal cells. While the majority of human
melanoma cells are highly sensitive to TRAIL, some do not undergo cell death in response to
TRAIL. To elucidate the molecular basis of this resistance, we analysed the TRAIL receptor
expression of several melanoma lines. All cell lines tested coexpressed the signaling receptors
TRAIL-R1 and -R2, whereas one of the resistant lines was de®cient in TRAIL-R1. The
nonsignalling receptors TRAIL-R3 and -R4 were neither detectable in TRAIL-sensitive nor in
resistant melanoma cells. Normal human melanocytes which are resistant to TRAIL also expressed
TRAIL-R1 and -R2 but not TRAIL-R3 and -R4. Hence, the differences in TRAIL-sensitivity
might not be related to differential receptor expression. Low dose ultraviolet radiation (UV), which
by itself did not induce apoptosis, enhanced TRAIL-toxicity signi®cantly. Furthermore, UV
rendered resistant melanoma cells highly susceptible to TRAIL. FACS analysis revealed that UV
did not in¯uence TRAIL receptor expression. Induction of TRAIL susceptibility by UV was
blocked upon inhibition of the death receptor associated protease, caspase-8, while blockade of
caspase-9 was less effective. The UV-effect was still observed when UV irradiation was applied up
to 6 h before TRAIL exposure. The sensitizing effect of UV was signi®cantly reduced when UV
irradiation was performed at 4°C. Since keeping cells at low temperatures during UV exposure is
known to inhibit UV-induced death receptor clustering, which is functionally relevant, we
hypothesize that UV might render cells susceptible to TRAIL via facilitating death receptor
clustering.
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Transgenic Expression of Survivin in Keratinocytes Counteracts UVB-Induced
Apoptosis and Cooperates with Loss of p53
D. Grossman and D. Altieri*
Dermatology, University of Utah and the Huntsman Cancer Institute, Salt Lake City, Utah; *Pathology,
Yale University School of Medicine, New Haven, Conneticut
The apoptosis inhibitor survivin has been implicated in both cell cycle control and apoptosis
resistance. To investigate apoptotic pathways in keratinocytes in vivo, transgenic mice were
generated expressing survivin under the control of a keratin 14 (K14) promoter. K14-survivin mice
developed normally, without abnormalities of skin or hair. Basal keratinocyte proliferation in vivo
was unaffected. Neither keratinocyte proliferation nor hyperplasia induced by UVB or phorbol
ester was enhanced. The generation of sunburn cells in vivo, however, was signi®cantly (p < 0.01)
reduced in K14-survivin mice compared to non-transgenic littermates. UVB-induced apoptosis of
keratinocytes in vitro was blocked by caspase inhibitor ZVAD-fmk, and was reduced in transgenic
keratinocytes. By contrast, transgenic keratinocytes were susceptible to apoptosis induced by anti-
Fas in vitro. Given the expression of survivin in nonmelanoma skin cancer, we investigated its
impact in p53-dependent apoptotic pathways. K14-survivin transgenic mice also de®cient in one
p53 allele (K14-survivin-p53+/± mice) were signi®cantly (p < 0.01) more refractory to sunburn
cell formation than either K14-survivin (p53+/+) mice or non-transgenic p53+/± mice, and
keratinocytes isolated from K14-survivin-p53+/± mice were as resistant as those from p53±/± mice
to UVB-induced apoptosis in vitro. These studies demonstrate that survivin expression in
keratinocytes confers resistance to UVB-induced apoptosis without affecting epidermal
proliferation or differentiation, and suggest that survivin may counteract the p53-mediated
apoptotic pathway in keratinocytes.
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Gadd45 Regulates the G2/M Checkpoint Via cdc2 Kinase, DNA Repair and Cell Death
in Mouse Keratinocytes after UV Exposure
T. Maeda, A. Hanna, A. Sim, P. Chua, M. Chong, O. Nikaido, A. Fornace, and V. Tron
Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; *Radiation Biology,
Kanazawa University, Kanazawa, Japan; ²the Gene Response Section, Division of Basic Sciences, National
Cancer Institute, National Institutes of Health, Bethesda, Maryland
Gadd45 is a p53-dependent, multifunctional protein. We investigated the role of Gadd45 in the
UVB response using irradiated normal human and Gadd45 def®cient mouse keratinocytes. An
RNA protection assay and Western blotting demonstrated that Gadd45 was induced by UVB. Up-
regulation of GADD45 mRNA was observed at 4 h after irradiation (100, 300 or 600 J per m2
UVB) and it remained for 24 h. The induction of Gadd45 protein was observed at 8 h after
irradiation and it remained at least for 48 h with the strongest induction at 300 J per m2. Cell cycle
kinetics was assessed using ¯ow cytometry. G2/M and S phase arrest were both observed after
exposure to UVB, however, only G2/M arrest was Gadd45 dependent. To establish the
mechanism of the G2/M arrest, the activity of cyclin kinase cdc2 was assayed. After
immunoprecipitation of cell lysates from irradiated Gadd45+/+ and Gadd45±/± cells with cdc2
antibody, the kinase activity was assessed via histone H1 phosphorylation. While cdc2 kinase
activity, thought to be G2 speci®c, remarkably decreased at 6 h after exposure in Gadd45+/+ cells,
the activity was not reduced in Gadd45±/± cells. Post-UV global genomic DNA repair was
assessed using the slot-western technique with a thymine dimer speci®c antibody. DNA from UV-
exposed Gadd45+/+ and Gadd45±/± cells was applied on a nitrocellulose membrane, followed by
incubation with the thymine dimer antibody. Gadd45±/± cells showed slower nucleotide excision
repair than Gadd45+/+ cells. And ®nally, the cytotoxic effect of UVB was assessed using ¯ow
cytometry and crystal violet staining. Gadd45±/± cells showed higher UV sensitivity. Our results
suggest that Gadd45 is, at least in part, involved in regulating the G2/M checkpoint after UV
exposure, by regulating cdc2 kinase. In addition, Gadd45 enhances global genomic repair and
regulates cell death. Gadd45 appears to be an important factor in maintaining genomic integrity in
keratinocytes after UV exposure.
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Disruption of Mitochondrial Function During UV-Induced Apoptosis of Human
Keratinocytes Requires Activation of Protein Kinase C
M. Denning, L. Sitailo, S. Tibudan, Y. Wang, and S. Alkan
Pathology, Loyola Univeristy Medical Center, Maywood, Illinois
The perturbation of mitochondria structure and function is a critical component of the UV
radiation death effector pathway. We investigated the involvement of protein kinase C (PKC)
activation in triggering mitochondrial alterations in normal human keratinocytes. In keratinocytes
undergoing UV-induced apoptosis, PKCd is cleaved by caspase-3, generating a constitutively
active PKCd catalytic domain. No other PKC isoforms are cleaved during UV-induced
keratinocyte apoptosis. Inhibition of PKC activity protected keratinocytes from UV-induced
apoptosis and the loss of cell viability as measured by the MTT assay, which is dependent upon
mitochondrial redox reactions. The release of cytochrome c from mitochondria is an early,
caspase-independent event in UV apoptosis, and it was not blocked by PKC inhibition.
Generation of reactive oxygen species is also an early event in UV signaling, and reactive oxygen
species levels were not reduced by PKC inhibition. In contrast, the loss of mitochondrial
membrane potential is a late event, and it was blocked by PKC inhibition and the general caspase
inhibitor zVAD. The PKCd catalytic domain generated after UV irradiation was localized to the
mitochondria by biochemical fractionation. In addition, ectopically expressed PKCd catalytic
domain induced apoptosis and colocalized with the mitochondrial probe MitoTraker Red by
confocal microscopy, strongly suggesting a mitochondrial target for PKCd. To identify substrates
for the mitochondrial PKCd catalytic domain that may be components of the UV signaling
pathway, in vitro kinase assays were performed using puri®ed mitochondria and recombinant
PKCd. Several preferred mitochondrial substrates were observed, and the identi®cation of these
proteins is under investigation. In summary, these results identify the mitochondria as a functional
target for the PKCd catalytic domain in keratinocytes undergoing UV-induced apoptosis.
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UV-Induced Activation of PI3-Kinase/AKT Pathway is Mediated by both ROS and p38
in Cultured Human Keratinocytes
Y. Wan, Q. Zhang, S. Sullivan, K. Souza, and S. Mehta*
Biology, Providence College, Providence, Rhode Island; *Surgery, Roger Williams Medical Center,
Providence, Rhode Island
Our previous study has shown that as a Ying-Yang balance in response to UV irradiation, PI3-
kinase/AKT cell survival pathway was transiently activated, followed by cell death in human skin
in vivoand in cultured human keratinocytes in vitro. The present study focuses on the upstream
pathways leading to activation of AKT. Our study using cultured human keratinocytes
demonstrates that UV (30 mJ per cm2) induced phosphorylation of p38 and AKT in a time
dependent manner. Phosphorylation of p38 started at 5 min post UV irradiation, peaked at about
30 min, and remained elevated for up to 2 h. Phosphorylation of AKT (Ser473 and 308) occurred
at 15 min post UV treatment, peaked at about 1 h, and remained elevated for up to 2 h. We also
observed that H2O2 induced phosphorylation of both p38 and AKT in a time dependent manner.
Pretreatment of human keratinocytes with LY294002 inhibited UV-induced phosphorylation of
AKT, suggesting the involvement of PI3-kinase. Pretreatment with NAC, an antioxidant,
abrogated UV-induced AKT phosphorylation without apparent effect on p38 phosphorylation,
suggesting the involvement of reactive oxygen species in AKT activation in response to UV
irradiation. Also,an NADPH oxidase inhibitor, DPI reduced UV-induced AKT activation,
suggesting the presence of NADPH oxidase in the activation process. Pretreatment with
SB203580, a p38 inhibitor,only partially inhibited UV-induced phosphorylation of AKT,
suggesting the role of p38 in AKT activation by UV irradiation. Based on our earlier observations
that UV activates Rac1-regualted NADPH oxidase and generates ROS and the data presented
here, we conclude that the upstream pathways leading to PI3-kinase/AKT activation preceding the
induction of apoptosis due to UV irradiation are mediated by ROS and p38 in cultured human
keratinocytes.
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ATR (Ataxia Telangiectasia and Rad3-Related) Mediates a p53-Independent Pathway
Required for Survival after UV
Y. Kim, P. Nghiem, P. Park, B. Desai, and S. Schreiber
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts
Ultraviolet-induced DNA damage causes cell cycle arrest at G1 and prior to mitosis in order to
insure repair in advance of division. ATR has been suggested as essential for damage-induced p53
phosphorylation at serine-15 following UV radiation, and hence implicated as important in p53
activation by UV. Although serine-15 phosphorylation is correlated with activation of p53, study
of ATR's true role in the activation of p53 has been hampered by the lack of a means to alter ATR
function in cells with an intact p53 pathway (prior studies were carried out in SV40 transformed
cells). In order to address this question we generated two stable cell lines with four characteristics:
(1) Cells possess an intact p53/G1 response to DNA damage (2) Dominant negative (kinase dead)
ATR or wild type ATR can be induced by doxycycline addition (3) No expression of inducible
constructs occurs at baseline, and (4) Induced expression of the target allele exceeds endogenous
ATR by 3±5 fold. Colony survival assays showed that these cells were 10-fold more sensitive to
UV, ionizing radiation or cis-platinum after expressing ATR- kDa, while ATR-wt expression had
no effect. Although we observed a transient defect in serine-15 phosphorylation of p53 at 3 h after
damage, there was no effect of expressing ATR- kDa on damage-induced p53 up-regulation
(Western blotting), DNA binding (gel shift), p21 transcription (RNAse protection) or G1 cell
cycle arrest (propidium-iodide FACS). These data from cells with wild type p53 lead us to
conclude that ATR does not participate in p53 activation as suggested by work done in SV40
transformed cells. Rather, we show that ATR- kDa expression causes cells to improperly proceed
into mitosis despite UV damage. This statement is based in part on studies of ATR- kDa expressing
synchronized cells which produce mitotic phosphoproteins earlier after UV treatment than control
cells. In a separate abstract we report that genetic or pharmacologic interference with ATR
function causes massive chromosomal fragmentation and premature chromatin condensation in
cells treated with low dose DNA damage suggesting ATR normally blocks mitotic entry in DNA
damaged cells. We conclude that ATR plays a role in a p53-independent mitotic entry checkpoint
essential for survival after UV and other types of DNA damage.
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Mechanisms of Insulin-Like Growth Factor-1 Receptor-induced Survival of Ultraviolet
B Radiation in Keratinocytes
D. Lewis and D. Spandau
Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; *Biochemistry & Molecular
Biology, Indiana University School of Medicine, Indianapolis, Indiana
In the skin, keratinocytes express the insulin-like growth factor-1 receptor (IGF-1R) but they do
not synthesize insulin-like growth factor-1 (IGF-1). Dermal ®broblasts support the proliferation of
keratinocytes in the epidermis by secreting IGF-1. Similar to what is seen in vivo, activation of the
IGF-1R in normal keratinocytes grown in vitro results in cell growth and replication. However,
following the UVB irradiation of cultured normal human keratinocytes, the IGF-1R no longer
functions as a mitogenic factor, but actually inhibits further cellular proliferation while promoting
cell survival. In order to establish a model system to explore this dichotomy of functions, we sought
to determine if the IGF-1R in the immortal human keratinocyte cell line HaCaT functioned
similarly to that in normal human keratinocytes. HaCaT keratinocytes were grown in the presence
of neutralizing a-IGF-1R antibodies or unrelated a-IgG antibodies before being irradiated with
increasing doses of UVB. HaCaT cells with neutralized IGF-1R were found to be 10 times more
sensitive to low doses of UVB irradiation than HaCaT cells in which the IGF-1R function was
unperturbed. HaCaT keratinocytes were also grown in serum-free M154 keratinocyte medium,
containing the full allotment of growth factors, or in M154 medium in which the insulin level was
reduced from the normal 5 mg per ml to 50 ng per ml (LoIn medium). HaCaT cells grown in LoIn
will only have activated insulin receptors, as 50 ng per ml insulin is insuf®cient to activate the IGF-
1R. HaCaT cells in either M154 or LoIn medium were irradiated with increasing doses of UVB.
Once again, HaCaT cells were more sensitive to UVB-induced apoptosis in the absence of IGF-
1R (in LoIn medium) at low doses of UVB. These ®ndings indicate that HaCaT cells can be used
as a model to study the function of the IGF-1R in response to UVB irradiation. In order to
accomplish this goal, we have recently established a genetically modi®ed HaCaT cell line in which
the function of the IGF-1R can be selectively inactivated.
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Chemopreventive Effect of the Cyclooxygenase Inhibitor Sulindac Against UVB-
Induced Expression of Surrogate Markers of Skin Cancer
M. Athar, K. Morel, K. An, A. Kim, L. Kepelovich,* and D. Bickers
Dermatology, College of Physicians & Surgeons, Columbia University, New York, New York; *Division of
Cancer Prevention, North CarolinaI, Bethesda, Maryland
Sulindac is a nonsteroidal anti-in¯ammatory drug with demonstrated potency as a chemopreven-
tive agent in animal models of carcinogenesis and in patients with familial adenomatous polyposis.
In addition, it reduces bradykinin-induced edema in human skin. Since tumor promotion is
generally associated with exposure to pro-in¯ammatory stimuli, it is likely that anti-in¯ammatory
agents may have potent antitumor effects. In this study, we tested the hypothesis that the
cylooxygenase inhibitor, sulindac, can protect against UVB-induced injury that is crucial for the
induction of cancer. Exposure of SKH-1 hairless mice to a single dose of UVB (240 mJ per cm2)
induces various in¯ammatory responses including erythema, edema, epidermal hyperplasia,
in®ltration of polymorphonuclear leukocytes, etc. Topical application of sulindac (1.25±5.0 mg/
0.2 ml acetone) to dorsal skin of SKH-1 hairless mice either 2 h prior to or immediately after UVB
exposure substantially inhibited these in¯ammatory responses in a dose-dependent manner. Oral
administration of sulindac in drinking water (160ppm) for 15 days prior to and during UVB
irradiation similarly reduced these in¯ammatory responses. These potent anti-in¯ammatory effects
of sulindac suggested the possibility that the drug could inhibit signaling processes that relate to
carcinogenic insult by UVB. Accordingly studies were conducted to assess the ef®cacy of sulindac
in attenuating UVB-induced early surrogate molecular markers of photodamage and carcinogen-
esis. UVB exposure enhanced the expression of p53, c-fos, cyclins D1 and A and PCNA 24 h after
irradiation. Treatment of animals with either topical or oral administration of sulindac largely
abrogated the expression of these UVB-induced surrogate markers. These results indicate that
cyclooxygenase inhibitors such as sulindac are effective in reducing UVB-induced events relevant
to carcinogenesis and that this category of drugs may prove to be effective chemopreventive agents
for reducing the risk of photocarcinogenesis in human populations.
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Ultraviolet B-Induced Activation of Stat3 is Associated with Epidermal Growth Factor
Signaling in HaCaT Cell
T. Bito, M. Ashida, A. Budiyanto, M. Ueda, and M. Ichihashi
Dermatology, Kobe University school of medicine, Kobe, Japan
STATs are a class of transcription factors that become activated upon tyrosine phosphorylation.
Recent studies have demonstrated that constitutively activated Stat3 signaling directly contributes
to oncogenesis by stimulating cell proliferation and preventing apoptosis. Chronic exposure of
human skin to ultraviolet (UV) radiation is the major causative factor for skin cancer. We
investigated the role of UVB on Stat3 activation and its regulatory mechanisms. Electrophoretic
mobility shift assay revealed that constitutive activation of Stat3 was very low in both normal
human keratinocyte and an immortalized keratinocyte cell line (HaCaT), whereas three SCC cell
lines showed high constitutive activation. A single exposure of HaCaT cells to UVB activated Stat3
in a time- and dose-dependent manner. The activation started at 30 min, peaked at 1 h, and
remained activated at least for 6 h following UVB exposure. The elevated DNA-binding returned
to the basal level at 12 h. Stat3 activation of HaCaT cell by UVB was reduced dose-dependently by
treatment with a tyrosine kinase inhibitor, Genistein. In addition, treatment with an inhibitor of
epidermal growth factor (EGF) receptor also down-regulated the UVB-induced Stat3 activation.
Finally, pretreatment of HaCaT cells with Genistein increased the UVB-induced apoptosis. These
results indicate that Stat3 signaling may have some crucial role for UV-response and it might
prevent excessive apoptosis by UV light, and may contribute to skin carcinogenesis.
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Anti-Photocarcinogenic Effects of Baicalein
A. Lazinsky, Y. Lu, W. Qiao, and H. Wei
Dermatology, Mount Sinai Medical Center, New York, New York
Baicalein is an active ingredient from Chinese herb Huang Qin (Scutellaria Baicalensis) and has
been shown to have anti-in¯ammatory and anticancer effects. In this study, the protective effects of
baicalein on ultraviolet B radiation (UVB)-induced skin carcinogenesis have been investigated.
Baicalein of 1 and 5 mmol in acetone or 0.1% and 0.5% in Lubrajel was applied to SKH-1 female
mice prior to escalating doses of UVB radiation ranging from 30 to 90 mJ per cm2 in two separate
experiments. The mice were treated biweekly for a period of 25 weeks. Topical application of
baicalein prior to UVB radiation delayed tumor expression as well as overall tumor numbers in a
dose-dependent manner in both experiments. Baicalein at 1 and 5 mmol in acetone offere 80%
protective effects, and baicalein at 0.1 and 0.5% in Lubrigel showed ~29% and ~44% average
inhibition, respectively. Further study revealed that baicalein signi®cantly inhibited UVB-induced
oxidative DNA damage as evidenced by substantial reduction of UVB-induced 8-hydroxy
deoxyguanosine in an in vitro system. In addition, baicalein was shown to down-regulate UVB-
mediated phosphorylation of epidermal growth factor receptor and activation of mitogen-activated
protein kinases. In conclusion, our studies demonstrate that herbal ¯avonoid baicalein prevents
UVB-induced skin carcinogenesis in hairless mice with inhibition of oxidative DNA damage as
anti-initiation, and down-regulation of transduction signaling cascades as antipromotion
mechanisms.
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EGF Receptor Transactivation Mediated by the Proteolytic Production of HB-EGF
(Heparin-Binding EGF-like Growth Factor) is Essential for TPA-Induced Keratinocyte
Migration
S. Tokumaru, Y. Hnanakawa, Y. Shirakata, N. Toriu, and K. Hashimoto
Dermatology, Ehime University, Ehime, Japan
12-O-tetradecanoylphorbol-13-acetate (TPA) regulates various biological functions through PKC
activation. In human keratinocytes, TPA induced keratinocyte migration in a dose-dependent
manner, with a 2-fold optimum at 10 ng per ml. Recently, it was reported that EGF receptor
(EGFR) transactivation was mediated by the proteolytic production of EGFR ligands, such as HB-
EGF. Speci®cally, extracellular stimuli unrelated to EGFR ligands induce shedding of EGFR
ligands, by converting the membrane-anchored form of EGFR ligands on the cell surface to the
soluble form. Then, released EGFR ligands bind to EGFR, resulting in EGFR activation. This
observation led us to hypothesize that TPA-induced keratinocyte migration is mediated by an
EGFR transactivation mechanism, since TPA is known to trigger HB-EGF shedding. First, we
analyzed the effect of TPA on HB-EGF shedding. Ten ng per ml TPA induced rapid shedding of
HB-EGF in a dose-dependent manner within 10±15 min Subsequent maximal activation of EGFR
was observed at 15 min OSU8-1, an HB-EGF shedding proteinase inhibitor (JCB, 151:209±219,
2000), almost completely inhibited TPA-induced keratinocyte migration as well as HB-EGF
shedding at 10 mM. In addition, anti-HB-EGF neutralizing antibody (10 mg per ml) inhibited TPA-
induced keratinocyte migration by 75%. To further con®rm the role of shed HB-EGF, the effect of
CRM197 was examined. CRM197, a nontoxic mutant of diphtheria toxin, speci®cally binds to
the EGF-like domain of HB-EGF and neutralizes the activity of human HB-EGF, but not other
EGFR ligands. CRM197 completely inhibited TPA-induced keratinocyte migration at 1 mg
per ml. Treatment with anti-EGFR neutralizing antibody (10 mg per ml) and EGFR kinase-speci®c
inhibitor AG1478 (30 nM) inhibited TPA-induced keratinocyte migration by 75 and 100%,
respectively. Taken together, these data demonstrate that HB-EGF shedding is essential for TPA-
induced keratinocyte migration. This is the ®rst report that EGF receptor transactivation mediated
by the proteolytic production of HB-EGF plays a central role in a biologically important
phenomenon of keratinocytes.
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Cell Cycle Alterations During Ultraviolet B-Induced Murine Skin Tumorigenesis
A. Kim, M. Athar, J. Gautier, and D. Bickers
Dermatology, Columbia University, New York, New York
Solar ultraviolet B (UVB) radiation causes extensive cellular DNA damage and the p53 tumor
suppressor gene plays a pivotal role in DNA repair, G1 cell cycle arrest, and apoptosis. p53
mutations and dysregulated cell cycle associated proteins have been implicated in the pathogenesis
of UVB-induced nonmelanoma skin cancer (NMSC). We have previously shown that in different
transformed human epidermoid cell lines lacking p53, UVB induces distinct p53-independent cell
cycle alterations. In this study, we evaluated the in vivo correlation between cell cycle alteration and
skin tumor development in SKH-1 hairless mice exposed to 180 mJ per cm2 of UVB radiation 5
days a week for 37 weeks in a complete carcinogenesis protocol. Cell cycle analysis of keratinocytes
from UVB-irradiated mice showed a gradual increase in S phase cells that correlated with
developing epidermal hyperplasia. Mcm5, involved in the initiation of DNA replication, was also
increased in the epidermis early in the course of UVB radiation, whereas Cdc6 was induced
primarily in papillomas/SCCs. The immunohistochemical distribution of p53 and cyclins A and
D1 was con®ned initially to sporadic single cells and gradually developed into foci of patchy,
intense staining in the basal and granular layers of UVB-exposed epidermis. p53 was expressed in
all papilloma sections examined, whereas cyclins D1 and A showed 68% and 71% staining in these
lesions, respectively. In UVB-induced SCCs p53 was strongly expressed in 90% of the tumors.
Patchy staining of cyclin D1 was detected in 55% of lesions, whereas cyclin A staining was limited
to 27%. Sequencing analysis of the p53 gene in UVB-induced tumors showed characteristic UVB-
induced mutations, comparable to immunohistochemical detection of mutant p53 protein using
mutant speci®c antibodies. Our data indicate that UVB-induced cell cycle dysregulation occurs by
multiple mechanisms and that cyclin A and Mcm5, as well as p53 are likely primary targets in
NMSC tumorigenesis.
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The B7/CTLA-4 Signaling Pathway Plays a Critical Role in Murine
Photocarcinogenesis
S. Beissert, J. Bluestone,* A. Sharpe,² T. Schwarz, and S. Grabbe
Department of Dermatology, University of Muenster, Muenster, Germany; *Diab. Center, UCSF, San
Francisco, California; ²Department of Path., Harvard U., Boston, Massachusetts
UV radiation (UVR) not only induces skin cancer by its direct mutagenic effects but also by
suppressing cellular immunity. Altered B7 costimulation plays a role in UV-induced
immunosuppression. Ligation of CD28 by B7 stimulates T cells, whereas B7/CTLA±4 interaction
inhibits T cell activation. To investigate B7/CTLA-4 signaling during photocarcinogenesis we
irradiated groups of mice with UVB 3x/ week for 6 months. To block B7/CTLA-4 signaling, one
group of mice was treated with an antagonistic anti-CTLA-4 Ab i.p. after UVR. Controls were
either injected with an irrelevant IgG Ab or left untreated. Chronic UVR induced tumor
development in all animals of both control groups. In contrast, in the anti-CTLA-4 Ab treated
group only 9 out of 20 mice developed skin tumors. Moreover, anti-CTLA-4 treatment induced
strong protective tumor immunity because UV-induced tumors which grew progressively in
control mice were rejected upon s.c. transplantation into anti-CTLA-4 treated animals. Since
CTLA-4 is able to bind to B7-1 and B7-2 surface molecules, we next used mice de®cient in both
B7-1 and B7-2 for photocarcinogenesis studies. Accordingly, B7 double-de®cient mice showed a
signi®cantly reduced skin tumor development. To clarify whether there are differences between
the two costimulatory B7 molecules in terms of UV-induced cutaneous carcinogenesis, mice
de®cient in either B7-1 or B7-2 were chronically UV-exposed. B7-1±/± mice displayed no
differences in UV-induced skin tumors compared to the controls. Interestingly, B7-2±/± mice
developed UV-induced skin cancer much earlier than the controls. Together, these data indicate
that blocking B7/CTLA-4 signaling by anti-CTLA-4 Ab induces immune protection against the
development of UV-induced skin tumors. Furthermore, B7-2-mediated costimulation appears to
play a more critical role in the protection against photocarcinogenesis than B7-1.
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ATR is Required for a Mitotic Entry Checkpoint that Prevents Premature Chromatin
Condensation after UV Exposure
P. Nghiem, P. Park, Y. Kim, C. Vaziri,² and S. Schreiber
Chemistry & Chemical Biology, Harvard University, Cambridge, Massachusetts; *Cutaneous Oncology,
Dana-Farber Cancer Institute, Boston, Massachusetts; ²Cancer Research Center, Boston University, Boston,
Massachusetts
ATR (Ataxia Telangiectasia and Rad3-related) is homologous to yeast protein kinases required for
survival after UV. In a separate abstract we describe the generation of stable human cell lines
inducible for wild type or a dominant negative (kinase dead) isoform of ATR. Expression of the
kinase dead isoform (ATR- kDa) markedly sensitized cells to multiple types of DNA damage but
did not affect p53 function or G1 arrest after damage. Without damage, ATR- kDa had no effect
even when expressed for two weeks. In the presence of low dose damage (UV, ionizing radiation
or hydroxyurea), ATR- kDa expressing cells underwent profound chromosomal fragmentation as
revealed by mitotic spreads. This fragmentation was analogous to that described as ``premature
chromatin condensation'' (PCC) induced by caffeine and DNA damage (Schlegel & Pardee,
Science, 1986). Caffeine has recently been shown to inhibit ATR protein kinase activity in vitro.
Indeed, we ®nd in vivo that ATR- kDa promoted caffeine's ability to sensitize to DNA damage,
while ATR-wt rescued cells from this radiosensitizing effect of caffeine. Cell synchronization
experiments showed that ATR is most important in mid-S phase to prevent PCC and apoptosis.
Consistent with a presumed role downstream of ATR, adenoviral expression of the kinases Chk-1
or Chk-2 rescued PCC caused by ATR- kDa, while expression of the dominant negative isoforms
of these kinases promoted PCC. Because they often lack a DNA damage-responsive G1
checkpoint, cancer cells are often more sensitive to the loss of later cell cycle checkpoints than
normal cells. We mimicked the loss of the G1 checkpoint by adenoviral expression of G1/S cyclins
(cyclin E or CDK2). Indeed, expression of these cyclins synergized with ATR inhibition to cause
increased sensitivity to damage. This result coupled with the sensitivity of S phase cells to ATR
inhibition suggests ATR as a possible target for a radiosensitizing agent. We conclude that ATR
plays an essential role in a checkpoint which prevents lethal premature mitosis in cells which have
received low dose DNA damage.
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The C-Kit Signaling Pathways in Normal and Mastocytosis Mast Cells
I. Chan, K. Kayashima, Y. Ma,* B. Longley,* and M. Tharp
Dermatology, Rush-Presbyterian-St-Luke's Medical Center, Chicago, Illinois; *Dermatology, College of
Physicians & Surgeons of Columbia University, New York, New York
The C-kit receptor is a tyrosine kinase vital in the development and survival of mast cells (MCs).
Mutated c-kit autoactivation is associated with the development of adult mastocytosis. Mitogen
activated kinases (MEKs) and Janus kinases (JAKs) are pivotal enzymes in c-kit signaling pathways.
We examined the roles of JAK-3 and MEKs on the proliferation of mastocytosis cell lines HMC-1
and RMT, which express autoactivated c-kit. When added to these cells for 3 days, the JAK-3
inhibitor WHI-P131 (5 and 20 mM) decreased the number of HMC-1 by 53 6 14% and 61 6 19%
and RMT by 46 6 8% and 58% 6 19%, when compared to controls. The MEKs inhibitor UO126
(5 and 20 mM) also reduced the growth of HMC-1 (47 6 7% and 54 6 11%) and RMT (23 6 9%
and 33 6 10%). When stem cell factor (SCF, 30 ng per ml) was added to these cultures, it did not
signi®cantly reverse the growth inhibiting effects of both WHI-P131 and UO126. Neither
inhibitor induced signi®cant cell death in these cultures. We also investigated the role of c-kit on
normal skin MCs using in vitro MC maturation model. When added to neonatal foreskin cell
cultures that containing MC precursors for 7 days, SCF (30 ng per ml) enhanced the number of
mature MCs to 34 6 15% above controls. The JAK-3 inhibitor did not alter this SCF maturation
effect. These results demonstrate that JAK-3 and MEKs are important enzymes in the signaling
pathways of auto-activated c-kit. Since their inhibition results in decreased mastocytosis MC
proliferation, the primary role of these kinases appears to be in cell division. In contrast, JAK-3
appears play little role in normal skin MC maturation because inhibition of the enzyme did not
reduce the number of mature MCs in culture. We conclude that c-kit play an important role in
MC proliferation and maturation, but the c-kit signaling pathways for MC proliferation and
maturation differ.
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Differences in Proliferation and Maturation Between Normal and Mastocytosis Mast
Cells
K. Kayashima, I. Chan, and M. Tharp
Dermatology, Rush-Presbyterian-St-Luke's Medical Center, Chicago, Illinois
We have examined the development of mast cells (MCs) in normal skin and mastocytosis lesions by
analyzing the expression of proliferative cell nuclear antigen (PCNA) and the BCL-2 oncoprotein
with speci®c mAbs. MCs were identi®ed with conjugated avidin and mAbs for chymase and
tryptase. In normal skin, less than 2% of MCs expressed PCNA and all cells were BCL-2-negative,
whereas 30±95% of mastocytosis lesional skin MCs expressed PCNA and 10±45% of these MCs
were BCL-2 positive. To con®rm these observations in vitro, normal skin MCs in culture and the
mastocytosis cell lines (HMC-1 and RMT) with activating c-kit mutations were also examined.
Normal skin MCs cultured in medium alone had less than 2% PCNA-expression and all of these
cells were BCL-2-negative. With the addition of stem cell factor (SCF, 30 ng per ml) to these cells
for 7 days, 25% of normal MCs expressed PCNA, but none dividing MCs were observed and the
total number of MCs decreased by 8% when compared to the added number of cells at day 0. All
these cells remained BCL-2-negative. In contrast, more than 95% of the mastocytosis cell lines
expressed both PCNA and BCL-2. The results of this study indicate that mastocytosis MCs with c-
kit auto-activation in tumor and culture are highly proliferative and these cells may avoid apoptosis
by expressing BCL-2 oncoprotein. In contrast, normal skin MCs in tissue and culture appear to
have very low proliferation activity and do not express BCL-2. These latter observations have led
us to propose that SCF activation of c-kit in normal skin MCs leads primary to maturation rather
than proliferation.
598
Folliculotropic Mycosis Fungoides with Central Nervous System Involvement
M. Ke, N. Kamath, M. Nihal,³ D. Mikkola,³ O. Koc,² S. Stevens, A. Gilliam, K. Cooper, and G.
Wood
Dermatology Case Western Reserve University, Cleveland, Ohio; *Pathology, Case Western Reserve
University, Cleveland, Ohio; ²Medicine, Case Western Reserve University, Cleveland, Ohio;
³Dermatology, Louis Stokes Department of Veterans Affairs Medical Center, Cleveland, Ohio;
§Dermatology, Department of Veterans Affairs Medical Center, Madison, Wisconsin; ¶Dermatology,
University of Wisconsin, Madison, Wisconsin
Folliculotropic mycosis fungoides is a rare variant of cutaneous T-cell lymphoma, mycosis
fungoides (MF) type characterized by atypical lymphocytes preferentially in®ltrating the hair
follicle epithelium relative to the epidermis. We describe the ®rst case in which laser capture
microdissection was used to show that the atypical lymphocytes within the hair follicle epithelium
were part of the same tumor clone as those in the epidermis and the patient's blood. This is also the
®rst case of folliculotropic mycosis fungoides with involvement of the central nervous system. The
successful procurement and analysis of atypical lymphocytes from hair follicle epithelium by laser
capture microscopy ushers in a new era in molecular diagnostics. In reviewing the literature
describing atypical lymphocytes in®ltrating hair follicle epithelium relative to the epidermis, we
encourage the use of the term ``folliculotropic MF.'' Our case also supports previous ®ndings in
classic MF patients that CNS involvement can occur in advanced disease.
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Up-Regulated L-Selectin and Diminished Integrin Expression in SeÂzary Cells:
Functional Consequences Under Physiologic Shear Stress Conditions
S. Hwang and D. Fitzhugh
Dermatology Branch, National Cancer Institute, Bethesda, Maryland
Although aberrations in adhesion molecule expression by lymphoma cells have been reported, the
functional consequences of these changes are unclear. Herein, we report a patient with SeÂzary
syndrome whose peripheral blood T cells (90%) consisted of a TCRVb17+ malignant clone as
detected by TCRVb-speci®c mAb. Thin plaques which showed a dense in®ltrate of TCRVb17+
cells were present on 70% of the patient's body surface. By ¯ow cytometry, peripheral blood
malignant T cell adhesion molecule abnormalities included an 80% down-regulation of LFA-1
compared to normal controls and no detectable expression of a4 integrin. Under shear stress
conditions (1.5 dynes per cm2) in a parallel plate ¯ow chamber, malignant T cells failed to arrest on
recombinant ICAM-1 in the presence of several chemokines and displayed an 80% decrease in the
ability to arrest on TNF-a activated dermal microvascular endothelial cells compared to normal
CD4+ memory T cells (mTC). Cutaneous lymphocyte-associated antigen (CLA) expression was
detected in ~25% of malignant T cells in the peripheral blood, but was expressed in < 10% of
TCRVb17+ T cells in the dermis. By contrast, 95% of malignant T cells in peripheral blood
expressed L-selectin (CD62L), and (as others have reported with CTCL) L-selectin ligand was
detected in dermal blood vessels at affected skin sites by MECA79 mAb. Compared to normal
CD4+ mTC, malignant T cells expressed 2-fold more L-selectin and rolled in 6-fold greater
numbers/unit area on L-selectin ligand (n = 5, p < 0.0001). Thus, aberrant expression of integrins
led to striking defects in SeÂzary cell arrest on activated endothelial cells in vitro. Malignant T cells in
this patient, however, entered skin and produced signi®cant clinical disease. We propose that up-
regulated expression of L-selectin may be a novel mechanism by which malignant T cells may
target skin in greater numbers and compensate for diminished integrin expression.
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Borrelia Burgdorferi is Absent in Cutaneous B-Cell Lymphomas within the United
States
N. Kamath, G. Wood,² J. Guitart,§ B. Smoller,¶ S. Kohler, P. Heald, and L. Cerroni
Dermatology, Case Western Reserve University, Cleveland, Ohio; *Dermatology, Louis Stokes Veterans
Affairs Medical Center, Cleveland, Ohio; ²Dermatology, University of Wisconsin, Madison, Wisconsin;
³Dermatology, Veterans Affairs Medical Center, Madison, Wisconsin; §Dermatology, North-western
University, Chicago, Illinois; ¶Dermatology, University of Arkansas, Little Rock, Arkansas;
**Dermatology, Stanford University, Stanford, California; ²²Dermatology, Yale University, New Haven,
Conneticut; ³³Dermatology, University of Graz, Graz, Austria
An association between Borrelia burgdorferi and cutaneous B-cell lymphoma (CBCL) has been
made in several European countries. The evidence in favor of such an association has recently been
based on more de®nitive tests for the pathogenetic role of Borrelia burgdorferi in CBCL, including
positive cultures or PCR ampli®cation of borrelial DNA from lesional skin. However, there has
been only one negative report of Borrelia burgdorferi in ®ve North American cases of CBCL.
Therefore, we retrieved 38 cases of primary and secondary CBCL from different geographic
locations of the United States. Two separate techniques were used to detect borrelial DNA by
PCR, a nested PCR method to amplify a Borrelia burgdorferi-speci®c gene as well as a borrelial
chromosomal Ly-1 clone ampli®cation method. Southern blot hybridization was used for
con®rmation of the PCR results. No Borrelia burgdorferi-speci®c DNA was detected in any of the
38 CBCL cases, whereas detectable PCR products were obtained with our positive controls. Our
®ndings suggest that Borrelia burgdorferi plays no role in the development or pathogenesis of
CBCL in the United States. The ®ndings also suggest that the geographic variation of the clinical
manifestations of Borrelia burgdorferi is indeed real and may be secondary to the genetic and
phenotypic differences between species present in Europe and North America.
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